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Mast cells contribute to numerous physiological processes and diseases including 
immunological and neurological roles. Mast cells degranulate, releasing potent mediators, 
following signal transduction initiated by receptor crosslinking. Previously, we showed that the 
environmental toxicant arsenic and the antibacterial agent triclosan inhibit mast cell 
degranulation; thus, we have investigated the mechanisms underlying their inhibitory action. We 
have discovered that arsenic targets early steps in the mast cell signaling pathway: it inhibits 
phosphorylation of early tyrosine kinase Syk and of Syk’s direct substrate PI3K. Arsenic’s 
tyrosine phosphorylation inhibition causes inhibition of calcium influx into the cytosol, a key 
event necessary for degranulation.   
Pharmaceutical agent triclosan also inhibits calcium influx but, in contrast to arsenic, 
does not inhibit early steps in the pathway. We have discovered that one of triclosan’s targets in 
the mast cell signaling pathway is phospholipase D (PLD): PLD activity is decreased by 
triclosan. Triclosan does not inhibit activity of key enzyme protein kinase C but does delay its 
translocation to the plasma membrane and translocation of its substrate MARCKS to the cytosol.  
In addition, we have shown that another mechanism of triclosan toxicity, mitochondrial 
uncoupling, also occurs in vivo. We developed a high-throughput assay to measure bioenergetics 
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of living zebrafish embryos and showed that triclosan exposure decreases ATP production 
without causing mortality of zebrafish.  
Finally, in preparation for comparative studies of toxicant effects on mast cells in vivo 
using zebrafish and in vitro using the mast cell model RBL-2H3, we aimed to develop a tryptase 
assay of mast cell degranulation that could be used in both systems. However, we discovered that 
RBL-2H3 cells express neither mRNA nor protein of several tryptase genes. Overall, the 
findings in this thesis provide biochemical and cellular explanations for known human health 
effects of triclosan and arsenic and set the stage for future comparative toxicology studies of 
mast cell function. 
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CHAPTER 1 
INTRODUCTION 
1.1 Mast cell signaling pathway 
1.1.1 Mast cell 
Mast cells (MCs) are immune-effector cells that are well-known for their roles in allergic 
reactions. MCs are present in all chordates, which possess a notochord (Kuby, 1997;  Prykhozhij 
and Berman, 2014). Chordates include the vertebrates, the urochordate (e.g. sea squirts), and the 
cephalochordates (e.g. lancelets), thus MCs are likely one of the most conserved immune cells, a 
fact which implies their crucial roles evolutionarily in an organisms’ survival and function. In 
fact, not only are MCs found in most species, but also found in nearly every tissue (Kuby, 1997). 
They are involved in myriad physiological and pathophysiological processes, including 
host defense against infectious agents, innate and acquired immunity, homeostatic responses, 
wound repair, tissue remodelling, allergy, asthma, autoimmunity, infectious disease, cancer, 
inflammatory bowel disease, and even central nervous system disorders such as autism, anxiety, 
and multiple sclerosis (Metcalfe et al., 1997;  Williams and Galli, 2000;  Galli et al., 2005a;  
Silver and Curley, 2013;  Girolamo et al., 2017).  
These diverse actions of MCs result from diverse mediators released from MCs. In 
response to a wide range of stimuli, MCs degranulate, secreting stored mediators in cytoplasmic 
granules, such as histamine, neutral protease (e.g. chymase, tryptase, carboxypeptidase), β-
hexosaminidase, serotonin, heparin, and some cytokines (Schwartz and Austen, 1980). Also, 
activated MCs can synthesize cytokines, chemokines, lipid mediators, and other inflammatory 
mediators de novo (Galli et al., 2005a;  Shelburne and Abraham, 2011). MCs derive from 
hematopoietic cells in the bone marrow and migrate to various tissues for maturation (Rodewald 
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et al., 1996;  Chen et al., 2005). MCs are found in nearly all tissue types, including at interfaces 
with the environment, such as skin, gastrointestinal linings, oral mucosa, blood capillaries, 
lymphatic vessels, and near nerve terminals (Theoharides et al., 2012a;  Blank and Benhamou, 
2013). This positioning is advantageous for MCs to serve as a first line of defense to pathogens 
and to coordinate inflammatory reactions to outside stimuli (Abraham and St John, 2010).  
MCs are phenotypically and functionally heterogeneous depending on the 
microenvironment in which they mature. Thus the ubiquity of MCs’ presence among species and 
tissues have induced different MC subtypes, while some of basic constituents of MCs are still 
conserved (Baccari et al., 2011). For example, human MCS are subcategorized into MCTC and 
MCT, by the presence of proteases (Irani et al., 1986). Tryptase is often utilized as a granule-
associated MC marker since it is presented all human MC subtypes.  
Since the discovery of MC by Paul Ehrlich in 1878, many studies on MC biology and 
function have been reported. Because of difficulty in isolation and culturing primary mast cells, 
several immortalized mast cell models have been established, including rat basophilic leukemia-
clone 2H3 (RBL-2H3), human HMC-1, and human LAD2. MCs contain several extracellular 
receptors including the FcεRI, Toll-like receptors, interleukin receptors, c-kit receptor, and more 
(Metcalfe, 2008;  Passante et al., 2009). Among those mast cell models, RBL-2H3 cells are the 
most commonly utilized for over 40 years, since they are easy to grow, display mature mast cell 
characteristics, have robust expression of the high affinity receptor for IgE (FcεRI) on the plasma 
membrane, and most importantly encompass core signaling machinery of human mast cells 
(Barsumian et al., 1981). Therefore, RBL-2H3 (“RBL”) cells have been extensively used to 
study interactions of IgE high affinity receptor FcεRI with its ligands and the signaling pathway 
leading to degranulation is well-described. Other mast cells also have been employed in MC 
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studies; however, each has its own limitations: HMC-1 cells are poorly granulated and lack 
FcεRI (Nilsson et al., 1994) and LAD2 cells require long doubling time (> 2 weeks). 
Measurement of degranulation from RBL cells is typically performed by quantifying the release 
of β-hex or histamine, which will be detailed later in this chapter. 
 
1.1.2 Mast cell signaling 
Degranulation is classically initiated by antigen (Ag)-crosslinking of immunoglobulin E 
(IgE)-bound FcεRI receptor (Kuby, 1997). FcεRI is a tetrameric receptor composed of one 
extracellularly-exposed α chain plus membrane-spanning β (one) and γ (two) chains (Metzger et 
al., 1982;  Metzger et al., 1986;  Ravetch and Kinet, 1991). FcεRI β and γ subunits possess 
cytoplasmic immunoreceptor tyrosine-based activation motifs (ITAMs) (Reth, 1989;  Cambier, 
1995;  Daeron, 1997). Antigen crosslinking of FcεRI causes phosphorylation of ITAMs by non-
receptor protein tyrosine kinase (PTK) Lyn (Xiao et al., 2005). Phosphorylated ITAMs bind 
proteins with Src-homology-2 (SH2) domains, leading to activation (Cohen et al., 1995;  
Furumoto et al., 2004;  de Castro et al., 2010;  Siraganian et al., 2010). Phosphorylated sites on  
become docking areas for another PTK spleen tyrosine kinase (Syk), which contains an SH2 
domain (de Castro et al., 2010;  Siraganian et al., 2010).  Binding to FcεRI causes a 
conformational change in Syk, resulting in autophosphorylation (Benhamou et al., 1993;  
Minoguchi et al., 1994;  Pribluda et al., 1994;  Zhang et al., 2000) and results in Syk’s 
phosphorylation/activation by Lyn. 
In addition to the Lyn-propagated signaling pathway, the complementary PTK Fyn pathway is 
initiated upon FcεRI receptor aggregation (Rivera and Gilfillan, 2006). Fyn signaling leads to 
activation of the phosphatidylinositol-3-OH kinase (PI3K) pathway (Gu et al., 2001). 
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Importantly, Syk is essential for FcεRI-mediated signaling in mast cells since Syk is required for 
both Lyn-directed and Fyn-directed pathways (Costello et al., 1996;  Zhang et al., 1996).  
 
Figure 1. 1. Overview of the mast cell degranulation signaling pathway. 
Crosslinking of IgE-bound FcεRI by multivalent antigen (Ag) results in phosphorylation 
cascade to activate several enzymes (Lyn, Syk, PI3K and PLCγ). Activated PI3K generates 
PIP3 from PIP2. PLCγ hydrolyzes PIP2 to DAG and IP3. IP3 binds to its cognate receptor on 
the ER, causing depletion of Ca2+ from internal ER storage to the cytosol, resulting in STIM1 
(calcium sensor in the ER membrane) interaction with Orai1 (subunit of CRAC channel) for 
influx of Ca2+ across plasma membrane into the cell. ER stores get replenished by reuptake 
of cytosolic Ca2+ into the ER through SERCA pump. Ca2+ and/or DAG activate PKC. 
Activated PKC translocates from cytosol to the plasma membrane where it phosphorylates 
substrates in its proximity, such as MARCKS, which tightly binds to PIP2. Phosphorylated 
MARCKS dissociates from the plasma membrane and enters the cytosol, thus exposing PIP2 
to be accessible to other proteins. Another major target of PKC is PLD, which is localized 
either to cytoplasmic granules or at the plasma membrane, to facilitate granule translocation 
and fusion to the plasma membrane. Granules are mobilized along with microtubules for 
degranulation. Degranulation process generates and requires ROS.   
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Activated Syk phosphorylates the adaptor protein linker for activation of T cells (LAT) 
(Saitoh et al., 2003), which physically brings together proteins such as Grb2 (Growth factor 
receptor-bound protein 2), Gads, SLP-76, Vav, and the enzyme phospholipase C γ (PLC γ). 
Next, PLC 1 is phosphorylated by Syk or by a Tec family tyrosine kinase, Itk (Interleukin-2-
inducible T-cell kinase) or Btk (Bruton’s tyrosine kinase) (Ishiai et al., 2000). Gads (Grb2-
related adaptor downstream of Shc) binds SLP-76 (SH2 domain-containing leukocyte protein of 
76 ) (Ishiai et al., 2000), which is phosphorylated by Syk and then which binds Btk and Vav 
(Kettner et al., 2003). Next, Lyn phosphorylates and activates Btk, which activates PLC 1 
(Benhamou et al., 1992;  Beaven and Metzger, 1993) via its Pleckstrin Homology (PH) domain. 
Btk binds to plasma membrane lipids phosphatidylinositol 4, 5-bisphosphate (PIP2) and 
phosphatidylinositol 3, 4, 5-trisphosphate (PIP3) (Fluckiger et al., 1998;  Scharenberg and Kinet, 
1998). 
Syk activates PI3K, which converts PIP2 into PIP3 (Kitaura et al., 2000). PIP3 activates 
Rac/Rho GTPases resulting in remodeling of the actin cytoskeleton, also called membrane 
ruffling (“ruffles” of the polymerized actin cytoskeleton) (Hawkins et al., 1995;  Parker, 1995). 
PI3K also activates sphingosine kinase-S1P (sphingosine-1-phosphate), which produces S1P, 
thus supporting Ca2+ mobilization (Choi et al., 1996;  Melendez and Khaw, 2002;  Urtz et al., 
2004), protein kinase C (PKC) activation, and degranulation (Olivera et al., 2007).   
PLC γ hydrolyzes PIP2 to yield inositol-1, 4, 5-trisphosphate (IP3) and diacylglycerol 
(DAG). IP3 then binds to its receptor IP3R in the endoplasmic reticulum (ER) membrane, thereby 
releasing Ca2+ from ER to the cytosol (Berridge, 1993;  Taylor and Thorn, 2001). This emptying 
of ER Ca2+ leads to second influx of Ca2+ across the plasma membrane into the cytosol through 
calcium release-activated calcium (CRAC) channels. STIM-1 (Stromal interaction molecule 1) in 
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the ER membrane and Orai1 (the pore subunit of CRAC channels) are responsible for this event.  
When ER Ca2+ is depleted, STIM1 goes through a conformational change (Liou et al., 2005;  
Fahrner et al., 2013) and binds to Orai1(Feske et al., 2006;  Vig et al., 2006). This interaction 
causes opening of CRAC channels, inducing a flood of extracellular Ca2+ coming into the cytosol 
(Roos et al., 2005;  Hogan et al., 2010), which is termed “store operated calcium entry” (SOCE) 
(Putney, 1986;  Putney, 1990;  Clapham, 1995). Sarco/endoplasmic Ca2+-ATPase (SERCA) 
pumps refill Ca2+ into the ER after cytosolic Ca2+  influx (Ma and Beaven, 2011), for later usage.  
Replenishment of the ER Ca2+ can be inhibited by selective SERCA inhibitor thapsigargin, 
which will be utilized in Chapter 2 for arsenic mechanism studies (Thastrup et al., 1990;  Lytton 
et al., 1991).  
Another of PLC γ’s products, DAG, along with elevated Ca2+ and reactive oxygen 
species (ROS), are involved in activation of PKC. It has been known that intracellular ROS is 
generated as well as required during mast cell degranulation (Swindle et al., 2004;  Min and 
Shin, 2009;  Weatherly et al., 2018).  PKC is family of Ser/Thr kinases, which is categorized into 
three subfamilies, classical (cPKC), novel (nPKC), and atypical (aPKC), based on their 
biochemical and structural properties of their bindings to DAG and/or Ca2+ (Ozawa et al., 1993b;  
Newton, 1995;  Newton, 2001). The cPKC isoforms (PKC α, βI, βII, and γ) contain conserved 
functionally active C1 domains (which bind DAG) (Newton, 2001) as well as C2 domains 
(which bind Ca2+ and acidic phospholipids). The nPKC isoforms (PKC δ, ε, θ, and η) contain the 
C1 domain, but lack functional C2 domains, thus, are activated by DAG and unresponsive to 
Ca2+ (Newton, 1995).  
PKC β (cPKC) and δ (nPKC) are particularly important in IgE–mediated degranulation 
and ruffling (Nechushtan et al., 2000;  Cho et al., 2004). Activation of PKC changes its affinity 
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to the plasma membrane, causing to translocate to the plasma membrane. Translocated PKC is 
then fully active via conformational changes to reveal its active site (Newton, 2010). Stimulation 
of RBL-2H3 cells causes a rapid translocation of PKC δ from the cytosol to the plasma 
membrane (Cho et al., 2004). Also, PKC δ translocation and degranulation are inhibited by ROS 
attenuation (Cho et al., 2004). Myristoylated alanine-rich C-kinase substrate (MARCKS) is one 
of the abundant PKC substrate (Aderem, 1992). MARCKS tightly binds to PIP2 at the plasma 
membrane in unstimulated cells (Heo et al., 2006). In stimulated MCs, translocated PKC 
phosphorylates MARCKS, which dissociates from the plasma membrane, thus exposing PIP2 to 
be accessible to other proteins (e.g. PLC γ) for sustained signaling for degranulation (Gadi et al., 
2011). Also, PIP2 is necessary in assembly of the soluble N-ethylmaleimide–sensitive factor 
attachment protein receptor (SNARE) machinery required for degranulation (Tadokoro et al., 
2015).   
Another target of activated PKC is phospholipase D (PLD) in mast cells (Lin and 
Gilfillan, 1992) . PLD hydrolyzes phosphatidylcholine (PC) into phosphatidic acid (PA), which 
plays important roles as a second messenger for diverse cellular functions(Wakelam et al., 1997;  
Cockcroft, 2001;  O'Luanaigh et al., 2002;  Zeniou-Meyer et al., 2007).  Also PA can be 
converted to DAG by PA phosphohydrolase, resulting in a secondary rise in DAG levels in the 
cells (Nakashima et al., 1991;  Lin et al., 1992), important for the sustained activation of the 
DAG-dependent PKC isoforms (Baldassare et al., 1992;  Nishizuka, 1995;  Peng and Beaven, 
2005).  Additionally, PA plays a critical role in regulating mast cell morphology (Marchini-
Alves et al., 2012). Structurally, mammalian PLD contains lipid (PIP3 and PIP2) -binding 
domains and a PKC-binding domain, but lacks a Ca2+ binding domain (Henage et al., 2006;  
Selvy et al., 2011). However, studies showed that Ca2+ and PIP2 act as crucial cofactors for 
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mammalian PLD activation (Sciorra et al., 2002;  Henage et al., 2006;  Selvy et al., 2011), even 
though mammalian PLD activity is insensitive to changes in cytosolic Ca2+ concentration in vitro 
(Hammond et al., 1997). 
Also several studies showed that PLD can be activated by agents to elicit intracellular 
Ca2+ rise, such as Ca2+  ionophore (Lin and Gilfillan, 1992), thapsigargin (Cissel et al., 1998) and 
PMA (Lin and Gilfillan, 1992). In addition, compound 48/80, a MC secretagogue, induces PLD 
activation (Chahdi et al., 2000).  
Mammalian PLD is expressed as two isoforms: PLD1 has low basal activity and is 
located at the cytoplasmic granules. In stimulated MC, PLD1 undergoes translocation to the 
plasma membrane (Choi et al., 2002;  Lee et al., 2006). PLD2 is constitutively expressed near 
the plasma membrane (Choi et al., 2002;  Lee et al., 2006). These spatial distinctions of two 
isoforms have led scientists to postulate that PLD1 is involved in granule translocation to the 
plasma membrane while PLD2 is involved in membrane fusion of MC granules (Choi et al., 
2002).  However, a recent study using PLD1- and PLD2-knockout mice found that PLD1 is a 
positive regulator in MC degranulation, but PLD2 is a negative regulator, since PLD2 deficiency 
enhanced microtubule formation (Zhu et al., 2015).    
MC granule transport is facilitated by microtubules, while granule docking and fusion to 
the plasma membrane is assisted by SNARE complexes (Guo et al., 1998;  Baram et al., 1999;  
Paumet et al., 2000;  Blank et al., 2002;  Logan et al., 2003;  Puri and Roche, 2008;  Tiwari et al., 
2008;  Woska and Gillespie, 2012). Microtubule polymerization is indispensable for 
degranulation (Urata and Siraganian, 1985;  Tasaka et al., 1991;  Marti-Verdeaux et al., 2003;  
Smith et al., 2003). SNAREs are  located on vesicular (v-SNAREs) and target membranes (t-
SNAREs) (Woska and Gillespie, 2012) and mediates the final stages of priming, docking, and 
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fusion of granules with the plasma membrane (Puri and Roche, 2008). SNAREs form a complex 
by direct interaction with synaptotagmins (Syts) with help of PIP2 (Dai et al., 2007a;  Tadokoro 
et al., 2015). Syt is a Ca2+ sensor protein, which contains C2 calcium-binding domains (Dai et 
al., 2007a). Even though Syts were first characterized as a neuronal Ca2+ sensor in the pre-
synaptic axon terminal, several studies have identified Syts homologs in MCs (Baram et al., 
1998;  Baram et al., 1999;  Baram et al., 2001;  Kimura et al., 2001). In addition, a study 
revealed that PIP2 enhanced synaptotagmin- SNARE-mediated membrane fusion of MC granules 
only in the presence of Ca2+ (Tadokoro et al., 2015).  Therefore, the components of a quaternary 
complex (SNARE- PIP2- synaptotagmin- Ca
2+) are all necessary for granule docking, fusion and 
exocytosis. 
The result of mast cell signaling is degranulation, but also causes F-actin polymerization 
simultaneously. PI3K activation of Rac/Rho GTPases leads to actin rearrangements, resulting in 
membrane “ruffling,” or the rearrangement of the actin cytoskeleton. Lamellipodia that fail to 
establish stable adhesions become detached from the substrate and retracted toward the cell 
body; during this retraction process, actin-rich membrane protrusions, or membrane ruffles, are 
formed (Giannone et al., 2007). Ruffles are compartments of active actin reorganization (Borm 
et al., 2005). Actin cytoskeletal rearrangement is not an essential element of the degranulation 
pathway (degranulation occurs even when ruffling is stopped by actin inhibitor cytochalasin D 
(Holowka et al., 2000)), but the two share common events such as activation of PKC and influx 
of Ca2+ (Pfeiffer et al., 1985;  Yanase et al., 2011). A recent study has shown that the use of 
inhibitors of PKCβ and PKCα inhibited both ruffling and degranulation. The Rho guanine 
nucleotide exchange factor Vav and also Cdc42 have been shown to be associated with mast cell 
degranulation and ruffling (Guillemot et al., 1997;  Pivniouk et al., 2003;  Zeng et al., 2003).  
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PLD2 also is important for membrane ruffle formation, in a mechanism involving PLD2 
interactions with Grb2 and Rac (Mahankali et al., 2011).  
 
1.1.3 Mast cell granule-associated mediators  
Most of the physiological and pathophysiological functions of mast cells are closely 
associated with the actions of the myriad immunomodulatory granule mediators. The preformed 
and pre-activated compounds in the granules are released rapidly (~seconds to minutes) for 
immediate and acute reactions, such as alteration of vascular permeability, vasodilation, and 
adhesiveness (Metcalfe et al., 1997;  Theoharides et al., 2012a). These mediators include 
histamine, proteases (tryptase, chymase, carboxypeptidase A and cathepsin G), β-
hexosaminidase, proteoglycans (heparin), serotonin, and some cytokines (e.g. tumor necrosis 
factor-α [TNF-α] (Olszewski et al., 2006;  Olszewski et al., 2007), Interleukin-4 [IL-4] (Wilson 
et al., 2000;  Hines, 2002).  Newly synthesized mediators are also released to the extracellular 
environment, such as  leukotriene C4 (LTC4), prostaglandin D2 (PGD2), platelet-activating factor, 
chemokines, and other cytokines (Metcalfe et al., 1997;  Galli et al., 2005b), which plays an 
immunoregulatory function by recruiting macrophages, neutophils, dendritic cells and T-cells to 
the site of infection (Abraham and St John, 2010). 
Histamine is probably the most well-known pro-inflammatory granule-associated 
mediator, but it is not exclusively released by mast cells. The action of histamine is local and 
short-lived since it gets rapidly degraded upon release (Hines, 2002), which is modulated by 
binding to its receptors (H1, H, H3 and H4), found in many cell types, such as smooth muscle, 
epithelia, and neurons, causing vasodilation, bronchoconstriction, and edema (Theoharides et al., 
1982). Furthermore, these histamine receptors are expressed in other immune cells, including 
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neutrophils, eosinophils, lymphocytes, and macrophages, implying that histamine can modulate 
the function of these cells (Carlos et al., 2006). 
Many MC granule constituents are proteases, in particular, tryptase and chymase. 
Positively charged granule proteases bind tightly to negatively charged proteoglycans, which 
serve as a scaffold for stable complexes of charged molecules (Pejler et al., 2007).  
Mast cell tryptase is a family of trypsin-like serine proteases (Caughey, 2011) that cleave 
sites after basic amino acids such as Arg and Lys (Lehninger et al., 2005). Tryptase requires the 
proteoglycan heparin to be enzymatically active (Hallgren et al., 2001). In general, tryptases can 
be grouped into three main types, α (I-II), β (I-III), and γ (transmembrane). The main tryptases in 
humans are β-tryptases, which are the products of two genes, TPSB2 and TPSAB1 (Caughey, 
2011). The orthologues of β-tryptases are found in mouse and rat, which are mMCP-6, mMCP-7, 
Tpsb2, and Tpsab1. Tryptase acts upon many substrates, receptors and zymogens (Schwartz, 
1990), leading to host defense, tissue -remodeling/repair, pro-inflammatory as well as anti-
inflammatory reactions (Caughey, 2007). For example, lung tryptase elicits bronchial 
constriction to protect airways from entry of pathogens or foreign substances, by degrading 
bronchodilating peptides (Tam and Caughey, 1990), cleaving extracellular matrix in the 
bronchial wall (Gruber et al., 1989), or activating protease-activated receptor (PAR)-2 which 
modulates inflammatory responses (Dai et al., 2007b). Another important role of tryptase is 
wound healing and tissue remodeling, by promoting the proliferation of fibroblasts and type 1 
collagen production (Hartmann et al., 1992). Anti-inflammatory action of tryptase is also 
reported that tryptase destroys pro-inflammatory cytokines, such as IL-6, IL-13 and TNF-α, 
consequently reducing inflammation (Zhao et al., 2005). Intriguingly, tryptase is closely related 
to neurological diseases, such as schizophrenia and multiple sclerosis (MS). In MS, tryptase level 
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is remarkably elevated (Rozniecki et al., 1995). In murine models, β-tryptase expression is 
upregulated during the inflammatory reaction against a parasitic infection (Ide et al., 1995) and 
formation of keloid tissue (Ong et al., 2010).  Overall, tryptase is a crucial player in 
inflammation, tissue homeostasis, and innate immunity. 
Because MC tryptase is an abundant mediator unique to mast cells, it serves as a 
canonical biomarker for anaphylaxis, mastocytoma, and systemic mastocytosis. In clinical 
settings, tryptase level in the patient plasma is measured for diagnosis of MC diseases 
(Bussmann et al., 2007).  In the laboratory, active tryptase can be measured by incubation with a 
substrate such as N-α-benzoyl-DL-Arg-p-nitroanilide (BAPNA) or tosyl-Gly-Pro-Lys-p-
nitroanilide: tryptase cleaves the bond between the Arg or Lys and the p-nitroaniline (pNA), 
releasing chromogenic pNA, measurable in a plate reader (Lavens et al., 1993).  
Another serine protease, chymase, also participates in anti- and pro-inflammatory 
reactions and host defense.  It facilitates maintenance of gut barriers, bronchoconstriction, 
vasoconstriction, and defense against parasites (Nakano et al., 1997;  Caughey, 2007).  Chymase 
along with carboxypeptidase A3 play a prominent role in degrading venom-associated peptides 
and toxins (Akahoshi et al., 2011).  Carboxypeptidase A3 also controls systemic toxicity of 
endogenous vasoconstricting peptides during sepsis (Maurer et al., 2004). 
β- hexosaminidase (β-hex) is an exoglycosidase that cleaves terminal sugars (Schwartz et 
al., 1979).  β-hex enzyme catalyzes degradation of GM2 ganglioside, and mutations in this 
enzyme lead to neurodegenerative diseases (Bayleran et al., 1987;  Tifft and Proia, 1997). β-hex 
has been successfully used as a MC function marker because it is released in parallel with 
canonical MC marker histamine (Schwartz et al., 1979). For many of the studies using RBL 
cells, degranulation has been quantified via measurement of released β-hex by incubating with 
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substrate resulting fluorescent product, easily detected in a microplate reader (Naal et al., 2004), 
but tryptase release has not typically been used as a RBL-2H3 degranulation marker. 
 
1.2  Zebrafish as a model for mast cell and mitochondria 
1.2.1 Zebrafish as models for toxicology 
Zebrafish (Danio rerio) have emerged as a powerful vertebrate model organism for 
genetic and developmental biology because of their small size, low-cost maintenance, high 
fecundity, short generation time, easy gene manipulation, external transparent development, and 
availability of extensive genomic resources (Ward and Lieschke, 2002;  Sullivan and Kim, 2008;  
Ellett and Lieschke, 2010).  In addition, their physiological equivalence with mammalian 
systems provides an intriguing model of human disease (Ward and Lieschke, 2002;  Yoder et al., 
2002;  Lieschke and Currie, 2007).   
Zebrafish (ZF) are gaining popularity in toxicology as an attractive system as well, owing 
to their striking similarities to mammalian toxicity profiles, and their easily-monitored drug or 
toxicant effects (Spitsbergen and Kent, 2003;  Link et al., 2006;  Lieschke and Currie, 2007;  
Scholz et al., 2008;  Oppedal and Goldsmith, 2010;  Lam et al., 2012).  Moreover, ZF are 
currently the best-suited vertebrate model for high-throughput toxicity screening, capable of 
bridging the in vitro cell-based systems and in vivo mammalian models (Sukardi et al., 2010;  
Tanguay, 2018).  
ZF represent a more pertinent and valuable model organism for environmental toxicants 
(Bambino and Chu, 2017), especially toxicants that are detected in aquatic environments (Scholz 
et al., 2008) which provide information for both human health and aquatic toxicology and 
ecology, since aquatic pollution has become a serious global issue. For example, Mizell and 
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Romig utilized ZF embryos to monitor effects of common aquatic pollutants, such as dioxin (e.g. 
TCDD), benzene, and toluene (Mizell and Romig, 1997). The continuous observation of 
phenotypic changes upon toxicant exposure owing to transparent body and rapid growth are sure 
to provide significant advantages to developmental toxicologists.  
Numerous studies have examined the effects of endocrine disruptor chemicals (EDCs), 
including bisphenol A (BPA), ethinyl estradiol (EE2), and polybrominated diphenyl ethers 
(PBDEs), using ZF embryos and larvae, on changes in gene transcription and hormonal levels 
(Chung et al., 2011;  Velasco-Santamaria et al., 2011;  Chen et al., 2012;  Cardoso et al., 2017;  
Souder and Gorelick, 2018). Also, metal toxicology studies have employed ZF: those metal 
toxicants include mercury, zinc, cadmium, lead, and arsenic (Chan et al., 2006;  Senger et al., 
2010;  Richetti et al., 2011;  Wu et al., 2012). The rise of organic pollutants in the environment, 
mostly polyaromatic hydrocarbons (PAHs), has been reported as a serious health concern in 
recent years. The sources of PAHs include pesticides, naphthalene, benzopyrene, and 
dichlorophenol products. Many ZF studies have found adverse effects of PAHs on development, 
gene expression, nucleic acid, oxidative stress and endocrine systems of ZF embryos (Kienle et 
al., 2009;  Hawliczek et al., 2012;  Huang et al., 2012;  Ma et al., 2012;  Shao et al., 2012;  Xing 
et al., 2012).  
It is worth noting that the ZF model is equipped with genomic data [its genome has been 
fully sequenced and annotated (Howe et al., 2013)], numerous transgenic morphants, and easy 
genetic-manipulation. Since technologies in molecular/genetics/bioinformatics have advanced 
remarkably, recent toxicological studies have expanded the scope to elucidating molecular 
mechanisms and cellular targets, in addition to describing end-point toxicity to chemicals. Thus, 
the increased and augmented recognition and usage of ZF in toxicology is promising. 
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1.2.2 Zebrafish in mast cell studies  
Despite the many advantages of ZF, utilizing ZF in mast cell studies has not been 
extensively explored yet, partly because of the lack of information on ZF mast cells up until 
recently. Only a decade ago, the Berman lab first characterized ZF mast cells (Dobson et al., 
2008); thus, this area of ZF MC studies are still at an early but promising stage. In those studies, 
carboxypeptidase A5 (cpa5), which is homologous to human CPA1 and mouse Cpa3, was 
identified as a MC specific marker in ZF (Dobson et al., 2008;  Da'as et al., 2012). Application 
of an anti-human FcεRI and anti-human tryptase antibody to ZF revealed FcεRI receptor-like and 
tryptase homologs in ZF (Da'as et al., 2011).  Furthermore, techniques were developed to 
monitor MC degranulation in adult ZF by injecting c48/80 (MC stimulant) and quantifying the 
release of tryptase using a N-alpha-benzoyl-DL-arginine-p-nitroanilide (BAPNA), chromogenic 
synthetic tryptase substrate (Dobson et al., 2008;  Da'as et al., 2011). A systemic mastocytois 
(SM) model has been developed in ZF, which is characterized by excessive accumulation of 
MCs, by inducing genetic mutaion in the c-Kit receptor to generate transgenic animal (Balci et 
al., 2011;  Balci et al., 2014). Overall, these studies found that ZF MCs share similarities in 
innate and adaptive immune responses with humans (Dobson et al., 2008;  Da'as et al., 2011;  
Da'as et al., 2015).  
Additionally, the Berman laboratory has developed a mast cell degranulation assay using 
adult ZF to study by tryptase as a degranulation marker (Dobson et al., 2008;  Da'as et al., 2011).  
After adult ZF were injected intraperitoneally with MC stimulant c48/80, blood samples are 
collected by cardiac puncture and incubated with BAPNA. This assay showed an increase in 
blood tryptase levels, ~60% above controls (Dobson et al., 2008).  Later, this tryptase assay also 
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produced a significant readout for MC degranulation by injection of mouse IgE followed by 
DNP-BSA antigen injection in adult ZF (Da'as et al., 2011). 
Although these studies done by the Berman lab (2018 and 2011) demonstrate the 
feasibility of using ZF as a model to study MCs in vivo, using adult ZF to measure MC 
degranulation has drawbacks: their small size (3-4 cm) precludes large-scale extraction of plasma 
where tryptase is detected. In addition, all the chemicals need to be injected intraperitoneally and 
blood samples are collected manually with frequent anesthetization of the animals. Therefore, 
this method is costly, labor-intensive and low-throughput. Recently, Yang et al.(2015) reported 
an in vivo, microplate-based colorimetric tryptase assay using ZF embryos (Yang et al., 2015), 
rather than adult ZF. In this method, all the drugs and reagents, including c48/80 and BAPNA, 
are directly added to the fish water and animals are arrayed in microplate for direct readout of 
signals in a microplate reader. Thus, this method can be utilized as a high-throughput assay. 
β-hexosaminidase release as a MC degranulation marker has been utilized in the RBL-
2H3 cell line, which is one of the most widely used in vitro MC systems. Thus, previous findings 
on ZF MCs have strongly motivated us to establish tryptase assay in vitro models using RBL 
mast cells, to be able to parallel studies of MCs in vitro and in vivo. However, in Chapter 4, we 
detail our finding that RBL cells do not express tryptase genes.  
 
1.2.3 Zebrafish in mitochondrial studies 
Mitochondria are often noted as powerhouses which generate energy (adenosine 
triphosphate, ATP) in all eukaryotic cells. Also, mitochondria are involved in regulation of 
calcium signaling since they can store and release calcium in concert with the ER (Pacher et al., 
2000).  During ATP synthesis, mitochondria also consume oxygen as the final electron acceptor; 
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thus, ATP production and oxygen consumption in mitochondria are tightly coupled, and this 
process is called oxidative phosphorylation (Lehninger et al., 2005).  
Because of the important roles of mitochondria, they have been a subject of studies in 
various scientific fields. However, most of studies on mitochondria have been done in cell 
culture or mitochondria isolated from animal models (Newton et al., 2005;  Ajao et al., 2015).  
Due to the unique features of ZF being transparent and possessing advanced genetic tools, 
scientists have utilized ZF to investigate mitochondria in a living, intact organism (Kim et al., 
2008;  Paquet et al., 2014;  Noble et al., 2015;  Bergamin et al., 2016;  Zhou et al., 2018).  
Our lab has previously showed that the antimicrobial agent triclosan (TCS) suppresses 
MC degranulation in vitro (Palmer et al., 2012;  Weatherly et al., 2013). In our search of 
mechanisms underlying MC inhibition by TCS, we found that TCS is a proton ionophore 
mitochondrial uncoupler (MU) in multiple cell types (Weatherly et al., 2016).  Proton ionophore 
MUs interfere with ATP synthesis by transporting hydrogen ions across the inner mitochondrial 
membrane, thus bypassing the proton channel of ATP synthase (Heytler and Prichard, 1962). 
Disruption of the proton gradient also causes the electron transfer chain to operate more 
vigorously, so oxygen consumption rate (OCR) is increased by proton ionophore MUs. 
Additionally, we and others have revealed that TCS inhibits mitochondrial membrane potential 
(Attene-Ramos et al., 2015;  Weatherly et al., 2018).  
To align with our in vitro studies, we developed a novel in vivo assay using ZF embryos 
in 96-well high-throughput format utilizing XFe 96 Extracellular Flux Analyzer, to measure 
mitochondrial bioenergetics (Shim et al., 2016b)—see Chapter 5. As expected, ATP-linked 
respiration decreases and OCR increases on TCS exposure. There are other studies using 
zebrafish for mitochondrial bioenergetics; however, these studies employed relatively low-
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throughput 24-well plates and required laborious placement of screens into each individual well 
to contain ZF within the well during the signal acquisition (Stackley et al., 2011;  Bestman et al., 
2015).  
A recent study by Paquet et al. (2014) reported development of a transgenic ZF which is 
labeled with mitochondrial markers attached to fluorescent proteins (“MitoFish”). The authors 
used MitoFish to examine mitochondrial dynamics in real-time via in vivo imaging (Paquet et al., 
2014). Similarly, another group generated the transgenic ZF line MTS-Kaede, in which 
mitochondria are labeled in neurons, to study mitochondrial transport (Bergamin et al., 2016). 
Dopaminergic neuron-specific (Noble et al., 2015) and neutrophil-specific (Zhou et al., 2018) 
mitochondria transgenic ZF lines have also established recently. Thus, the potential for use of 
zebrafish in toxicity testing of mitochondrial function is great and growing.  
 
1.3 Arsenic and triclosan  
1.3.1 Arsenic  
Arsenic (As) exposure is a global concern since it is ubiquitously detected in soil, water, 
and air, from natural or anthropogenic sources (Abdul et al., 2015). The major route of human 
exposure is diet, via foods or drinking water, with the additional concern of occupational-related 
arsenic exposure for certain groups (Arslan et al., 2017). In the United States, the allowed level 
of As in drinking water set by Environmental Protection Agency (EPA) is 10 ppb; however, 
there are many parts of the world (e.g. West Bengal, Bangladesh, Taiwan, and South America) 
which the As level in drinking water is very high:  hundreds of ppb to ppm.  Thus, across the 
world, hundreds of millions people are at risk of As exposure.  
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Many human epidemiological studies have reported strong association between 
populations exposed to high levels of As and prevalence of numerous disorders and diseases.  
The International Agency for Research on Cancer (IARC) has classified inorganic arsenic as a 
carcinogen.  A study done in Argentina showed that inorganic As exposure is associated with 
high incidence of colorectal, lung, breast, prostate, and skin cancers (Bardach et al., 2015).  
Many other studies also reported that urinary arsenic concentration is positively correlated with 
frequency of lung cancer (Steinmaus et al., 2010;  Melak et al., 2014), bladder cancer (Melak et 
al., 2014), squamous cell carcinoma (Gilbert-Diamond et al., 2013), basal cell carcinoma 
(Leonardi et al., 2012), and non-melanoma skin cancer (Kim et al., 2017). Also, a high As level 
detected in blood is also related to bladder cancer and renal cancer (Mostafa and Cherry, 2013).  
Arsenic exposure is also correlated to diabetes (James et al., 2013;  Grau-Perez et al., 
2017), cardiovascular disease (Wade et al., 2015;  Wu et al., 2015), skin lesions (Chung et al., 
2006;  Rahman et al., 2006;  Mondal et al., 2016), chronic kidney diseases (Hsueh et al., 2009), 
hypertension (Guha Mazumder et al., 2012), and child pneumonia (George et al., 2015). 
Additionally, a study done by Wu et al. (2011) found a positive correlation between arsenic 
exposure and birth defects (Milton et al., 2010;  Wu et al., 2011). Human health problems caused 
by As are reviewed in (Abdul et al., 2015).   
 Our lab has previously demonstrated that mast cell degranulation is dampened by 
inorganic Arsenite in Ag-stimulated RBL cells (Hutchinson et al., 2011). We then have sought 
out the mechanisms of arsenic’s inhibitory action on MCs and revealed that early tyrosine kinase 
phosphorylation was significantly decreased by As exposure. Specifically, the levels of 
phosphorylation of Syk kinase and one of the Syk substrates, PI3K, are reduced upon As 
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exposure in activated RBL cells (Shim et al., 2016a). This mechanistic study is detailed in 
Chapter 2. 
Interestingly, arsenic has been employed in traditional Chinese medicine over 5000 years 
to treat asthma. Our findings of inhibitory action of As on mast cells, which is a key player for 
asthma, might be the mechanism of this treatment. Moreover, As has shown to decrease asthma 
symptoms in mice (Chu et al., 2010) and to abrogate anaphylactic response in guinea pigs 
(Poriadin et al., 1977).  
 
1.3.2 Triclosan  
Triclosan (TCS) is a broad-spectrum antimicrobial agent that has been widely used in 
consumer products since its original usage in clinical settings in 1972. During 2003–2004, the 
National Health and Nutrition Examination Survey (NHANES) measured triclosan in urine and 
TCS was detected in approximately 75% of the people tested (Calafat et al., 2008). More recent 
survey studies in Korea, Denmark, and China reported 93% (Kim et al., 2011), 79% (Frederiksen 
et al., 2013) and 100% (Li et al., 2013) detection rates of TCS from 140-300 test subjects.  
By the late 2000s, TCS was found in over  90% of soap products (FDA, 2013) until it 
was banned by the FDA in consumer soap products in 2016 (Kux, 2016) and hospital sterilizing 
products in 2017 (Fischer, 2017). However, TCS remains in other consumer products, such as 
toothpaste, and other household products (e.g. toys, kitchenware, bedding, fabric etc.).  
 Numerous emerging epidemiological studies report adverse human health consequences 
to TCS exposure. Since several studies have demonstrated that TCS is an endocrine disrupting 
chemical (Wang and Tian, 2015;  Wang et al., 2015;  Ruszkiewicz et al., 2017), and an 
epidemiological study showed prenatal TCS exposure affects thyroid hormone levels (Wang et 
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al., 2017). Also maternal TCS level is strongly associated with reproduction (Wang et al., 2015;  
Hua et al., 2017) and fetal growth and development, such as fatal abnormalities, birth weight, 
head circumference (Lassen et al., 2016;  Etzel et al., 2017;  Wei et al., 2017). Additionally, 
studies done in 2018 reported abnormalities of sperm morphology (Jurewicz et al., 2018), and 
lowered cognitive test scores in children (Jackson-Browne et al., 2018) linked to triclosan 
exposure. Intriguingly, while urinary TCS concentration level is inversely associated with body 
mass index and waist size (Li et al., 2015), one epidemiological study presented a positive 
correlation between TCS exposure and high risk of gestational diabetes (Ouyang et al., 2018). 
Most of mechanisms causing these health consequences by TCS are not fully elucidated, 
however, several studies have provided molecular and biochemical data about TCS.  TCS 
increases reactive oxygen species (ROS) generation, which leads to oxidative DNA damage (Lv 
et al., 2016), or tumorigenesis (Yueh et al., 2014). TCS alters gene expression in mice (Yueh et 
al., 2014;  Marshall et al., 2015), which potentially induces cancer formation.  Abnormal gene 
expression profiles were observed in TCS-exposed sea urchins (Hwang et al., 2017). Calcium 
homeostasis is also modulated by TCS exposure (Ahn et al., 2008;  Cherednichenko et al., 2012;  
Weatherly et al., 2018).  Finally, TCS’s detrimental effects on mitochondrial function has been 
explored by us and others (Ajao et al., 2015;  Shim et al., 2016b;  Weatherly et al., 2016).  
Our lab has investigated the effects of TCS on mast cell degranulation. First, we have 
developed the method to prepare TCS in aqueous buffer and determine the resultant 
concentration by spectrophotometer, to avoid unnecessary confounding effects of organic 
solvents (Weatherly et al., 2013). We found that TCS rapidly inhibits MC degranulation in Ag-
mediated as well as Ca2+ ionophore-stimulated RBL cells (Palmer et al., 2012). This finding was 
replicated in human (HMC-1) mast cells (Weatherly et al., 2016). Inhibited MC degranulation by 
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TCS might be a potential explanation for the TCS usage as a treatment of atopic dermatitis (Tan 
et al., 2010). 
We then endeavoured to elucidate the mechanisms by which TCS disrupts degranulation. 
Recently, we have demonstrated that TCS is a proton ionophore mitochondrial uncoupler (MU) 
in several cell types (RBL, HMC-1.2, NIH-3T3, and primary human keratinocytes) and in living 
zebrafish (Shim et al., 2016b). In both in vitro and in vivo models, TCS inhibits ATP production 
and increases OCR. We also revealed that TCS disrupts mitochondrial structure, mitochondrial 
membrane potential and calcium signaling (Weatherly et al., 2018). In addition, Popova et al. 
(2018) demonstrated that TCS acts as a protonophore, which permeates artificial bilayer lipid 
membranes, thus transporting protons across the membrane, resulting in membrane 
depolarization. Interestingly, TCS showed more potent protonophoric activity than carbonyl 
cyanide 3-chlorophenylhydrazone (CCCP), which is a canonical protonophore/MU. TCS’s 
protonophoric activity was also tested using bacterial membrane and isolated rat liver 
mitochondria: TCS elicited bacterial membrane depolarization and induced mitochondria 
swelling in rat liver. This study also showed that TCS induces calcium efflux from mitochondria, 
leading to disruption of calcium homeostasis, in agreement with our previous data by Weatherly 
et al. (Popova et al., 2018;  Weatherly et al., 2018). Thus, these studies strongly suggest that 
TCS disrupts mitochondrial function and membrane potential. 
We further investigate the targets of triclosan’s inhibitory action in the MC signaling 
transduction pathway, in particular, two key signaling molecules downstream of Ca2+ influx: 
protein kinase C (PKC) and phospholipase D (PLD). The detailed of mechanistic studies on 
these molecules will be discussed in Chapter 3. 
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1.4 Current studies 
Mast cells are physiologically important cells, involved in myriad biological events as 
well as various diseases.  Thus, disruption of mast cell function might trigger many unfavourable 
effects in an organism.  
Arsenic exposure is a global concern since it is commonly detected in drinking water and 
food sources. While arsenic is known to inhibit MC function (Hutchinson et al., 2011), until now 
the underlying biochemical mechanisms were unknown. Chapter 2 describes the molecular 
mechanisms underlying inorganic Arsenite inhibition of MC degranulation:  by hampering early 
tyrosine kinase Syk and its substrate PI3K. 
Synthetic antimicrobial agent triclosan has also been shown to inhibit MC function, but 
the underlying molecular mechanisms were previously unknown. Chapter 3 reveals triclosan’s 
molecular targets in the MC signaling pathway, which are very different from arsenic’s targets. 
Since our previous findings on TCS effects on Ca2+ mobilization in stimulated MCs, we 
examined downstream key players post Ca2+ influx. We found that PLD activity was strongly 
impeded, and subcellular translocations of PKC and its substrate, MARCKS, were delayed by 
TCS. 
In Chapter 4, we report that one of the most utilized MC cell culture model RBL-2H3 
cells do not express the classical mast cell marker tryptase. We have developed and employed 
several assays to detect tryptase release from the RBL cell supernatant, but no measureable 
signals were detected. We also examined the expression of mRNA transcript of tryptase genes 
from RBL by PCR, but no tryptase mRNA was detected. Before this study, the question of why 
tryptase was not typically utilized in RBL-2H3 mast cell studies was unanswered for decades. 
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Finally, Chapter 5 depicts a novel in vivo high-throughput assay using zebrafish embryos 
to measure mitochondrial bioenergetics. Previously, TCS had been shown to be a proton 
ionophoric mitochondrial uncoupler in numerous cell lines (Ajao et al., 2015;  Weatherly et al., 
2016) and in isolated mitochondria (Newton et al., 2005), but this mitotoxicity had not yet been 
confirmed in an animal.  Using this method, we have demonstrated that TCS is a mitochondrial 
uncoupler in a living organism, zebrafish. 
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CHAPTER 2 
ARSENIC INHIBITS MAST CELL DEGRANULATION VIA SUPPRESSION OF 
EARLY TYROSINE PHOSPHORYLATION EVENTS1 
2.1 Abstract 
Exposure to arsenic (As) is a global health concern. We previously documented an 
inhibitory effect of inorganic Arsenite on IgE- mediated degranulation of RBL-2H3 mast cells 
(Hutchinson et al., 2011). Mast cells are tissue-resident cells that are positioned at the host-
environment interface, thereby serving vital roles in many physiological processes and disease 
states, in addition to their well-known roles in allergy and asthma. Upon activation, mast cells 
secrete several mediators from cytoplasmic granules, in degranulation. The present study is an 
investigation of Arsenite’s molecular target(s) in the degranulation pathway. Here, we report that 
arsenic does not affect degranulation stimulated by either the Ca2+ionophore A23187 or 
thapsigargin, which both bypass early signaling events. As also does not alter degranulation 
initiated by another non-IgE-mediated mast cell stimulant, the G-protein activator compound 
48/80. However, arsenic inhibits Ca2+ influx into antigen-activated mast cells. These results 
indicate that target of arsenic in the degranulation pathway is upstream of Ca2+ influx. Phospho-
Syk and phospho-p85 phosphoinositide 3-kinase enzyme-linked immunosorbent assays data 
show that arsenic inhibits early phosphorylation events. Taken together, this evidence indicates 
that the mechanism underlying arsenic inhibition of mast cell degranulation occurs at the early 
tyrosine phosphorylation steps in the degranulation pathway.  
 
                                                 
1  A portion (50%) of this work was performed by Rachel Kenndey (Kennedy, R.H., 2013. Effects of endocrine 
disrupting chemicals on mast cell function, Electronic Theses and Dissertations. University of Maine) with the 
remainder being performed by Juyoung Shim. 
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2.2 Short Abstract 
Arsenite (As) inhibits IgE-mediated degranulation of RBL-2H3 mast cells. Mast cells 
serve vital roles in many physiological processes and diseases. Upon activation, mast cells 
secrete mediators from cytoplasmic granules, in degranulation. Here, we report that As does not 
affect degranulation stimulated by Ca2+ ionophore A23187, thapsigargin, or the G-protein 
activator compound 48/80, all of which bypass early signaling events. However, arsenic inhibits 
Ca2+influx into antigen-activated mast cells. Syk and phosphoinositide 3-kinase ELISA data 
show that arsenic inhibits early phosphorylation events. 
 
2.3 Introduction 
Exposure to arsenic is a major human health concern according to both the World Health 
Organization and the Agency for Toxic Substances and Disease Registry (NRC, 2001;  ATSDR, 
2007).  Millions of people worldwide are exposed to high levels of arsenic from a variety of 
natural and anthropogenic sources, including drinking water, various foods, pesticides, mining 
sites, and toxic waste sites. Many private water wells in the U.S., as well as those around the 
world (such as South America and Bangladesh) routinely contain levels of As well above 50 ppb 
(parts per billion; µg/L), and sometimes as high as 3000 ppb (ATSDR, 2007).  
Chronic exposure to arsenic, in particular via drinking water, has been correlated to many 
diseases, including severe dermatological disorders (Smith et al., 2000;  Xia et al., 2009;  Paul et 
al., 2013), respiratory diseases (Smith et al., 1992;  Hopenhayn-Rich et al., 1998;  Putila and 
Guo, 2011), diabetes/obesity (Abernathy et al., 1999;  Maull et al., 2012), and cardiovascular 
disease (Chen et al., 2009;  Huang et al., 2009;  Smith and Steinmaus, 2009;  Abhyankar et al., 
2012;  Das et al., 2012). Arsenic exposure also inhibits hematopoietic and immune systems 
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(NRC, 2001) and causes neurological and cognitive impairments (Wasserman et al., 2004;  
Wasserman et al., 2007;  Chen et al., 2009). Moreover, arsenic is a known human carcinogen, 
which affects almost all major organs including liver, kidney, bladder, skin and lung (Ferreccio 
et al., 2000;  Chiu et al., 2004;  Liaw et al., 2008;  Heck et al., 2009;  Putila and Guo, 2011;  Liu-
Mares et al., 2013;  Mostafa and Cherry, 2013;  Naujokas et al., 2013;  Saint-Jacques et al., 
2014). 
We recently demonstrated that antigen-stimulated degranulation of the mast cell model 
rat basophilic leukemia cells (RBL-2H3) is inhibited by non-cytotoxic doses of inorganic 
Arsenite (Hutchinson et al., 2011). Mast cells are multi- effector immune cells that participate in 
the first line of defense against parasites. Mast cells, found in most human tissues (Kuby, 1997), 
are also major effectors in allergic responses, asthma, other innate immune processes, and 
carcinogenesis. Mast cells are also involved in neurological conditions such as multiple sclerosis, 
autism, and anxiety (Silver and Curley, 2013).  The RBL-2H3 mast cell model is biologically 
very similar to human basophils and rodent mucosal mast cells (Fewtrell, 1979;  Seldin et al., 
1985;  Metzger et al., 1986).  
Arsenic can be detected in a variety of human samples, and urine and blood are usually 
the major materials that are monitored for arsenic exposure (Kraus et al., 2000). However, 
arsenic can be stored and concentrated in the tissues of many organs such as kidney, lung, skin, 
and liver (Benramdane et al., 1999), and mast cells are found in most human organs, as we 
discussed in Hutchinson, et al. (2011). In fact, the concentrations of arsenic found in tissue tend 
to be higher (up to ~7-350 fold higher) than in blood (Benramdane et al., 1999). In a previous 
article (Hutchinson et al., 2011), we noted several publications reporting human tissues 
containing between 100 and 6000 ppb arsenic. For example, one study examined tissue arsenic 
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concentrations in people who had regularly consumed drinking water containing 220-2000 ppb 
arsenic and found several hundred to several thousand ppb arsenic (Schroeder et al., 1968).  
Since mast cells function within tissues, it is necessary to study arsenic concentrations that are 
found within tissues. Thus, the 100-750 ppb arsenic concentrations employed in this study are 
biologically relevant. 
Highly granulated, mast cells respond to various stimuli by partially or completely 
releasing the contents of their granules, which include a range of mediators such as histamine 
and serotonin. The mechanism underlying arsenic inhibition of the function of mast cell 
degranulation is not yet known. Given the complexity of the degranulation signal transduction 
pathway and the similarities to signaling pathways in other immune cells, such as T cells, there 
are many potential targets for arsenic inhibition.  
Degranulation is a process that classically begins with antigen crosslinking of IgE-bound 
FcεRI receptors, which abound on the mast cell surface (Kuby, 1997). The physical aggregation 
of the receptors results in their tyrosine phosphorylation by the protein tyrosine kinase Lyn 
(Kinet, 1999;  Xiao et al., 2005). Phosphorylation of the receptor causes the protein tyrosine 
kinase spleen tyrosine kinase (Syk) to be recruited to the receptor (Benhamou et al., 1993;  On et 
al., 2004). The activation of Syk (Minoguchi et al., 1994;  Zhang et al., 2000), leads to the 
activation of phospholipase C (PLC) γ (Benhamou et al., 1992;  Beaven and Metzger, 1993) and 
results in Ca2+ mobilization (Ferris et al., 1989;  Millard et al., 1989;  Putney et al., 2001), which 
is essential to degranulation (Zhang et al., 1996). 
PLC 1 is an important player in Ag-receptor signaling: it catalyzes the hydrolysis of the 
membrane phospholipid phosphatidylinositol 4,5-bisphosphate (PIP2) to generate second 
messengers inositol-1,4,5 - trisphosphate (IP3) and diacylglycerol (DAG). IP3 initiates the release 
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of Ca2+  from internal stores (i.e., the endoplasmic reticulum [ER]), while DAG is responsible for 
activation of an assortment of protein kinase C (PKC) isoforms (Kalesnikoff and Galli, 2008).  
Activated PKC phosphorylates the cytoskeletal protein myosin, important for degranulation 
(Ludowyke et al., 1989). 
A second signaling pathway resulting in IP3 generation is initiated by phosphoinositide 3-
Kinase (PI3K), which is activated by Syk (Okkenhaug and Vanhaesebroeck, 2003;  Mocsai et 
al., 2010) and which phosphorylates inositol lipids to generate the signaling molecules PIP2 and 
PIP3 (Kitaura et al., 2000). PIP2 is then used by PLC γ to generate IP3. PH domains within PLC 
γ, Vav, Akt, Btk, and PDK1 mediate binding of these proteins to PIP2 and to PIP3, thus drawing 
these proteins to the plasma membrane for activation (Kitaura et al., 2000;  Abramson and Pecht, 
2007). For example, PDK1 activation leads to activation of PKC δ, important for degranulation. 
Overall, PI3K activates Ca2+ influx and degranulation of mast cells (Ching et al., 2001). 
IP3 is crucial for degranulation. Activation of IP3 receptors initiates a biphasic increase in 
intracellular Ca2+ (Berridge, 1993;  Taylor and Thorn, 2001). The binding of IP3 to its receptors 
in the ER causes Ca2+ to be released from the internal ER stores, causing depletion of Ca2+ from 
the ER. IP3 receptors are ion channels that allow for passive diffusion of Ca
2+  from the ER 
(Scharenberg et al., 2007). Depletion of Ca2+ stores results in an influx of Ca2+  across the plasma 
membrane through calcium release-activated calcium (CRAC) channels (Hogan et al., 2010), 
which is referred to as “store operated calcium entry” (SOCE) (Putney, 1986;  Putney, 1990;  
Clapham, 1995), producing an extracellular Ca2+ influx and calcium-release activated current 
(Kraft and Kinet, 2007). The major players in “store operated calcium entry” are STIM-1 (Liou 
et al., 2005;  Zhang et al., 2005), an ER calcium sensor which interacts directly with Orai1 
channels (Feske et al., 2006;  Vig et al., 2006), the pore subunit of CRAC channels within the 
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plasma membrane, to couple depletion of ER Ca2+ with activation of CRAC channels. Influx of 
Ca2+ across the plasma membrane permits reuptake of Ca2+ into the ER through 
sarco/endoplasmic Ca2+-ATPase (SERCA) pumps (Ma and Beaven, 2011), which actively pump 
Ca2+ from the cytosol into the ER to replenish internal stores (Scharenberg et al., 2007).  
Depletion of the ER pool of Ca2+ by either IP3 or the compound thapsigargin (selective inhibition 
of SERCA) (Thastrup et al., 1990;  Lytton et al., 1991) leads to entrance of Ca2+ into the cell 
(Ma and Beaven, 2011). Overall, the primary synergistic signals for secretion are an increase in 
intracellular Ca2+ as well as activation of PKC (Ozawa et al., 1993a). 
Next, increases in intracellular Ca2+ and PKC translocation work in tandem to activate 
phospholipase D (PLD) (Lin and Gilfillan, 1992). In fact, PLD can be activated in RBL-2H3 
cells via several means: FcεRI receptor crosslinkers (Dinh and Kennerly, 1991;  Ali et al., 1996), 
thapsigargin (Cissel et al., 1998), Ca2+ ionophore (Lin and Gilfillan, 1992), and compound 48/80 
(Chahdi et al., 2000). PLD hydrolyzes phosphatidylcholine into phosphatidic acid (PA), which 
has been shown to stimulate PLC γ (Nishizuka, 1995). PA is converted to DAG by PA 
phosphohydrolase, thus causing a secondary rise in intracellular DAG levels (Nakashima et al., 
1991;  Lin et al., 1992). These increases have been shown to be important for the translocation 
and activation of the DAG-dependent isoforms of PKC (Lin et al., 1992;  Nishizuka, 1995;  Peng 
and Beaven, 2005). PLD1 is involved in granule translocation, and PLD2 is involved in 
membrane fusion of the granules (Choi et al., 2002).  Granules are transported from the cell 
interior to the plasma membrane with the help of microtubules, where they dock with the help of 
multiple soluble N-ethylmaleimide-sensitive factor attachment protein receptors (Guo et al., 
1998;  Baram et al., 1999;  Paumet et al., 2000;  Blank et al., 2002;  Logan et al., 2003;  Puri and 
Roche, 2008;  Tiwari et al., 2008;  Woska and Gillespie, 2012). The result of mast cell signaling 
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is fusion of intracellular granules with the plasma membrane, causing the release of histamine, 
serotonin, leukotrienes, cytokines, β-hexosaminidase, and enzymes that trigger the symptoms of 
allergy and asthma and that play many other crucial physiological roles (Kopeć et al., 2006). 
Simultaneously, F-actin polymerization causes membrane “ruffling.” 
Actin cytoskeletal rearrangement is not an essential element of the degranulation pathway 
(degranulation occurs even when ruffling is stopped by actin inhibitor cytochalasin D (Holowka 
et al., 2000)), but the two share common events such as activation of PKC and influx of Ca2+ 
(Pfeiffer et al., 1985;  Yanase et al., 2011). In a recent paper by Yanase et al. (2011), it was 
shown that the use of inhibitors of PKC β and PKC α inhibit both ruffling and degranulation. 
PLD2 also is important for membrane ruffle formation.  
As part of our investigation of arsenic’s mechanism of mast cell inhibition, we utilized 
another non-IgE-mediated stimulating method, compound 48/80 (c48/80), a polybasic mast cell 
secretagogue which has potent anaphylactic properties in vivo (Lagunoff et al., 1983;  Chahdi et 
al., 2000) and which effects degranulation from rat mast cells (Johnson and Moran, 1969). 
Compound 48/80 is believed to act by the stimulation of heterotrimeric G-proteins (Chahdi et al., 
2000), in particular, via Gi-2 and Gi-3 in RBL-2H3 cells (Senyshyn et al., 1998). Pretreatment of 
RBL-2H3 cells with the flavonoid quercetin causes an increase in histamine-containing 
intracellular granules (Trnovsky et al., 1993) and an over-expression of Gi-3α and Gi-2α 
(Senyshyn et al., 1998;  Chahdi et al., 2000), so pre-incubation of RBL-2H3 cells with quercetin 
is required prior to exposure with c48/80 in order to make the cells responsive to c48/80-induced 
degranulation (Galli et al., 2008). Phospholipase D (PLD) is stimulated by c48/80 in quercetin-
treated RBL-2H3 cells (Aridor et al., 1990;  Senyshyn et al., 1998;  Chahdi et al., 2000). 
Compound 48/80 induces a Ca2+ -dependent degranulation response that releases Ca2+ from 
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intracellular pools (Aridor et al., 1990;  Hirasawa et al., 1995;  Senyshyn et al., 1998), and 
transiently activates phospholipase C (PLC), possibly through indirect activation of PLD (Ali et 
al., 1990;  Aridor et al., 1990;  Park et al., 1991;  Yamada et al., 1992;  Senyshyn et al., 1998). 
Therefore, due to c48/80’s mechanism of action, we were able to assess the possibility of arsenic 
targeting PLC, PLD, and calcium influx. 
It is well established that Ca2+ influx is a crucial for mast cell degranulation. To explore 
whether the level of FcεRI-mediated cytoplasmic Ca2+ in RBL-2H3 mast cells is changed by 
arsenic exposure, we developed a microplate-based method to monitor the level of Ca2+ utilizing 
the fluorescent Ca2+ indicator. Using this method, we were able to measure the cytosolic Ca2+ 
levels in real time for over 2h after cells were stimulated and exposed to arsenic.  
Finally, we evaluated the effect of arsenic on key phosphorylation events, crucial early 
signaling events in the mast cell degranulation pathway. It has previously been demonstrated that 
arsenic affects tyrosine phosphorylation events (Qian et al., 2003), including T cell signal 
transduction (Soto-Peña and Vega, 2008). Arsenic trioxide inhibits the PI3K/Akt pathway in 
chronic lymphocytic leukemia cells (Goussetis and Platanias, 2010). PI3K is a heterodimeric 
enzyme composed of a catalytic subunit (p110) and a regulatory subunit (p85) (Koyasu, 2003). 
PI3K is activated by Syk kinase (Okkenhaug and Vanhaesebroeck, 2003). Here we have 
examined the effect of arsenic on PI3K and Syk kinase by employing enzyme-linked 
immunosorbent assays (ELISA). The global phosphorylated Syk levels in the Ag-activated RBL 
cells were measured. For PI3K, both the phosphorylated p85 subunit of PI3K and the total PI3K 
p85 subunit were evaluated. 
In this study, we unraveled the molecular mechanism used by Arsenite to inhibit mast 
cell function. We employed multiple experimental approaches in RBL-2H3 cells to determine 
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the mechanism of arsenic inhibition of mast cell degranulation. Here we present mechanistic data 
resulting from degranulation assays utilizing various stimulants, F-actin imaging, Ca2+ 
measurements, and ELISAs probing early phosphorylation events. We demonstrate that arsenic 
acts very early in the signaling pathway leading to degranulation, inhibiting the nearly immediate 
event of Syk kinase phosphorylation.  
 
2.4 Materials and Methods 
2.4.1 Chemicals and Reagents 
A23187 ionophore, compound 48/80 (c48/80), quercetin, dimethyl sulfoxide (DMSO), 
sodium azide, and sulfinpyrazone were purchased from Sigma Aldrich (St. Louis, MO, USA). 
Thapsigargin (Tg) was obtained from Calbiochem/EMD Millipore (Billerica, MA, USA). 
Tyrodes buffer, bovine serum albumin (BSA)-Tyrodes (BT), sodium acetate buffer, and glycine 
carbonate buffer were prepared as previously described (Hutchinson et al., 2011). A low- Ca2+ 
Tyrodes (containing 0.9 mM rather than the typical 1.8 mM CaCl2) was used in all c48/80 
experiments. Chemicals of the highest possible purity were used. All buffers and media were 
sterile-filtered with VacuCap bottle-top filter devices (0.2 μM; Pall Life Sciences, Port 
Washington, NY, USA). 
Arsenic was prepared under sterile conditions as 10 mM stocks of inorganic sodium 
(meta) arsenite (CAS no. 7784-46-5; manufactured by either JT Baker, Phillipsburg, NJ, USA; or 
Fluka, Seelze, Germany), and dissolved in sterile cell culture water (BioWhittaker Lonza, 
Walkersville, MD, USA). The stock was 0.2-μM filtered and stored as previously described by 
(Hutchinson et al., 2011). 
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Ca2+ ionophore A23187 was prepared by dissolving A23187 powder into 100% DMSO 
for a final concentration of 2.5 mg/ml.  The solution was transferred to a microcentrifuge tube 
with a parafilmed lid and was wrapped in aluminum foil, for storage at -20 °C. On the day of an 
experiment, this stock was diluted directly into BT solution to create ionophore concentrations of 
1.5 x 10-7 M and 2 x 10-7 M (0.004% DMSO). 
Tg was prepared as described in (Weatherly et al., 2016). The highest DMSO vehicle 
concentration used in these experiments was 0.001 % (v/v).  
Compound 48/80 was prepared using aseptic conditions as 30 mg/ ml stocks dissolved in 
cell culture water, aliquoted into sterile polypropylene microfuge tubes, and frozen at -20 °C 
until the day of use, so that each individual aliquot underwent only one freeze/thaw cycle. 
Quercetin was prepared as a 60 mM stock from anhydrous quercetin powder in 100% DMSO. 
Cells were treated with 20µM quercetin in RBL media (Hutchinson et al., 2011), resulting in a 
DMSO vehicle concentration of 0.033 % (v/v). 
Fluo-4/AM (Life technologies, Grand Island, NY, USA) was dissolved in 100% DMSO 
to prepare a 911µM stock and stored at -20 °C until the day of use, so that each individual 
aliquot underwent only one freeze/thaw cycle. 
 
2.4.2 RBL-2H3 Cell Culture 
Cell culture methods were those of (Hutchinson et al., 2011) 
 
2.4.3 Cytotoxicity Assays 
Trypan blue exclusion assays were performed as previously described in detail by 
Hutchinson et al. (2011) and Palmer et al. (2012). In general, the details remained unchanged, 
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with the exception of the use of c48/80, which required a slightly different procedure in order to 
accommodate a 48h quercetin pre-treatment as well as the use of a low- Ca2+ Tyrodes buffer. 
Accordingly, RBL-2H3 cells were plated into sterile tissue culture treated, six-well plates (VWR, 
Radnor, PA, USA) at a density of 0.85 x 106 cells/well in RBL medium supplemented with 20 
μM quercetin and incubated for 48 h at 37°C, 5% CO2. After 48 h, spent medium was discarded, 
and fresh RBL medium was added to the cells for 30 min at 37°C, 5% CO2. This liquid was then 
discarded, and low Ca2+ Tyrodes buffer ± 25 μg/ml c48/80 or vehicle ± arsenic was added to 
each well for 15 min at 37°C, 5% CO2. This medium was removed, and wells were washed with 
2 mL low Ca2+ Tyrodes to remove dead cells. Following removal of this wash, wells were rinsed 
with 1 mL trypsin. Plates were then incubated with 1 mL fresh trypsin for 10 minutes at 37°C, 
5% CO2 to allow cells to dislodge completely from the plates. Further removal of cells after this 
incubation was accomplished by repeated pipetting of the cell-containing trypsin into the wells, 
removing visible traces of cells from the surface of the well. The cell-containing trypsin was then 
quenched by addition into 1 mL of RBL media. Equal volumes of this mixture and trypan blue 
stain (Trypan Blue 0.4% solution in 0.85% NaCl; BioWhittaker Lonza) were then combined, and 
cell viability was assessed by counting those cells able to exclude the trypan blue stain using a 
hemocytometer (Bright-line, Hausser Scientific, Horsham, PA, USA). Values of living cells were 
then normalized to the vehicle values for any given assay before data compilation. 
Lactate dehydrogenase (LDH) assay was performed as previously described (Hutchinson 
et al., 2011;  Palmer et al., 2012). 
ATP production and cytotoxicity were assayed via Promega (Madison, WI, USA) Toxglo 
kit instructions as described in (Weatherly et al., 2016).  Arsenic exposures lasted 1 h. 
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2.4.4 Antigen-Mediated Degranulation Assay 
Cells were sensitized by IgE, as described in (Weatherly et al., 2013).  IgE-bound FcεRI 
receptors of RBL cells were aggregated by dinitrophenyl (DNP)-BSA multivalent Ag ± arsenic 
(for 1 h). Degranulation (release of β-hexosaminidase) was measured via a fluorescence-based 
96-well microplate reader assay, as illustrated in (Weatherly et al., 2013). 
 
2.4.5 Confocal Imaging of Membrane Ruffling 
Experiments were performed as in (Palmer et al., 2012). Arsenic was used in place of 
triclosan; thus, vehicle in control samples was cell culture water. 
 
2.4.6 Ca2+ Ionophore-Stimulated Degranulation in RBL-2H3 Cells 
This assay was essentially performed as described by (Weatherly et al., 2013), except that 
two different Ca2+ ionophore A23187 doses (1.5 x 10-7 M and 2 x 10-7 M) were used, based on 
their ability to elicit a low-range and mid-range level of degranulation, respectively, with this lot 
of A23187. Additionally, arsenic (in place of triclosan) was diluted into A23187/BT solution at 
the noted concentrations (0.004% DMSO vehicle in all samples).  
 
2.4.7 Thapsigargin-Induced Degranulation 
To test the ability of arsenic to alter an earlier Ca2+ signaling event than that induced by 
A23187 Ca2+ ionophore, we used Tg, a known inhibitor of SERCA in mammalian cells. 
Degranulation experiments were conducted similarly to antigen-stimulated RBL-2H3 
degranulation experiments (Weatherly et al., 2013), except that there was no IgE pretreatment 
and that RBL-2H3 cells were treated with 4.6 nM Tg for one hour (37 °C and 5% CO2) in the 
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presence of 0-750 ppb arsenic. To combine multiple experiments, data were normalized to the 
response elicited by 4.6 nM Tg in the presence of arsenic vehicle only (cell culture water). 
 
2.4.8 Compound 48/80-Mediated Degranulation 
RBL cells were harvested after 2-5 days of growth via trypsinization, and were 
resuspended at a density of 0.25 x 106 cells/ml in fresh RBL medium ± 20μM quercetin. One 
hundred microliter of this suspension per well was plated in black flat-bottom, tissue culture-
treated, sterile, 96-well plates (Greiner Bio-One, Monroe, NC, USA). After 48 h in a 5% CO2 
incubator at 37°C, spent RBL medium ± quercetin was removed by decanting. From here, 
sample wells were washed twice with 0.9 mM Ca2+ (low-calcium) Tyrodes, and 100 μl/well 
fresh RBL medium was added to cells for 30 min (Galli et al., 2008). Stimulated cell samples 
then received 200μl aliquots of c48/80, spontaneous release cells received plain low Ca2+ 
Tyrodes, and lysed cells received Triton-X 100 diluted to 0.2% (v/v) in low- Ca2+ Tyrodes. 
Degranulation (release of β-hexosaminidase) was quantified as previously described (Weatherly 
et al., 2013). 
 
2.4.9 Calcium measurement assay 
RBL-2H3 cells (100µL/well) were plated in a 96-well plate in RBL media at a density of 
0.5 x 106 cells/ml and incubated overnight at 37°C and 5% CO2. Also, 2 mM sulfinpyrazone 
solution in Tyrodes buffer was prepared, vortexed, and rotated at 37°C overnight. On the 
following day, cells were sensitized with 0.1 µg/ml anti-DNP IgE (Sigma) (in RBL media; 
100µL per well) for 1 h at 37°C and 5% CO2. Sulfinpyrazone solution (2mM) was sterilized 
using syringe filtration (0.2 µm), after its pH was adjusted to 7.4, and then was diluted to 0.6 mM 
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using BT (2 mg/mL BT). The stock of 911µM Fluo-4/AM dye was diluted to 4.55 µM using BT. 
For DMSO control samples, 0.5% DMSO-BT was also prepared. Some of the 4.55 µM Fluo-
4/AM-BT was further diluted to be 2.5 µM using 0.6 mM sulfinpyrazone in BT (Fluo-4/AM-
sulfinpyrazone-BT) and 0.27% DMSO-sulfinpyrazone- BT was also prepared as the 
corresponding vehicle control. 
After 1h IgE-sensitization, cells were washed with warm BT (200 µL per well), followed 
by addition of 100 µL per well of 4.55 µM Fluo-4/AM-BT, 0.5% DMSO-BT, or BT (all in the 
absence of sulfinpyrazone), to the appropriate wells for 1 min. Immediately after 1 min, these 
solutions were discarded, and 200 µL per well of 2.5 µM Fluo-4/AM-sulfinpyrazone- BT, 0.27% 
DMSO-sulfinpyrazone-BT, or 0.6 mM sulfinpyrazone- BT was added for 30 min at 37°C. After 
30 min of Fluo-4 incubation, cells were washed twice with 0.6 mM sulfinpyrazone - BT (200 µL 
per well), and then 250 µL per well of 0.6 mM sulfinpyrazone-BT were added for the baseline 
fluorescence reading at 485 nm excitation and 528 nm emission for 2 min (42 s intervals between 
readings). The sulfinpyrazone-BT solutions were discarded from the plate, and 240 µL per well 
of 0.6 mM sulfinpyrazone-BT ± 0.0002 µg/mL antigen ± 750 ppb arsenic were added to the 
corresponding wells. Fluorescence readings, at 485 nm excitation and 528 nm emission, were 
taken for 1 h post- stimulation (42 s intervals between readings). 
After the hour, for maximal Ca2+ readings, which are a measurement of cell number per 
well, 10 µL of 10% Triton-X 100 (TX-100) was added to each well. The fluorescence reading 
was taken after a10 min incubation (with agitation) at 37°C. TX-100 fluorescent values for all 
replicates were averaged, and no differences among samples were determined by one-way 
ANOVA followed by Tukey’s post- test (data not shown), indicating that all wells contained 
equal numbers of cells. 
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Finally, 50 µL of 0.5M EDTA (USB, Cleveland, OH, USA), which chelates Ca2+ and 
lowers the fluorescent signal to the background level, was added to each well, and the 
fluorescence reading was taken after a 5 min incubation. Fluorescence levels dropped to no-Fluo-
4 background levels, and no statistically significant differences among samples were found (data 
not shown), indicating that measured fluorescence signals were due to the interaction of Fluo-4 
dye and Ca2+. 
 
2.4.10 Phospho-p85 PI3K ELISA  
A Fast Activated Cell-based ELISA Kit (Active Motif, Carlsbad, CA, USA) was used, to 
detect the levels of both phosphorylated and total PI3K p85 in the cell, according to the 
manufacturer’s instructions. RBL-2H3 cells (100 µL per well) were plated in a clear 96-well 
plate at a density of 0.5 x 106 cells/ml and incubated for 12-16 h at 37°C and 5% CO2. On the 
following day, after 1 h sensitization with 0.1 µg/ml anti-DNP IgE (Sigma), cells were 
stimulated with either 1µg/ml DNP-BSA antigen or BT (control) ± 750 ppb arsenic for 5 min at 
37°C. Next, cells were fixed with 4% formaldehyde (Sigma) in PBS (Lonza, Rockland, ME, 
USA) solution at room temperature for 20 min. Once the formaldehyde mixture was discarded, 
cells were washed three times with 1X wash buffer provided in the kit (200 µL per well per 
wash; 5 min gentle shaking per wash). The remaining steps were carried out according to the 
manufacturer’s directions. Absorbance was measured (at 450 nm) immediately after the addition 
of the “stop” solution. Cells were then stained with crystal violet, following the manufacturer’s 
protocol, and absorbance was read at 595 nm. The measured OD450 reading was then corrected 
for cell number by dividing the OD450 value by the OD595 value for each well.  
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2.4.11 Phospho-Syk ELISA 
PathScan® Phospho-Syk sandwich ELISA kit (Cell Signaling Technologies, Beverly, 
MA, USA) was used to detect endogenous levels of phosphorylated Syk according to the 
manufacturer’s instructions. This is a pan-tyrosine ELISA, able to detect altered phosphorylation 
for all Syk’s key Tyr residues. For this assay, RBL-2H3 (1.75 x 106 cells/mL) were plated on 10 
cm2 tissue-culture treated, sterile dishes (Cellstar, Greiner Bio-One, Monroe, NC, USA) at a 
volume of 6.5 mL per well (final cell density of 1.14x107 cells per dish), and were incubated 
overnight (12-16 h) at 5% CO2 and 37°C. Cells were sensitized overnight by addition of 1µg/ml 
anti-DNP IgE (generously provided by Drs. Barbara Baird and David Holowka, Cornell 
University) in RBL media or the following day for 1 h with 0.1 µg/ml anti-DNP IgE (Sigma). 
Following the overnight incubation, each dish was checked to ensure a cell confluence of 
80-90%. After IgE-sensitization (37°C and 5% CO2), spent IgE-media mixture was discarded, 
and dishes were washed twice with 5 ml BT to remove any unbound IgE. The 5 ml treatments 
added next included either BT for the unstimulated controls or DNP-BSA antigen at 1µg/ml for 
stimulated samples; all samples included arsenic or water vehicle (cell culture water, Lonza, 
Rockland, ME, USA). Dishes were incubated for exactly 5 min in a bacterial incubator at 37°C. 
Immediately, dishes were placed on ice, washed once with ice-cold PBS (~5 mL), and lysed with 
0.4 mL of ice-cold 1X lysis buffer containing phenylmethanesulfonyl fluoride solution for 5 min. 
(The 10X lysis buffer provided in the kit was diluted with sterile water before use;100 mM 
phenylmethanesulfonyl fluoride [Sigma] stock dissolved in ethanol was added at a concentration 
of 1 mM immediately prior to buffer addition). Next, cells were harvested by scraping and were 
placed into pre-cooled 2mL microcentrifuge tubes. Cell suspensions were sonicated three times 
on ice by introducing a clean sonicating probe directly into the sample. The sonicator (Branson 
 
 
41 
 
Sonifier, Branson Ultrasonics Corporation, Danbury, CT, USA) was set at output control of 5, 
duty cycle of 30, Timer at 2, 1 s in duration, with a 10 s break on ice in between sonications 
(these sonicating conditions were found to result in complete cell lysis; data not shown). Finally, 
the sonicated lysates were spun down at 14400xg for 10 min at 4°C. A volume of 100 µL of 
clarified supernatant was transferred to new, pre-cooled tubes containing 100 µL sample diluent 
(provided in kit). After a brief vortex, 100 µL of each diluted sample was placed into an 
appropriate ELISA well, sealed with parafilm, and incubated for 16-20 h at 4°C. The remaining 
steps were carried out according to the manufacturer’s directions. Absorbance was measured 
immediately after the addition of the “stop” solution.  
 
2.4.12 Statistical analyses 
Unless otherwise indicated in individual figures, results from degranulation experiments 
(using Ag ± A23187 Ca2+ ionophore, Tg, or c48/80) are reported as mean ± SEM, with 
significant differences determined using Graphpad Prism software (San Diego, CA, USA). For 
multiple-comparison testing, Tukey’s post hoc test was used following one-way ANOVA. In 
several cases, data required normalization in order to control for day-to-day variation of cell 
culture; in these instances, Tukey’s comparisons are reported with regard to a low dose of the 
agent used that was not significantly different from the 0 control to which all values were 
normalized. In the event that normalization was not required, significance was directly made to 
the 0 control.  
For calcium measurement assay, the data were analyzed as areas under the curve (AUC), 
a measure of total calcium response over a 30 or 60 min period. First, the fluorescence values 
before antigen stimulation (baseline) were averaged, then subtracted from the corresponding 
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antigen-stimulated samples’ fluorescence values. Next, those values were normalized to the last 
0 ppb arsenic time point. These normalized values were used to determine AUC via Graphpad 
Prism software. The AUC values were further normalized to each day’s 0 ppb arsenic AUC 
value, and the data from multiple days of experiments were expressed as a bar graph. The 
statistical significance was determined via one-way ANOVA with Tukey’s post hoc test 
For the phospho-p85 PI3K ELISA, the average value from the antigen + 750 ppb arsenic 
group was normalized to the average value from the antigen + 0 ppb arsenic group from each day 
before compiling multiple experiments, and significance was determined by one-sample 
unpaired t-test. For phospho-Syk ELISA, treatment samples (antigen ± 750 ppb arsenic) were 
expressed as a % increase over spontaneous control (no IgE/antigen) sample, and the statistical 
analysis was done by unpaired t-test.  
 
2.5 Results 
2.5.1 Short term exposure of arsenic inhibits antigen-mediated degranulation in RBL-2H3 
mast cells without cytotoxicity 
We have previously reported the ability of arsenic to inhibit degranulation in RBL-2H3 
mast cells following 1 h exposure to DNP-BSA antigen (Ag) (Hutchinson et al., 2011) (Fig.  
2.1).  
We next tested whether degranulation is inhibited within 15min of antigen and arsenic 
exposure. Based on initial 15-min DNP-BSA antigen dose response data (not shown), 0.0004 
μg/ml DNP-BSA antigen was chosen. This antigen dose was chosen because, in the absence of 
arsenic, it elicited a degranulation value of 9.4% ± 0.8% (SEM), which is similar to the response 
of the 0 ppb arsenic sample in Figure 2.1(Hutchinson et al., 2011). Arsenic (750 ppb) causes a 
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15% ± 2% (SEM) inhibition of the 0 ppb control value (Fig. A.1A). These data indicate the 
dampening effect of arsenic on antigen-mediated degranulation begins to occur quite rapidly in 
RBL mast cells. Arsenic has no significant effect on spontaneous degranulation (1.4% ± 0.1% 
[SEM]) during this time period (Fig. A.1B). 
 
Figure 2.1. Arsenic inhibits RBL-2H3 cell degranulation following 1 h exposure to 
dinitrophenyl-bovine serum albumin antigen. Effects of various concentrations of arsenic on 1 h, 
0.00016 μg/ml antigen-mediated degranulation were assessed as described (Hutchinson et al., 
2011).  In the absence of arsenic, this antigen dose elicited an average absolute degranulation 
response of 12 ± 2% (SEM; ~23% of the maximal response). Values represent means ± SEM for 
five independent experiments, where three replicates per dose were performed for each 
experiment. One-way ANOVA with Tukey’s post-tests (compared to the 1 ppb sample) were 
performed using Graphpad Prism software; *p< 0.05, ***p< 0.001. Reprinted from (Hutchinson 
et al., 2011) (Copyright 2010 John Wiley & Sons, Ltd.) 
 
To confirm the lack of cytotoxicity of high dose arsenic (up to 1500 ppb) seen in our 
previous work (Hutchinson et al., 2011), an additional cytotoxicity/mitochondrial function assay 
that measures both plasma membrane integrity and ATP production was performed. ATP is 
required for degranulation (Burgoyne and Morgan, 2003). Arsenic (up to 1500 ppb) is not only 
non-cytotoxic, but also does not disrupt ATP production (Fig. A2), even under buffer and timing 
conditions that allow for robust arsenic inhibition of antigen-stimulated degranulation (data not 
shown). Due to mammalian cell generation of ATP via both oxidative phosphorylation and 
glycolysis, glucose-free, galactose-containing media (“galactose media”) was utilized to avoid 
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ATP production via glycolysis in this experiment (Fig. A2 A-B).  In addition, neither 
cytotoxicity nor ATP depletion is observed in experiments utilizing glucose-containing media 
(Fig. A2 C-D), wherein cells produce sufficient ATP via glycolysis. 
 
2.5.2 Membrane ruffling of F-actin in RBL-2H3 cells is not qualitatively affected by arsenic 
RBL-2H3 cells were stained with Alexa 488-conjugated phalloidin to label F-actin and 
imaged with an Olympus confocal microscope. In the absence of FcεRI engagement (treatment 
with plain BT only, a “spontaneous release” control), cytoskeletal membrane ruffling is very 
limited or is not observed in cells (Fig. 2.2A). As seen in Fig. 2.2B, the addition of 750 ppb 
arsenic without an IgE-FcεRI crosslinking agent also does not lead to visible changes in F-actin 
distribution. Conversely, when IgE-bound FcεRI receptors were crosslinked by 0.00016 μg/ml 
DNP-BSA antigen, multiple membrane protrusions are observed (Fig. 2.2C). At this same 
antigen concentration (0.00016 μg/ml DNP-BSA) with the addition of 750 ppb arsenic, little or 
no qualitative difference is observed (Fig. 2.2D) compared to the no-arsenic control. Similar 
results are obtained with a mid-range dose of 0.0004 μg/ml Ag in the presence and absence of 
750 ppb arsenic (Fig. A3). In summary, co-incubation of RBL-2H3 with DNP-BSA antigen and 
750 ppb arsenic does not appear to substantially affect the extent of ruffling. 
 
2.5.3 As does not inhibit degranulation of RBL-2H3 cells when stimulated with A23187 
Ca2+ ionophore 
Stimulation of RBL-2H3 cell degranulation using Ca2+ ionophore has been detailed in the 
scientific literature (Siraganian et al., 1975;  Beaven et al., 1984;  Hanson and Ziegler, 2002). 
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This method of degranulation bypasses engagement of FcεRI receptors, causing Ca2+ influx 
across the plasma membrane. Use of Ca2+ ionophore therefore allows identification of arsenic’s 
cellular targets as being upstream or downstream of Ca2+ influx. Doses of A23187 ionophore 
were selected based on their non-cytotoxicity in a lactate dehydrogenase (LDH) assay (Fig. A4), 
in the presence of up to 750 ppb arsenic, which did not affect LDH enzyme activity (Fig. A5). 
 
 
 
 
 
 
 
 
Figure 2 2. F-actin ruffling during antigen-stimulated degranulation of RBL-2H3 cells. F-actin 
was visualized using Alexa Fluor 488 conjugated phalloidin. RBL-2H3 cells were exposed to (A) 
no antigen; (B) no antigen+750 ppb arsenic; (C) 0.00016 μg/ml antigen; (D) 0.00016 μg/ml 
antigen+750 ppb arsenic for 1 h before being fixed.  A representative set of images is shown. 
 
DMSO has been linked to inhibition of interleukin-8 production (Deforge et al., 1992), 
decreased NF-κB activation in macrophage cells (Kelly et al., 1994), and has been shown to 
activate PKC and scavenge free radicals (Ogura et al., 1995). Arsenic an oxygen radical 
scavenger, DMSO has also been shown to inhibit the production of reactive oxygen species 
(ROS) in experimental studies (Hei et al., 1998;  Liu et al., 2001). As ROS production has been 
shown to be vital to mast cell inflammatory responses (reviewed in (Swindle and Metcalfe, 
2007)), and there is a strong relationship between ROS and degranulation in RBL-2H3 (Suzuki 
et al., 2003), it was important that we ensure the level of DMSO used in these ionophore 
D)  
C)  
B)  A)  
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experiments does not impact degranulation in this way. We demonstrated that degranulation 
experiments containing 0.004% DMSO retain statistically significant inhibition, due to arsenic, 
of antigen-stimulated RBL-2H3 cells, and that DMSO at this concentration does not impact the 
cell’s ability to degranulate. A two-way ANOVA in Prism was performed to compare antigen-
stimulated degranulation experiments in the presence and absence of 0.004% DMSO: no 
statistically-significant difference was found (Fig. A6). These control data demonstrate that the 
degranulation values obtained from the A23187 Ca2+ ionophore tests are not impacted by the 
vehicle conditions. 
We used the probe 2',7'-dichlorodihydrofluorescein diacetate (Cell Biolabs; San Diego, 
CA), which measures various intracellular ROS, in order to directly test whether arsenic 
modulates ROS under the treatment conditions of the degranulation experiments. Neither 500 
nor 750 ppb arsenic affect intracellular ROS production at any time point measured for 1 h at 1-2 
min intervals (data not shown). 
           
Figure 2.3. Arsenic does not inhibit A23187 Ca2+ ionophore-stimulated degranulation in RBL-
2H3 cells. RBL-2H3 cells were harvested and plated as described in the “Methods” section. Cells 
were stimulated to degranulate for 1 h with either (A) 1.5 x 10-7 M (which caused an average 
absolute degranulation response of 11.5% ± 2.8% [SEM]) or (B) 2.0 x 10-7 M (which caused an 
average absolute degranulation response of 18.1% ± 3.2% [SEM]) A23187 Ca2+ ionophore. 
Resultant β-hexosaminidase was measured as described in “Methods.”  Values are means ± SEM 
from seven independent experiments per A23187 dose, each with three replicates per 
experiment. No statistical significance was determined by one-way ANOVA followed by 
Tukey’s post- test, where multiple comparisons were made to the 100 ppb sample. As, arsenic. 
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Regarding the use of Ca2+ ionophore on RBL-2H3 cells, 1 h treatment of 1.5 x 10-7 M 
A23187 elicited an average absolute degranulation response of 11.5% ± 2.8% (SEM) in the 
absence of As (Fig.2.3A); exposure to 2.0 x 10-7 M A23187 resulted in a degranulation value of 
18.1% ± 3.2% (SEM) (Fig.2.3B). Co-exposure to A23187 ionophore and arsenic (0-750 ppb) 
revealed no arsenic inhibition of degranulation (Fig.2.3). The lack of an inhibitory response due 
to As on Ca2+ ionophore-mediated degranulation strongly suggests a pathway target upstream of 
Ca2+ influx across the plasma membrane. 
 
2.5.4 As does not inhibit degranulation of RBL-2H3 cells when stimulated with 
thapsigargin 
There is a biphasic calcium modulation in RBL-2H3 cells. Before Ca2+ being shuttled 
across the plasma membrane in the degranulation pathway (which we facilitated, as detailed 
above, using A23187 ionophore), Ca2+ is released from internal ER stores. To investigate this 
earlier Ca2+ signaling event, we utilized the pharmacological agent Tg. We have found Tg to be 
extremely vulnerable to oxidation, requiring immediate use within 1-2 days of preparation. In the 
absence of arsenic, the average % degranulation response for 4.6 nM Tg was 11.9 + 3.9%; 
spontaneous release was 2.3 + 0.9% (mean ± SEM). As seen in Fig 2.4A, no significant 
difference in Tg-stimulated degranulation is caused by arsenic (Fig. 2.4A). A series of 
cytotoxicity experiments were performed to test whether 4.6 nM Tg ± arsenic is toxic to RBL-
2H3 cells. Trypan blue exclusion (Fig. 2.4B) and LDH (Fig. 2.4C) data demonstrate no 
cytotoxicity for Tg and arsenic concentrations tested in degranulation experiments after 1 h 
exposure. Collectively, these results indicate that arsenic’s cellular target is upstream of Ca2+ 
release from internal ER stores. 
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Figure 2.4. Arsenic does not inhibit Tg -induced degranulation. (A) Relative degranulation 
response of RBL-2H3 cells treated for 1hr with 4.6 nM Tg (which caused an average absolute 
degranulation response of 11.9 + 3.9% [SEM]), ± As. Values represent mean ± SEM of three to 
five experiments of triplicate samples per dose per experiment. A spontaneous release 
measurement (no Tg or As present) is depicted for reference. No significant difference was 
determined by one-way ANOVA. (B) trypan blue exclusion assays, the percentage of living cells 
present in the 0 nM Tg control is plotted against concentration of Tg (1.5 and 4.6 nM); all 
samples contain 750 ppb As. Values are means of two experiments, each with triplicate samples, 
where data were normalized to the 0 control (with no Tg and no As, but containing Tg vehicle of 
0.001% dimethyl sulfoxide). No significant difference was determined by one-way ANOVA. (C) 
Short-term cytotoxicity was determined using an LDH cytotoxicity detection kit; concentration 
of Tg is plotted against the percentage LDH released in the absence or presence of 750 ppb As; 
values represent individual wells (n = 6-9), and error bars are SD. No significant difference was 
determined by one-way ANOVA. As: arsenic; LDH, lactic dehydrogenase; Tg, thapsigargin. 
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β-hexosaminidase release by RBL-2H3 cells in a dose-dependent manner (data not shown) and 
non-cytotoxic manner (Fig.2.5B). We additionally confirmed that treatment with c48/80 and 
quercetin has no effect on background fluorescence as measured in the degranulation assay (data 
not shown). Although we determined that 25 μg/ml c48/80 induces a non-cytotoxic increase in β-
hexosaminidase release in the absence of quercetin pre-treatment, this modest response is 
enhanced by 48 h quercetin treatment (data not shown), allowing for greater dynamic range in 
which to study potential effects due to arsenic treatment.  
A      B 
        
 
Figure 2.5. Arsenic does not affect c48/80-induced degranulation of RBL-2H3 cells. (A) Effect 
of As on c48/80-mediated degranulation. Cells were pre-treated with quercetin and then co-
exposed to 25 μg/ml c48/80 (which caused an average absolute degranulation response of 7.7% ± 
0.6% [SEM]) and varying concentrations of As (0-750 ppb) for 15 minutes, followed by β-
hexosaminidase quantification as described in “Methods.” Data were normalized to the 0 ppb As 
response value of each experiment (n = 5). (B) LDH cytotoxicity assay indicating non-
cytotoxicity of 25 μg/ ml c48/80 treatment (n = 3). Cells were treated as in (A), and LDH release 
was measured as described in “Methods.” (A-B) values represent means ± SEM; statistical 
significance was determined by one-way ANOVA followed by Tukey’s post test (in A, 
comparison made to 100 ppb; in B, direct comparison is made to 0 μg/ml 48/80); *p< 0.05, 
***p< 0.001. As, arsenic; LDH, lactic dehydrogenase. 
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of c48/80 and arsenic does not cause cytotoxicity (Fig. 2.5B). While 50 ug/mL c48/80 is 
cytotoxic (Fig. 2.5B), this concentration was not used in the degranulation experiments (Fig. 
2.5A), which employed the non-cytotoxic dose of 25 μg/mL c48/80. 
 
2.5.6 As inhibits antigen-stimulated Ca2+influx 
Ca2+ influx is a key event in the signal transduction pathway leading to mast cell 
degranulation. To directly measure cytosolic Ca2+ levels, RBL-2H3 cells were incubated with 
fluo 4/AM fluorescent dye for 30 min, to allow dye uptake, and then were exposed to 0.0002 
μg/ml DNP-BSA antigen ± 750ppb arsenic. Next, fluorescence indicating levels of Ca2+ inside 
the cell were measured in a plate reader for 1 h post stimulation. Our data indicate that arsenic 
dampens Ca2+ influx into antigen-activated mast cells (Fig. 2.6). These results suggest that 
arsenic’s target lies upstream of the Ca2+ influx event. 
 
            
 
Figure 2.6. Arsenic dampens Ca2+ influx into antigen-activated RBL-2H3 cells.  Fluo-4/AM was 
used to measure Ca2+ levels within RBL-2H3 cells which had been sensitized with anti-
dinitrophenyl IgE (0.1μg/ml) for 1 h before exposure to ± 0.0002 μg/ml dinitrophenyl-bovine 
serum albumin antigen ± 750ppb As, at 30 min (A) or 1 h (B) post-antigen stimulation. Control 
samples received no As or antigen. Values represent mean (normalized to 0 ppb As) ± SEM of 
four experiments, with 8-16 replicates per dose per experiment. Statistical significance, as 
compared to the 0 ppb As sample, was determined by one-way ANOVA followed by Tukey’s 
post test; ***p<0.001. As, arsenic.  
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2.5.7 As inhibits phosphorylation of phosphoinositide 3-kinase 
PI3K is involved in a variety of cell functions because it catalyzes the production of 
many crucial lipid signaling molecules, including PIP2. PIP2 enables recruitment of a wide range 
of proteins containing Pleckstrin homology domains, thus drawing these proteins to the plasma 
membrane for activation (Abramson and Pecht, 2007). PIP2 is used by PLC γ to generate IP3, an 
important player in Ca2+ mobilization (Kalesnikoff and Galli, 2008). Overall, PI3K activation 
supports Ca2+ mobilization and degranulation. Therefore, we examined whether PI3K is affected 
by arsenic exposure. We utilized a commercially available Fast Activated Cell-based ELISA kit, 
which quantifies activated PI3K and/or total PI3K. Two primary antibodies provided from this 
ELISA kit recognize either phosphorylated p85, the regulatory subunit of PI3K or total PI3K p85 
levels, respectively. 
 
 
Figure 2.7. Arsenic inhibits phosphorylation of PI3K in RBL-2H3 cells. RBL-2H3 cells were 
sensitized with anti-dinitrophenyl IgE (0.1μg/ml) for 1 h before being treated with dinitrophenyl 
–bovine serum albumin antigen (1μg/ml) ± 750ppb As for 5 min. Levels of (A) phosphorylation 
of the p85 subunit of PI3K and (B) total p85 subunit of PI3K were measured with a Fast 
Activated Cell-based enzyme-linked immunosorbent assay kit. Data were plotted after correction 
for cell number (by use of crystal violet staining). Values represent mean (normalized to 0 ppb 
As) ± SEM of three to four experiments of triplicate samples. Statistical significance was 
determined by one sample t-test; **p<0.01. As, arsenic; PI3K, phosphoinositide 3-kinase. 
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Using this ELISA, we detected a significant decrease in phosphorylation of the p85 
subunit of PI3K due to 750 ppb arsenic exposure, compared to the 0 ppb arsenic group (Fig. 
2.7A). Because PI3K is constitutively associated with the kit receptor and because RBL-2H3 
cells’ kit receptor is known to be constitutively active, there is a high level of phosphorylated 
PI3K even in the absence of Ag stimulation in RBL-2H3 cells (Tsujimura et al., 1995). Thus, the 
data were normalized to the antigen-stimulated, 0 ppb arsenic samples, not to the unstimulated, 0 
ppb arsenic sample. The level of total p85 protein was unchanged regardless of arsenic treatment 
(Fig. 2.7B). These results suggest that arsenic interferes with antigen-activated phosphorylation 
of PI3K. 
 
2.5.8 As inhibits phosphorylation of Syk kinase 
Previous studies report that the regulatory subunit (p85) of PI3K is one of the direct 
binding partners of Syk protein (Okkenhaug and Vanhaesebroeck, 2003;  Mocsai et al., 2010). 
Since we observed the reduction of phosphorylation/activation level of PI3K (Fig. 2.7), we 
sought to investigate arsenic effects on phosphorylated Syk protein using a commercially 
available pan-tyrosine phosphorylated Syk ELISA. Using this ELISA, we detected significant 
changes in phosphorylated Syk protein between antigen-stimulated and spontaneous-release 
samples. Figure 2.8 compares antigen-stimulated samples ± 750 ppb arsenic and shows a 
significant decrease in phosphorylation of Syk protein due to arsenic treatment. Phospho-Syk 
ELISA data provide evidence that arsenic is interfering with early tyrosine phosphorylation 
events in the degranulation pathway in mast cells. 
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Figure 2.8. Arsenic inhibits phosphorylation of Syk kinase. RBL-2H3 cells were sensitized with 
dinitrophenyl IgE (0.1μg/ml) for 1 h before being treated with dinitrophenyl –bovine serum 
albumin antigen (1μg/ml) ± 750ppb As for 5 min. Phosphorylation of Syk was measured with a 
PathScan ® Phospho-Syk (panTyr) Sandwich enzyme-linked immunosorbent assay kit. Values 
are expressed as percent increase over spontaneous (no Ag) control samples and represent mean 
± SEM of four experiments, each of triplicate samples. Statistical significance was determined 
by one sample t-test; *p<0.05. Ag, antigen; As, arsenic. 
 
2.6 Discussion 
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downstream target proteins of Syk, such as PI3K (Fig. 2.7). Syk and PI3K are both activated 
rapidly (within min) after antigen exposure. In our previously published study (Hutchinson et al., 
2011), degranulation was inhibited by As in a 1 h treatment with DNP-BSA antigen. When we 
examined the same DNP-BSA antigen treatment in a shorter period (15 min), we found that As 
inhibits degranulation at this earlier time point as well, indicating that its effects are acute and 
rapid (Fig. A.1A). We also performed experiments with chronic arsenic exposure of mast cells 
and found that longer exposure of arsenic did not alter the extent of arsenic’s inhibition of 
degranulation (data not shown).  
Acute arsenic poisoning, at very high arsenic concentrations, can lead to inhibition of 
glycolysis and cellular ATP production, due to arsenic substitution for phosphate (DeMaster and 
Mitchell, 1973). While we earlier showed, via multiple methods, that arsenic is not cytotoxic to 
RBL-2H3 mast cells at the concentrations used in this study (Hutchinson et al., 2011), we had 
not yet determined whether arsenic affects ATP production under these experimental conditions. 
Here we show that arsenic doses up to 1500 ppb do not affect ATP production (Fig A2), 
suggesting that inhibition of catabolism and widespread phosphate substitution is not occurring. 
Under the same glucose-free conditions, the canonical mitochondrial uncoupler carbonyl cyanide 
3-chlorophenylhydrazone, which also inhibits degranulation of RBL-2H3 cells, decreases ATP 
production, with an EC50 of 0.8µM – 1.6 µM (95% Cl),with no cytotoxicity (Weatherly et al., 
2016). 
To narrow down arsenic’s target(s) in the mast cell signaling pathway, we investigated 
whether arsenic affects the F-actin rearrangement or “membrane ruffling” in RBL-2H3 cells, 
another phenotype of activated mast cells. This strategy tests for potential cellular targets for 
arsenic that are common to both the degranulation and membrane ruffling pathways, such as 
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PKC (Pfeiffer et al., 1985;  Yanase et al., 2011). Our finding of no or a small arsenic effect on 
membrane ruffling (Fig 2.2) supports the conclusion that cellular targets that are downstream of 
Ca2+ influx and that are common to both degranulation and ruffling are unaffected by arsenic. 
Ca2+ ionophore A23187 was utilized to bypass FcεRI and the early tyrosine 
phosphorylation events and to stimulate the release of granules through the influx of Ca2+ alone 
into the cell (Siraganian et al., 1975). In experiments utilizing A23187, we determined that 
arsenic does not inhibit degranulation (Fig 2.3), indicating that arsenic’s pathway target is 
upstream of Ca2+ influx across the plasma membrane. 
We also used the pharmacological agent Tg, which is a potent, cell permeable, IP3- 
independent intracellular Ca2+ releaser/SERCA pump blocker that acts a mast cell secretagogue 
(Rasmussen and Christensen, 1978;  Patkar et al., 1979). Like A23187 Ca2+ ionophore, Tg 
stimulates mast cell degranulation while by passing FcεRI crosslinking and early tyrosine 
phosphorylation events. However, unlike with A23187-induced cell activation, Tg stimulation 
does involve STIM-1 in the ER and the plasma membrane CRAC channels. Our data indicate 
that, with the use of the non-cytotoxic dose of 4.6 nM Tg to elicit degranulation, As does not 
inhibit degranulation (Fig 2.4). This concentration of Tg is within the documented IC50 for 
inhibiting SERCA (4-13 nM) (Calbiochem production information). Thus, these data show that 
arsenic’s cellular target not only lies upstream of Ca2+ influx across the plasma membrane, but 
also is not STIM-1 or other players in ER Ca2+ mobilization. 
In view of the fact that c48/80 activates degranulation via PLD in a Ca2+- dependent 
manner, c48/80-mediated degranulation assays can be used to measure toxicant effects on these 
portions of the degranulation pathway. Because there is no arsenic effect on cells stimulated to 
degranulate with c48/80 (Fig. 2.5), arsenic’s inhibitory actions on the degranulation pathway are 
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likely on some portion of the pathway that lies upstream of PLD and Ca2+ influx. Combined, the 
A23187 (Fig. 2.3), Tg (Fig. 2.4), and c48/80 (Fig. 2.5) data strongly suggest that arsenic’s 
inhibitory action lies upstream of all calcium signaling in the degranulation pathway. In addition, 
these data indicate that PKC, PLD and other enzymes activated following Ca2+ mobilization are 
not arsenic’s direct targets in RBL-2H3 mast cells. 
To investigate arsenic effects on events upstream of Ca2+ influx, we developed a 
microplate-based assay to measure the level of cytoplasmic Ca2+ after antigen exposure, ± 
arsenic, in RBL-2H3 mast cells. We found a strong inhibition of the antigen-stimulated Ca2+ 
level in the cells due to arsenic exposure after both 30 min and 60 min of exposure (Fig. 2.6). 
The dampened Ca2+ influx into arsenic-exposed cells is another indicator that arsenic’s target lies 
upstream of Ca2+ influx. Therefore, we investigated the effects of arsenic on early tyrosine 
phosphorylation events, which occur immediately after FcεRI receptor activation. 
Previous researchers have reported that arsenic may interfere with phosphorylation events 
during signal transduction. For example, Cheng et al. (2004) found that sodium Arsenite inhibits 
the Janus kinase signal transducer and activator of transcription cascade, via inhibition of 
phosphorylation of STAT3 specifically at tyrosine resides (Cheng et al., 2004). Moreover, Soto-
Peña et al. (2008) demonstrated that arsenic can interfere with phosphorylation of the kinases 
Lck and Fyn during T-cell signal transduction (Soto-Peña and Vega, 2008). In this study, we 
have found that arsenic inhibits phosphorylation of both PI3K and Syk kinases in antigen-
activated RBL-2H3 cells (Fig. 2.7 and 2.8), thus providing a mechanism for arsenic inhibition of 
mast cell degranulation.  
Arsenite has been shown in certain cases to interact with sulfhydryl groups of kinases and 
to form reactive oxygen species (ROS), which affect kinase activity (Liu et al., 2001). In this 
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study, we have found that arsenic does not affect ROS levels under the treatment conditions of 
these experiments. However, arsenic can directly bind to sulfhydryl groups of certain proteins, 
causing detrimental structural modification or denaturation (Chang et al., 2012). Syk kinase 
(both human and rat) contains numerous cysteine residues, five of which are located specifically 
in its kinase domain. Therefore, derangement of normal phosphorylation activity of Syk, via 
arsenic-sulfhydryl interactions, may be a mechanism underlying the inhibition of both antigen-
stimulated Syk phosphorylation and degranulation of mast cells. 
The implications of this mechanistic study can assist researchers to better understand a 
mode of arsenic toxicity that is likely to not be organism-specific or even mast-cell specific. 
Classic immunoreceptors, such as B cell receptors, T cell receptors, and Fc receptors, signal via 
similar mechanisms, and the signal transduction pathways present in mast cells share many 
similarities with those of T and B cells. Arsenic’s inhibition of Syk activity (and, subsequently, 
PI3K) in mast cells suggests that arsenic inhibits Syk and similar proteins in the same manner in 
numerous cell types. Syk has garnered attention as a potentially novel target for treatment of 
allergic and inflammatory disorders (Wong et al., 2004;  Ulanova et al., 2005;  Bajpai et al., 
2008). Because arsenic has now been shown to inhibit this vital process in allergy and asthma 
development, mast cell degranulation, our data strongly suggest that Syk could be a drug target 
to treat these diseases.  
In fact, arsenic has been employed in Chinese medicine to treat asthma (ATSDR, 2007).  
While arsenic inhibition of mast cells in vivo has not yet been directly demonstrated, arsenic has 
been shown to block anaphylactic responses in guinea pigs (Poriadin et al., 1977) and to alleviate 
asthma responses in mice (Zhou et al., 2006;  Chu et al., 2010). Also, arsenic-exposed, parasite-
infected children in Bangladesh were found to be thinner than controls also exposed to parasites 
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but not to arsenic (Minamoto et al., 2005), a result that suggests that arsenic exposure could 
inhibit mast cells in vivo, thus increasing helminth burden and wasting. Inhibition of mast cell 
function by arsenic was not offered as an explanation for these findings but is a possible 
mechanism of the in vivo effects described in these studies. 
In conclusion, we have shown that arsenic inhibits mast cell degranulation at 
environmentally relevant, non-cytotoxic doses, via inhibition of early tyrosine phosphorylation 
events. These data provide a molecular mechanism for arsenic’s effects on this ubiquitous cell 
type and suggest that As will have similar molecular targets in many additional cell types. 
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CHAPTER 3 
MOLECULAR MECHANISMS UNDERLYING ANTIMICROBIAL AGENT 
TRICLOSAN’S INHIBITION OF MAST CELL SIGNALING: ROLES  
OF PROTEIN KINASE C AND PHOSPHOLIPASE D 
3.1 Abstract 
Humans are exposed to antimicrobial agent triclosan (TCS) through use of TCS-
containing products. Exposed tissues contain mast cells, which are involved in numerous 
biological functions and diseases by secreting various chemical mediators through a process 
termed degranulation. We previously demonstrated that TCS inhibits mast cell degranulation. 
Previously, we discovered that TCS inhibits Ca2+ influx into antigen (Ag)-stimulated mast cells.  
Here, we have investigated TCS effects on protein kinase C (PKC) and phospholipase D (PLD), 
crucial signaling enzymes that are activated downstream of Ca2+ rise. Using fluorescent 
constructs and confocal microscopy, we found that TCS delays the timing Ag-induced 
translocations of PKC βII, PKC δ, and PKC substrate MARCKS, even while the overall ability 
of these molecules to translocate is unaffected by TCS.  Surprisingly, TCS does not inhibit PKC 
activity and actually increases PKC activity by 45 min post Ag.  While TCS does not 
significantly affect the ability of PLD1 to translocate toward the plasma membrane in response to 
Ag stimulation, TCS does strongly inhibit overall PLD activity within 15 min post Ag.  Our 
studies elucidate the biochemical mechanisms underlying triclosan’s inhibition of degranulation 
and pinpoint the timing of defects by TCS on the mast cell signaling pathway.  These results 
offer molecular predictions of triclosan’s effects on other mammalian cell types which share 
these crucial signal transduction elements and provide explanations for recent epidemiological 
findings implicating TCS in human health problems.   
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3.2 Introduction 
Triclosan (TCS) is a synthetic antimicrobial agent that was recently banned by the FDA 
from both consumer (Kux, 2016) and hospital soap products (Fischer, 2017). However, TCS still 
remains, at high concentrations, in other top-selling consumer products, such as toothpaste and in 
other “antibacterial” household products (e.g., toys, kitchenware, etc.). TCS from consumer 
products is readily absorbed when applied to human tissues, where it is not rapidly metabolized 
or cleared. The resulting human tissue levels are comparable to exposure levels used in this 
current cell study (TCS exposure is reviewed in (Weatherly and Gosse, 2017)).  Additionally, 
micromolar levels of TCS have been found in human body fluids in several published studies 
(also reviewed in (Weatherly and Gosse, 2017)). Thus, TCS dosages used in this current 
manuscript (10 µM in cell media for ≤ 1h) are directly relevant to actual human exposures to 
TCS products such as toothpaste.  
  Clinically, TCS has been used primarily as an antimicrobial (Daoud et al., 2014) and 
anti-gingival (Rover and Leu-Wai-See, 2014), and there have also been some potentially positive 
findings of TCS treatment of atopic dermatitis (Tan et al., 2010), which may be due to triclosan’s 
ability to inhibit mast cell function (Palmer et al., 2012). However, numerous recent 
epidemiological studies report detrimental TCS effects on human health, including problems 
with thyroid function (Wang et al., 2017), reproduction (Hua et al., 2017), immune function, 
development (Wei et al., 2017) (reviewed in (Weatherly and Gosse, 2017)). Additional recent 
epidemiological studies have also revealed increased risks of gestational diabetes (Ouyang et al., 
2018), abnormalities of sperm morphology (Jurewicz et al., 2018), and lowered cognitive test 
scores in children (Jackson-Browne et al., 2018), due to triclosan exposure. The cellular, 
molecular, and biochemical reasons for these health effects of TCS are not completely 
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understood but include mitochondrial toxicity (Ajao et al., 2015;  Shim et al., 2016b;  Weatherly 
et al., 2016), reactive oxygen species (ROS) generation (Lv et al., 2016), interference with 
cellular calcium dynamics (Ahn et al., 2008;  Cherednichenko et al., 2012;  Weatherly et al., 
2018), endocrine disruption (Ruszkiewicz et al., 2017), and modulation of cytokine gene 
expression (Yueh et al., 2014;  Marshall et al., 2015). 
As noted above, TCS inhibits mast cell (MC) function (Palmer et al., 2012;  Weatherly et 
al., 2013).  MCs are found in nearly every human body tissue and in numerous other species 
(Kuby, 1997). They are particularly enriched in tissues subject to contact with outside 
environmental stimuli, such as the skin, gastrointestinal tract, oral mucosa (Walsh, 2003), and 
respiratory mucosa (Abraham and St John, 2010)—and thus are targets for exposure to chemicals 
from personal care product application. MCs are key players in many physiological and 
pathological processes including allergy, asthma, autoimmunity, infectious disease, cancer, and 
even many central nervous system disorders such as autism, anxiety, and multiple sclerosis 
(Metcalfe et al., 1997;  Williams and Galli, 2000;  Galli et al., 2005a;  Silver and Curley, 2013;  
Girolamo et al., 2017). Therefore, inhibition of MC function has many potential consequences 
on human health. Many of the biochemical events crucial to MC function (such as cytoskeletal 
involvement, calcium signaling, protein kinase C, etc.) are also essential to signaling in 
numerous distinct cell types, including neurons and T cells. Thus, discovery of the biochemical 
mechanisms underlying TCS disruption of MCs leads to predictions of TCS effects in disparate 
cell types that share common signal transduction elements. 
Mast cells are activated by binding of multivalent antigen (Ag) to immunoglobulin E 
(IgE)-bound cell surface FcεRI receptors (Kinet et al., 1983), resulting in secretion of 
cytoplasmic granules which contain mediators such as histamine, tryptase, β-hexosaminidase, 
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serotonin, cytokines, chemokines, and lipid mediators (Schwartz and Austen, 1980). This process 
is termed as mast cell degranulation. FcεRI crosslinking by Ag leads to a tyrosine 
phosphorylation cascade that activates phospholipase C (PLC) γ, which catalyzes the hydrolysis 
of phosphatidylinositol 4,5-bisphosphate (PIP2) to yield diacylglycerol (DAG) and inositol 1,4,5- 
trisphosphate (IP3). While DAG activates protein kinase C (PKC) (Steinberg, 2008), IP3 binds to 
its receptor in the endoplasmic reticulum (ER) causes an efflux of Ca2+ from the ER (Berridge, 
1993), into the cytosol and also into mitochondria (Takekawa et al., 2012;  Furuno et al., 2015).  
Next, calcium release-activated calcium (CRAC) channels in the plasma membrane are 
activated, resulting in a flood of calcium into the cytosol (Putney et al., 2001). 
Within the cytosol, this elevated Ca2+, along with DAG and ROS (Swindle et al., 2004), 
binds to and activates the Ser/Thr family of protein kinase C (PKC) (Ozawa et al., 1993b;  
Steinberg, 2008). PKC isozymes are categorized into three subfamilies (classical [cPKC], novel 
[nPKC], and atypical [aPKC]), according to their biochemical and structural properties, such as 
their binding to DAG and/or Ca2+ (Ozawa et al., 1993b;  Newton, 1995;  Newton, 2001). Of 
particular importance in mast cells are certain cPKC isoforms (PKC α, βI, βII, and γ), which 
have conserved C1 domains (which bind DAG) (Newton, 2001) and C2 domains (which bind 
Ca2+ and acidic phospholipids). Also important to mast cell function are certain nPKC isoforms 
(PKC δ, ε, θ, and η), which are activated by DAG by binding to the C1 domain but which are 
lacking functional C2 domains and, thus, are lacking Ca2+ responsiveness (Newton, 1995).  In 
addition to DAG, activators of PKC δ include various agents such as phorbol esters, UV or 
ionizing radiation, growth factors, and ROS (Yoshida, 2007;  Lee and Yang, 2010).  PKC β and 
δ, which belong to cPKC and nPKC, respectively, are particularly important in IgE–mediated 
mast cell degranulation (Nechushtan et al., 2000;  Cho et al., 2004;  Yanase et al., 2011).  
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Stimulation of RBL-2H3 cells with either Ag or Ca2+ ionophore causes a rapid translocation of 
PKC δ from the cytosol to the plasma membrane (Cho et al., 2004). Also, PKC δ translocation 
and degranulation are both activated by ROS generation in mast cells (Cho et al., 2004).   
Activation of PKC causes its translocation from the cytosol to the plasma membrane, 
serving as a hallmark for PKC activation (Kraft and Anderson, 1983). Inactive PKC is located in 
the cytosol and autoinhibited by a pseudosubstrate (Nishizuka, 1995;  Brown and Kholodenko, 
1999). When Ca2+ binds to cytosolic PKC and alters its electrostatics and, hence, membrane lipid 
affinity (Codazzi et al., 2001), it can then bind DAG in the plasma membrane, leading to full 
activation of PKC by removal of pseudosubstrate from the active site. In other cases, DAG alone 
can recruit cytosolic PKC to the plasma membrane and induce conformational changes to 
activate PKC (Nishizuka, 1995;  Jaken and Parker, 2000). Once PKC is translocated and active, 
it phosphorylates substrates in its proximity in or near the plasma membrane.  One PKC substrate 
is myosin, the phosphorylation of which is important for actin cytoskeletal rearrangements 
(“membrane ruffling”) and degranulation (Ludowyke et al., 1989;  Choi et al., 1994). 
Another of PKC’s substrates is myristoylated alanine-rich C-kinase substrate (MARCKS) 
(Aderem, 1992).  In unstimulated cells, MARCKS tightly binds to PIP2 at the inner leaflet of the 
plasma membrane (Heo et al., 2006). When phosphorylated by activated/translocated PKC, 
MARCKS dissociates from the plasma membrane and enters the cytosol, thus exposing PIP2 to 
be accessible to other proteins (such as PLC γ, for generation of more second messengers) for 
signaling leading to degranulation (Gadi et al., 2011).  In addition, along with Ca2+, PIP2 is 
involved in the soluble N-ethylmaleimide–sensitive factor attachment protein receptor 
(SNARE)-mediated exocytotic machinery required for degranulation (Tadokoro et al., 2015).   
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Another major target of PKC is phospholipase D (PLD). Increases in intracellular Ca2+ 
and PKC translocation work in tandem to activate PLD in mast cells (Lin and Gilfillan, 1992) .  
Although there are many studies in other cell types showing that intracellular Ca2+ activates PLD 
activity (Exton, 1999;  Qin et al., 2009), the mechanisms of PLD activation by Ca2+ remain to be 
elucidated.  Structural analyses have shown that mammalian PLD does not contain a Ca2+ 
binding domain but does contain lipid (PIP3 and PIP2) -binding domains and a PKC-binding 
domain (Henage et al., 2006;  Selvy et al., 2011). While a study showed that mammalian PLD 
activity is insensitive to changes in cytosolic Ca2+ concentration in vitro (Hammond et al., 1997), 
Ca2+ and PIP2 act as essential cofactors for mammalian PLD activation within cells (Sciorra et 
al., 2002;  Henage et al., 2006;  Selvy et al., 2011). PLD activation involves Ca2+-dependent 
PKC isoforms (Wakelam et al., 1997;  Qin et al., 2009). A study using RBL-2H3 mast cells 
showed that PKC inhibitors decrease PLD activity and, subsequently, inhibit degranulation, 
suggesting a close relationship between PKC/PLD activation and degranulation in mast cells 
(Chahdi et al., 2002).  
PLD hydrolyzes phosphatidylcholine, creating phosphatidic acid (PA), an important 
second messenger for numerous cellular functions (Wakelam et al., 1997;  Cockcroft, 2001;  
O'Luanaigh et al., 2002;  Zeniou-Meyer et al., 2007).  PA stimulates PLC γ (Nishizuka, 1995) 
and also can be converted directly into DAG by PA phosphohydrolase—leading to a secondary 
rise in intracellular DAG levels (Nakashima et al., 1991). These increases in DAG are involved 
in activation of the DAG-dependent PKC isoforms (Baldassare et al., 1992;  Nishizuka, 1995;  
Peng and Beaven, 2005), suggesting that PKC-PLD activation is closely regulated in a 
complementary manner between the two enzymes in mast cells. Additionally, PA plays a critical 
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role in regulating mast cell morphology (Marchini-Alves et al., 2012). Continual activity of 
PLD2 is required for membrane ruffling in mast cells (O'Luanaigh et al., 2002).   
Two mammalian isoforms, PLD1 and PLD 2, are expressed in mast cells. PLD1 localizes 
to cytoplasmic granules and has low basal activity whereas PLD2 is constitutively expressed at a 
high level and is located at the plasma membrane (Choi et al., 2002;  Lee et al., 2006). 
Stimulation of mast cells activates both PLD isoforms, but only PLD1 undergoes translocation to 
the plasma membrane and drastic upregulation of its activity (Brown et al., 1998).  Even though 
many studies have agreed on the location and expression of PLD isoforms in mast cells, there 
have been controversial and conflicting data regarding the functions of these isoforms. Several 
studies have reported positive roles of both PLD isoforms in mast cell degranulation (Brown et 
al., 1998;  Chahdi et al., 2002;  Peng and Beaven, 2005;  Lee et al., 2006), with PLD1 involved 
in granule translocation and with PLD2 involved in membrane fusion of these granules (Choi et 
al., 2002).  However, one intriguing recent study using PLD1- and PLD2-knockout mice found 
that PLD1 positively regulates degranulation, while PLD2 is a negative regulator (PLD2 
deficiency enhanced microtubule formation) (Zhu et al., 2015).    
Microtubule polymerization is another essential player:  granules are mobilized to the 
plasma membrane along microtubules for degranulation (Smith et al., 2003). Agents that inhibit 
microtubule polymerization inhibit degranulation (Urata and Siraganian, 1985;  Tasaka et al., 
1991;  Marti-Verdeaux et al., 2003). Once granules are moved to the plasma membrane, they 
dock and fuse to the membrane with the help of PLD and multiple SNAREs in a Ca2+-dependent 
process (Guo et al., 1998;  Baram et al., 1999;  Paumet et al., 2000;  Blank et al., 2002;  Woska 
and Gillespie, 2012), resulting in degranulation. 
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Previously, we discovered that non-cytotoxic doses of TCS (5-20 μM), within 1 hour (15 
min-1 hour) cause strong, dose-dependent inhibition of degranulation (in either the rat mast cell 
model RBL-2H3 or the human mast cell line HMC-1) (Palmer et al., 2012;  Weatherly et al., 
2013;  Weatherly et al., 2016), and here we have sought to determine the underlying molecular 
mechanisms. Recently, we discovered that TCS drastically interferes with mast cell Ca2+ 
dynamics, at the ER, mitochondria, and cytosolic influx across the plasma membrane (Weatherly 
et al., 2018).  Therefore, we hypothesized that the cellular translocation and activity of Ca2+-
activated PKC and PLD enzymes, as well as the translocation of PKC substrate MARCKS, 
would be inhibited by TCS exposure.  
Here, we report that the effects of TCS on PKC, MARCKS, and PLD localization and 
activity in Ag-stimulated RBL-2H3 mast cells using biochemical assays and live-cell/real-time 
confocal microscopy. We have discovered that TCS delays translocation of PKC βII and δ to the 
plasma membrane and subsequently delays MARCKS dissociation from the plasma membrane, 
even while, surprisingly, overall PKC activity is uninhibited by TCS. Furthermore, we found that 
PLD activity in Ag-stimulated RBL-2H3 mast cells is decreased even while PLD1 translocation 
is unaffected by TCS. Together with our earlier published findings, these results paint a 
mechanistic picture of triclosan’s mode of action on mast cells and pinpoint the timing of TCS-
induced defects in the mast cell signaling pathway. 
 
3.3 Methods 
3.3.1 Chemicals and reagents  
 TCS (99%; Sigma-Aldrich) was freshly prepared each day in aqueous Tyrodes buffer as 
described in (Weatherly et al., 2013) and was used at non-cytotoxic doses (Palmer et al., 2012). 
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5-Fluoro-2-indolyl des-chlorohalopemide (FIPI) (Calbiochem) was dissolved in 100% DMSO to 
obtain 1 mM stock. Further dilutions were made in bovine serum albumin (BSA)-Tyrodes (BT) 
buffer to make 75nM (0.0075% DMSO) and 150 nM (0.015% DMSO). Phenylmethanesulfonyl 
fluoride (PMSF; Sigma) was dissolved in 100% ethanol to be 200 mM and was stored at -20 °C.  
 
3.3.2 Cell culture 
RBL-2H3 (“RBL”) mast cells were cultured as in (Hutchinson et al., 2011) and 
(Weatherly et al., 2013). 
 
3.3.3 Protein kinase C activity assay (ELISA) 
 A PKC Kinase activity kit (Enzo Life Science) was used to simultaneously measure the 
activity of multiple PKC isoforms (PKC α, βI, βII, γ, δ, ε, η, and θ).  RBL-2H3 cells were plated 
in 10 cm2 tissue culture-treated sterile dishes (Greiner Bio-One) (1.14 × 107 cells per dish, in 6.5 
mL media) and were incubated overnight (12–16 h) at 37 °C/5% CO2. The following day, cells 
were sensitized with 0.1 μg/mL monoclonal anti-dinitrophenol (DNP) mouse immunoglobulin E 
(IgE; Sigma-Aldrich) for 1 hour at 37 °C/5% CO2
 in RBL media.  After IgE sensitization, spent 
IgE media was discarded, and cells were washed with warm BT to remove excess IgE. Next, 
cells were exposed to either BT (control) or multivalent DNP–BSA antigen (Ag) in BT ± 10 μM 
TCS for 10 to 45 minutes at 37 °C.  Cell lysis buffer (1X; Cell Signaling Technology) was 
prepared from 10X stock, via dilution in PBS.  Immediately before use, PMSF was added to this 
1X cell lysis buffer for a final concentration of 1mM PMSF. After incubation, cells were washed 
with ice-cold PBS, then incubated for 1.5 minutes on ice with 400µL of ice-cold 1X cell lysis 
buffer containing 1mM PMSF. Next, cells were harvested by cell scraper (Falcon) and were 
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placed into pre-chilled microcentrifuge tubes and further lysed using a sonicator (Branson 
Sonifier, Branson Ultrasonics Corporation; set at output control 5 Watts, duty cycle of 30, 1 sec 
duration per sonication pulse, with a 5 sec break on ice in between sonications). Finally, the 
sonicated cells were centrifuged at 14,400xg for 10 minutes at 4°C, and lysate supernatants 
(technical duplicates, 30 µL per ELISA well, from each cell lysate) were used in the ELISA 
following the manufacturer’s protocol (except 1x lysis buffer was used as a background in place 
of the kinase assay dilution buffer included in the kit). PKC activity was determined by 
measuring the absorbance at 450 nm using a microplate reader (Synergy 2; Biotek).  During the 
90 min primary antibody incubation step of the PKC ELISA, a 25 µL aliquot of the remaining of 
cell supernatant of each sample was diverted for use in total protein concentration determination. 
The bicinchoninic acid (BCA) assay was performed, using Pierce BCA protein assay kit 
(Thermo), following the manufacturer’s protocol.    
Raw absorbance ELISA data were processed by first subtracting average background 
values (kit reagents in 1X lysis buffer with no cell supernatant) from each sample, and the 
background-subtracted duplicates were then averaged. These values were then divided by the 
total protein concentration of that particular sample, and finally were normalized to the 
unstimulated (no Ag) control for each experimental day. The percent increase of PKC activity 
over control was determined by subtracting the normalized control value from the normalized Ag 
or Ag + TCS values and dividing this number by the control value.  
 
3.3.4 Confocal imaging 
RBL-2H3 cells were transfected via electroporation using Amaxa Nucleofector kit T 
(Lonza) as described in (Weatherly et al., 2018).  Constructs used were YFP-PKCβII-YFP (a gift 
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from Alexandra Newton; Addgene plasmid #14866; “PKC βII”; (Violin et al., 2003)), GFP-
PKCδ -C1(2) (a gift from Tobias Meyer; Addgene plasmid # 21216; (Codazzi et al., 2001)), 
mRFP-MARCKS-ED (generously provided by Dr. Barbara Baird and Dr. David Holowka, 
Cornell University; “MARCKS”; (Gadi et al., 2011)), or PLD1-EGFP construct (generously 
provided by Dr. Michael Frohman of Stony Brook University and Dr. Shamshad Cockcroft of 
University College London; (O'Luanaigh et al., 2002;  Du et al., 2003)). Regarding GFP-PKCδ-
C1(2) (sometimes referred to herein as “PKC δ”), this short form of PKC δ, which only contains 
C1 (2) domains, has previously been employed to effectively investigate PKC δ translocation 
(Codazzi et al., 2001;  Mogami et al., 2003).  Both PKC constructs were cloned from R. 
norvegicus (rat) (Codazzi et al., 2001;  Violin et al., 2003), and MARCKS-ED and PLD1 DNA 
were from human (Du et al., 2003;  Gadi et al., 2011). The percent identities of PKC β, PKC δ, 
ED domain of MARCKS, and PLD1, between human and rat, from pairwise alignments using 
NIH Blast, are 98%, 90%, 96%, and 87%, respectively. 
Following electroporation, cells were plated (100,000 or 125,000 cells/well in 8-well 
ibidi plates) for overnight incubation in phenol red-free media (recipe is found in (Weatherly et 
al., 2018)), then sensitized with IgE, stimulated with Ag, and imaged via confocal microscopy as 
detailed in (Weatherly et al., 2018).  For YFP-PKCβII-YFP, GFP-PKCδ-C1(2), and PLD1-
EGFP, a 30 milliwatt multi-argon laser (515nm excitation for YFP and 488 nm excitation for 
GFP and EGFP, emission 505-605 nm bandpass filter) was used. For mRFP-MARCKS-ED, a 1 
milliwatt HeNe-Green laser (543 nm excitation, 560-660 nm emission filter) was used. Image 
acquisition speed was 10 µs/pixel. 
Images were then analyzed using NIH Fiji ImageJ software to examine individual 
transfected cells from each experiment. Only cells that appeared healthy (in DIC images), in 
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focus, and fluorescent above background (autofluorescence) levels were utilized for analysis.  To 
determine the “percentage translocation of transfected cells,” each transfected cell with 
movement of the fluorescent construct to (or, for mRFP-MARCKS-ED, away from) the plasma 
membrane at any time point during the 10 min post-Ag exposure video acquisition was noted, 
and the total percentage of transfected cells that underwent this movement was calculated. For 
only transfected cells that underwent translocation, the “time to first translocation” was defined 
as the time stamp of first image frame in which PKC moved to the plasma membrane, exhibiting 
a clear complete ring formation around the plasma membrane (in the case of mRFP-MARCKS-
ED, the time stamp utilized was that of the first image frame showing movement of the construct 
away from the plasma membrane).  
As a control to verify triclosan’s ability to inhibit mast cell function under these 
experimental conditions, the percentage of membrane ruffling, of transfected cells only, was 
calculated: differential interference contrast images were collected along with fluorescence 
images, and construct-transfected cells undergoing classical membrane ruffling (Palmer et al., 
2012) post Ag exposure were noted, as a percentage of all transfected cells, ± TCS. 
  
3.3.5 Phospholipase D Activity assay 
To examine PLD activity, the Amplex® Red phospholipase D assay kit (Molecular 
Probes) (which measures activity of both isoforms PLD1 and PLD2 simultaneously) was 
utilized. The kit reagents were prepared as described in the manufacturer’s protocol with the 
exception of using Tyrode’s buffer in place of 1X Reaction Buffer. 
RBL-2H3 cells (1.5 × 106 per well) were plated in tissue culture-treated, sterile 6-well 
plates (Greiner Bio-One) and incubated overnight (12–16 h) at 37 °C/5% CO2. On the second 
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day, cells were sensitized with IgE, then washed with BT as described in the “Protein kinase C 
activity assay (ELISA)” section above. Cell samples were then exposed to either BT or Ag (0.1 
or 0.001 μg/ mL), ± TCS or FIPI for 15 min at 37 °C. Immediately following this exposure, cells 
were placed on ice and washed with ice-cold PBS buffer. Triton-X 100 (Surfact-Amps X-100, 
10%, low carbonyl and peroxide; Thermo; “TX”) was diluted to 0.2% TX in PBS (Lonza). After 
removing all traces of the wash buffer, this 0.2% Triton-X (TX) buffer was added to the cells 
(300 μL/well). Next, cells were harvested by cell scraper (Falcon) into microcentrifuge tubes on 
ice, thoroughly vortexed and underwent a freeze-thaw cycle using liquid nitrogen immersion for 
30 seconds, followed by room temperature thawing. Lysed cells were then centrifuged for 10 
min at 14,400xg at 4°C. Each sample’s supernatant (100 μL/well) was then transferred to a well 
within a black-side, clear-bottom, sterile 96-well plate (Greiner Bio-One), in technical 
duplicates. Background fluorescence was measured by preparing control samples with 0.2% TX 
in PBS. The remaining steps were carried out according to the manufacturer’s directions. PLD 
activity was determined by measuring fluorescence intensity by microplate reader (Synergy 2; 
Biotek) at 530/25 nm excitation and 590/35 nm emission. 
 Raw data were processed by subtracting average background fluorescence (substrate and 
kit reagents in 0.2% TX-PBS with no cell supernatant) from each sample, and the background-
subtracted duplicates were then averaged. These values were then normalized to the unstimulated 
(no Ag) control for each experimental day. The percent increase of PLD activity over control 
was determined by subtracting the normalized control value from the normalized Ag or Ag + 
TCS values and dividing this number by the control value.  
 The effect of TCS on the activity of purified PLD from Arachis hypogaea and 
Streptomyces chromofuscus was measured as described above, except these purified PLD 
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preparations were used in place of supernatant from the cell lysates.  Purified PLD from 
Streptomyces chromofuscus (Sigma), purchased as a glycerol stock (50,000 units/mL), was 
diluted to be 0.125 units/mL in 0.2% TX-PBS before being used in the assay. Purified PLD from 
Arachis hypogaea (Sigma) was purchased as a lyophilized powder and first reconstituted in 
Tyrode’s buffer to 500 units/mL and then further diluted in 0.2% TX-PBS to a final 
concentration to be 2.5 units/mL. Because the optimal temperature for Arachis hypogaea PLD is 
at 30°C, experiments with this PLD, which were carried out at 37°C in order to match the 
cellular experiments, were performed with extended exposure time with TCS: 1 hour, instead of 
15 min. 
 
3.3.6 Degranulation Assay 
Degranulation was assayed via detection of β-hexosaminidase, a granule marker, as 
described in (Weatherly et al., 2013). 
 
3.3.7 Statistical analyses 
All analyses were done in Graphpad Prism.  Numbers of technical replicates and 
independent days of experiments are noted each figure legend. Significance levels were assessed 
via one-tailed t-tests or one-way ANOVA with Tukey’s post-hoc tests. 
 
3.4 Results 
We previously showed that, within a 60 minute co-exposure to TCS and antigen (Ag), 
non-cytotoxic TCS doses (5 µM and higher) inhibit RBL-2H3 mast cell degranulation elicited by 
a wide range of Ag doses (Palmer et al., 2012), including doses that elicit either minimal or 
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maximal degranulation responses.  Additionally, modest amounts of degranulation (~7% 
absolute degranulation) elicited by short 15 min exposures to low Ag doses are inhibited by TCS 
during as few as 15 min of co-exposure (Palmer et al., 2012).  However, the higher levels of 
degranulation (~35% absolute degranulation) elicited by high Ag doses (0.005 and 0.1μg/mL, 
used throughout much of this current manuscript) are not inhibited within the first 10 to 15 min 
of TCS exposure (data not shown) –even as degranulation is eventually and robustly inhibited by 
TCS within the full hour of co-exposure (Palmer et al., 2012).  In this study, we have examined 
TCS effects on several of the biochemical events that lead to full degranulation within 60 min of 
Ag exposure in order to pinpoint the timing of the molecular mechanisms leading to TCS 
inhibition of mast cell degranulation. 
 
3.4.1 Triclosan increases protein kinase C activity in Ag-stimulated RBL-2H3 mast cells.  
PKC is a key signaling enzyme involved in mast cell degranulation (Ludowyke et al., 
1989;  Ozawa et al., 1993a;  Gadi et al., 2011), and is activated by Ca2+ (Kang and Othmer, 
2007;  van Rossum and Patterson, 2009;  Land and Rubin, 2017) and by diacylglycerol (Ozawa 
et al., 1993b;  Steinberg, 2008).  Because TCS decreases cytosolic Ca2+ mobilization (Weatherly 
et al., 2018), we hypothesized that TCS inhibits PKC activity, thereby inhibiting degranulation in 
mast cells.  To probe this hypothesis, we utilized a PKC activity ELISA (Enzo life science) that 
measures the activity of eight PKC isoforms (α, βI, βII, γ, δ, ε, η, and θ) simultaneously. 
RBL-2H3 (RBL) mast cells  were stimulated by 0.1μg/mL DNP-BSA Ag for 10 min, or 
by 0.005 μg/mL DNP-BSA Ag for 15, 30, and 45 minutes, with and without 10 μM TCS. A 
control (no Ag stimulation) was also prepared. The lysates from each of the cell samples were 
used in the PKC activity ELISA. These data were normalized by the total protein concentration 
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values. Exposure of RBL cells to 0.1μg/ml Ag for 10 minutes causes a robust (~67%) increase in 
PKC activity over controls, as expected (Fig. 3.1A). 
 
Figure 3.1. TCS effects on PKC activity in Ag-stimulated RBL-2H3 mast cells.  Cells were 
stimulated with 0.1 g/ml Ag ± 10 µM TCS for 10 min (A) or with 0.005 g/ml Ag ± 10 µM 
TCS for 45 min (B) in BT.  After exposure, PKC activity was measured via ELISA, and 
absorbance was read at 450 nm using a microplate reader. Raw data were processed as described 
in the Methods section to normalize to both total protein concentration and to unstimulated 
controls, in order to calculate percentage increase of PKC activity over unstimulated control. 
Data presented are means ± SEM of at least three independent experiments; duplicates per 
treatment per experiment. Statistically significant results, comparing Ag-stimulated cells ± TCS 
exposure, are represented by * p < 0.05, determined by one-tailed t-test.  
 
Surprisingly, TCS has no effect on the ability of Ag to stimulate PKC activity at this 10 
min timepoint (Fig.3.1A).  Because cytosolic Ca2+ levels are only inhibited by ~10% by TCS 
within the first 10 min of Ag co-exposure, next we hypothesized that later time points would 
reveal TCS inhibition of PKC activity due to the greater reduction in cytosolic Ca2+ (compared to 
Ag-only control) caused by TCS at 15 min (~20% inhibition) and 60 min (~50% inhibition) post-
Ag stimulation (Weatherly et al., 2018). However, similar results were found in 15 and 30 min 
exposure experiments (Fig. B1), which showed robust Ag-stimulated increases in PKC activity 
that are, again, unaffected by TCS (Fig. B1A-B).  Interestingly, there is a significant TCS-
induced increase in Ag-stimulated PKC activity at the 45 min time point (Fig 3.1B).  Previous 
researchers showed that reactive oxygen species (ROS) can activate certain PKC isoforms 
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(thereby activating degranulation) (Bouwman et al., 2004;  Lee and Yang, 2010).  Also, we had 
previously found that ROS levels are increased by TCS exposure of Ag-stimulated RBL cells at 
this 45 min timepoint (Weatherly et al., 2018), which may explain triclosan’s activation of PKC 
at 45 min (Fig. 3.1B).   
 
3.4.2 Triclosan delays PKC βII and PKC δ translocation to plasma membrane in Ag-
stimulated RBL-2H3 mast cells 
Because the ELISA assay of PKC activation simultaneously measures eight PKC 
isoforms (Fig. 3.1), we hypothesized that potential TCS inhibition of key isoforms essential for 
degranulation may be masked by that measurement method.  Previous studies have reported that 
PKC β and PKC δ isoforms are particularly important for mast cell degranulation (Nechushtan et 
al., 2000;  Cho et al., 2004), so we investigated the activation of those individual key isoforms 
by monitoring their translocation using confocal microscopy.  PKC translocation, to the plasma 
membrane, is known to be a hallmark of its activation (Mochly-Rosen et al., 1990).  Thus, we 
utilized YFP-PKC βII-YFP and PKC δ C1 (2)-EGFP plasmids and transfected them via 
electroporation into RBL-2H3 mast cells, for transient expression. The translocation of PKC in 
real time in live cells over the course of 10 minutes was imaged by confocal microscopy.   
In unstimulated RBL mast cells, the majority of PKC βII and PKC δ are located in the 
cytosol (as shown in representative still frame images from the videos; “Control [No Ag]” 
columns in Fig. 3.2A, 3.3A).  Antigen (0.005μg/mL) stimulation causes both PKC isoforms to 
translocate rapidly to the plasma membrane (Fig. 3.2A, 3.2C, 3.3A, 3.3C). While addition of 
Ag+10 µM TCS does not affect the overall spatial translocation to the plasma membrane 
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compared to Ag-alone (Fig. 3.2A-B, 3.3A-B), temporal translocations of both PKC βII and PKC 
δ are delayed significantly by TCS (Fig. 3.2C, 3.3C, Table 3.1).   
 
 
Figure 3.2. TCS effects on PKC βII translocation to the plasma membrane in Ag-stimulated 
RBL-2H3 cells. RBL cells were transfected with the YFP-PKC βII-YFP plasmid. Live cell time-
lapse images were taken for 10 min immediately after addition of 0.005 µg/ml Ag or 0.005 
µg/ml Ag + 10 µM TCS in the cells by confocal fluorescence microscopy. Representative 
images per group, pre-exposure and at ~200 sec post-exposure are shown in (A).  Scale bar, 10 
µm. As described in Methods, the percentage of transfected cells with PKC βII that translocated 
from the cytosol to the plasma membrane within 10 min post addition of Ag ± 10 µM TCS are 
plotted in (B); first time of this translocation is plotted in (C).  As a control showing cellular 
inhibition by TCS, the percentage of transfected cells undergoing membrane ruffling within 10 
min (D) was calculated using Fiji image J.  For (B-D), values presented are derived from analysis 
of N= 43 for Ag-only cells and N=50 for Ag + 10 µM TCS cells.  Percentage translocation and 
percentage ruffling values in (B) and (D) are from six independent days of imaging, ± SEM.  
Translocation time values in (C) are averages over the 43 (Ag) and 50 (Ag + 10 M TCS) cells, 
± SEM. Statistically significant results, comparing Ag-stimulated cells ± TCS exposure, are 
represented by * p<0.05, ** p<0.01, determined by one-tailed t-test.  
 
 
Analyses of individual cells revealed that about two-thirds of transfected cells expressing 
PKC βII and nearly all cells expressing PKC δ undergo PKC translocation to the plasma 
membrane within 10 min of Ag stimulation, regardless of TCS exposure (Fig. 3.2B, 3.3B).  Also 
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in both PKC βII- and PKC δ-transfected cells, following the first rapid translocation to the 
plasma membrane, periodic oscillations of PKC translocation between the plasma membrane and 
the cytosol were observed in Ag-stimulated cells, and were unaffected by TCS exposure (data 
not shown); these oscillations were previously documented for PKC βI in RBL cells (Gadi et al., 
2011).  However, the average time for PKC to translocate to the plasma membrane for the first 
time is increased significantly by TCS:  a delay of about 80 sec for both PKC βII and PKC δ) 
(Fig. 3.2C, 3.3C, Table 3.1). 
To verify that TCS does, indeed, inhibit mast cell function under these experimental 
conditions (10 min of imaging of individual PKC-transfected, Ag-stimulated RBLs), we utilized 
the previously-shown TCS inhibitory effect on mast cell ruffling (Palmer et al., 2012).  We 
analyzed the percentage PKC-transfected cells that underwent cytoskeleton ruffling within 10 
min of Ag addition, ± TCS, which showed both the expected robust stimulation of membrane 
ruffling by Ag and triclosan’s inhibition (Fig. 3.2D, 3.3D).  This ruffling analysis (Fig. 3.2D, 
3.3D) also serves as a control showing that overexpression of the PKC constructs does not 
interfere with triclosan’s ability to inhibit mast cell signaling.  
Additionally, to further rule out unwanted effects of overexpression of PKC by transfection in 
RBLs, we measured the degranulation as described in (Weatherly et al., 2013), of PKC-
transfected, Ag-stimulated RBLs, ± TCS.  Exogenous overexpression of either PKC βII or PKC 
δ did not affect levels of mast cell degranulation compared to untransfected cells, and TCS 
inhibition of degranulation was, likewise, unaffected in these transfected cells (data not shown).  
Together, these controls confirm the validity of these transfection/confocal experiments for 
assessing TCS toxicity in mast cells.  
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Overall, Figures 3.2 and 3.3 indicate that TCS causes defects in PKC βII and PKC δ signaling 
by delaying their translocation to the plasma membrane.  However, these PKC isoforms do 
(eventually) translocate and display oscillatory movement in the presence of TCS, suggesting 
that their activity is not the major target of TCS in its inhibition of mast cell function. 
 
 
Figure 3.3. TCS effects on PKC δ C1 (2) translocation to the plasma membrane in Ag-
stimulated RBL-2H3 cells. RBL cells were transfected with the PKC δ C1 (2)-EGFP plasmid. 
Live cell time-lapse images were taken for 10 min immediately after addition of 0.005 µg/ml Ag 
or 0.005 µg/ml Ag + 10 µM TCS in the cells by confocal fluorescence microscopy. 
Representative images per group, pre-exposure and at ~200 sec post-exposure are shown in (A).  
Scale bar, 5 µm. As described in Methods, the percentage of transfected cells with PKC δ C1 (2) 
that translocated from the cytosol to the plasma membrane within 10 min post addition of Ag ± 
10 µM TCS are plotted in (B); first time of this translocation is plotted in (C).  As a control 
showing cellular inhibition by TCS, the percentage of transfected cells undergoing membrane 
ruffling within 10 min (D) was calculated using Fiji image J.  For (B-D), values presented are 
derived from analysis of N= 29 for Ag-only cells and N=47 for Ag + 10 µM TCS cells.  
Percentage translocation and percentage ruffling values in (B) and (D) are from five independent 
days of imaging, ± SEM.  Translocation time values in (C) are averages over the 29 (Ag) and 47 
(Ag + 10 M TCS) cells, ± SEM.  Statistically significant results, comparing Ag-stimulated cells 
± TCS exposure, are represented by ** p<0.01, determined by one-tailed t-test.  
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3.4.3 Triclosan delays MARCKS translocation to the cytosol in Ag-stimulated RBL-2H3 
mast cells 
In order to directly assess whether PKC activity is affected by TCS in individual, living 
RBL cells, we assessed TCS effects on MARCKS. MARCKS is one of the most abundant 
substrates for PKC in mast cells (Blackshear, 1993;  Gadi et al., 2011).  In resting cells, 
MARCKS is held at the plasma membrane via specific electrostatic interactions with membrane 
phospholipids at its basic effector domain (ED) domain. Upon Ag stimulation, serine residues 
within the ED domain are phosphorylated by translocated PKC, resulting in MARCKS 
dissociation from the plasma membrane (Graff et al., 1989;  Graff et al., 1989b). Thus, to 
determine whether TCS affects PKC kinase activity on its MARCKS substrate, we transfected 
the fluorescent construct mRFP-MARCKS-ED into RBL mast cells and monitored its 
translocation by confocal microscopy. 
Upon Ag (0.005μg/mL) stimulation, mRFP-MARCKS-ED dissociates from the plasma 
membrane and moves into the cytoplasm (Fig. 3.4A). TCS (10μM) does not affect the overall 
ability of mRFP-MARCKS-ED to translocate to the cytosol (Fig 3.4A, 3.4B). Thus, these results 
indicate that overall PKC kinase activity is not hindered by TCS, in agreement with Fig. 3.1A 
and Fig. B1. Also, oscillatory behavior in which mRFP-MARCKS-ED dissociates from and re-
associates with the plasma membrane in Ag-stimulated mast cells (Gadi et al., 2011) was 
observed, and the periodicity of mRFP-MARCKS-ED oscillations is not altered by TCS 
exposure (data not shown). 
We analyzed the percentage MARCKS-transfected cells that underwent cytoskeleton 
ruffling within 10 min of Ag addition, ± TCS, which showed both the expected robust 
stimulation of membrane ruffling by Ag and triclosan’s inhibition (Fig. 3.4D).  This ruffling 
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analysis (Fig. 3.4D) also serves as a control showing that overexpression of the MARCKS 
constructs does not interfere with triclosan’s ability to inhibit mast cell signaling.   
 
Figure 3.4. TCS effects on MARCKS translocation to the cytosol in Ag-stimulated RBL-2H3 
cells. RBL cells were transfected with the mRFP-MARCKS-ED plasmid. Live cell time-lapse 
images were taken for 10 min immediately after addition of 0.005 µg/ml Ag or 0.005 µg/ml Ag 
+ 10 µM TCS in the cells by confocal fluorescence microscopy. Representative images per 
group, pre-exposure and at ~200 sec post-exposure are shown in (A).  Scale bar, 5 µm. As 
described in Methods, the percentage of transfected cells with MARCKS that translocated to the 
cytosol within 10 min post addition of Ag ± 10 µM TCS are plotted in (B); first time of this 
translocation is plotted in (C).  As a control showing cellular inhibition by TCS, the percentage 
of transfected cells undergoing membrane ruffling within 10 min (D) was calculated using Fiji 
image J.  For (B-D), values presented are derived from analysis of N= 80 for Ag-only cells and 
N=45 for Ag + 10 µM TCS cells.  Percentage translocation and percentage ruffling values in (B) 
and (D) are from three independent days of imaging, ± SEM.  Translocation time values in (C) 
are averages over the 80 (Ag) and 45 (Ag + 10 M TCS) cells, ± SEM.  Statistically significant 
results, comparing Ag-stimulated cells ± TCS exposure, are represented by ** p<0.01, 
determined by one-tailed t-test.  
 
Further analyses of individual MARCKS-transfected, Ag-stimulated RBL cells revealed 
that TCS causes a defect in MARCKS signaling by delaying MARCKS dissociation from the 
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plasma membrane (by about 70 sec) (Fig 3.4C, Table 3.1). Overall, figure 3.4 data indicate that 
TCS causes a defect in PKC activity and MARCKS signaling, shown by delayed translocation to 
the plasma membrane.  However, MARCKS does (eventually) translocate and displays normal 
oscillatory movement in the presence of TCS, suggesting that MARCKS is not the major target 
of TCS in its inhibition of mast cell function. 
Table 3.1. Average time of first translocation of transfected cells 
Sample Ag exposure (sec) # of cells 
(N) 
Ag+ 10μM TCS exposure (sec) # of cells 
(N) 
PKC βII-YFP 170 ± 20 43 250 ± 20 50 
PKC δ (C1)-EGFP 160 ± 20 29 240 ± 20 47 
mRFP-MARCKS-ED 170 ± 20 80 240 ± 30 45 
 
3.4.4 Triclosan and FIPI, a PLD inhibitor, decrease PLD activity in Ag-stimulated RBL-
2H3 mast cells 
Cytosolic Ca2+ and PKC translocation work in tandem to activate phospholipase D (PLD) 
(Lin and Gilfillan, 1992), which is another key player in the mast cell signaling pathway leading 
to degranulation (Chahdi et al., 2002).  To examine whether TCS affects PLD activity, we 
utilized the fluorescence-based Amplex® Red phospholipase D assay kit, which measures the 
activity of both PLD1 and PLD2 isoforms at the same time.  
First, we performed Ag-dose response assays measuring PLD activity by the Amplex® 
kit (data not shown). From these dose responses, we chose two Ag doses, 0.1µg/mL and 
0.001µg/mL, which both produced robust activation of PLD activity, for further cellular PLD 
activity experiments with TCS exposure. With 0.1µg/mL Ag stimulation for 15 min, PLD 
activity is increased ~30% over the basal level in unstimulated control cells (Fig. 3.5A). This Ag-
stimulated PLD activity is inhibited (decrease by ~50%) by 10µM TCS (Fig. 3.5A). A similar 
level of PLD inhibition was observed in cells stimulated by 0.001µg/mL Ag (data not shown).  
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These inhibitory effects of TCS on PLD activity were only observed in Ag-stimulated mast cells, 
not in resting RBL cells (data not shown). 
 
Figure 3.5. TCS effects on PLD activity in Ag-stimulated RBL-2H3 mast cells.  Cells were 
stimulated with 0.1 g/ml Ag ± 10 µM TCS for 15 min (A) or with 0.1 g/ml Ag ± 75 nM FIPI 
for 15 min (B) in BT.  After exposure, PLD activity was measured via Amplex® Red kit, and 
fluorescence was read using a microplate reader. Raw data were processed as described in the 
Methods section to normalize to unstimulated controls, in order to calculate percentage increase 
of PLD activity over unstimulated control. Data presented are means ± SEM of at least three 
independent experiments; triplicates per treatment per experiment. Statistically significant 
results, comparing Ag-stimulated cells ± TCS or FIPI exposure, are represented by * p < 0.05, 
determined by one-tailed t-test. (C) Degranulation was measured described in (Weatherly et al., 
2013) after cells were exposed to 0.1g/ml Ag ± FIPI, for 1 hour. Spontaneous represents control 
cells that are not exposed to either antigen or FIPI.  Values were then normalized to 0.1g/ml 
Ag+ 0 nM FIPI. Data presented are means ±SEM of five independent experiments; three 
replicates per experiment. No significance among FIPI exposures was determined by one-way 
ANOVA followed by Tukey’s post-hoc test. 
 
As a control, degranulation was also measured under the same experimental conditions 
used for these cellular PLD assays: modest degranulation responses were stimulated by Ag 
(0.1µg/mL and 0.001µg/mL) and were inhibited by TCS within the 15 min timeframe of these 
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experiments (data not shown). We also confirmed that triclosan’s inhibition of PLD activity is a 
true cellular effect and is not due to TCS interference with the components of the Amplex® kit 
(Fig. B2).  
In another control experiment, we employed a known direct PLD inhibitor, FIPI, which 
irreversibly binds to the HKD (histidine, lysine, aspartic acid) domain in the catalytic site of PLD 
and inhibits both the PLD1 and the PLD2 isoforms (Su et al., 2009b).  As expected, Ag-
stimulated PLD activity is strongly inhibited by 75 nM FIPI (Fig. 3.5B). Interestingly, inhibition 
of PLD activity by 75 nM FIPI, and even higher doses of FIPI at 150 nM, did not lead to 
inhibition of degranulation (Fig. 3.5C), in agreement with a study done by Yanase et al. (Yanase 
et al., 2009).   
    
3.4.5 Triclosan does not significantly affect PLD1 translocation to the plasma membrane in 
Ag-stimulated RBL-2H3 mast cells  
Previous studies have shown that the PLD1 isoform, not PLD2, translocates toward the 
plasma membrane upon activation (Brown et al., 1998). Also, while activity of both PLD 
isoforms is measured simultaneously by the Amplex® kit, recent literature suggests that only the 
PLD1 isoform is positive regulator of degranulation (Zhu et al., 2015). Thus, we next performed 
real-time fluorescence imaging of PLD1-EGFP translocation to detect the spatiotemporal 
changes of PLD1 after co-exposure of Ag and TCS.  
Upon Ag (0.1 μg/mL) stimulation, PLD1-EGFP translocates gradually to the plasma 
membrane, with variable onset times of ~2 to 10 minutes following Ag addition (Fig. 3.6A)—in 
contrast to the rapid and complete translocation patterns exhibited in the PKC βII, PKC δ, and 
MARCKS translocations.  Further analyses showed that even though co-exposure of Ag with 
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TCS appears to modestly decrease PLD1 translocation toward the plasma membrane, the effect 
is not statistically significant (Fig. 3.6A-B).   
 
 
Figure 3.6. TCS effects on PLD1 translocation toward the plasma membrane in Ag-stimulated 
RBL-2H3 cells. RBL cells were transfected with the EGFP- PLD1 construct. Live cell time-lapse 
images were taken for 10 min immediately after addition of 0.1µg/ml Ag or 0.1µg/ml Ag + 10 
µM TCS in the cells by confocal fluorescence microscopy. Representative images per group, 
pre-exposure and at ~8 min post-exposure are shown in (A).  Scale bar, 5 µm. As described in 
Methods, the percentage of transfected cells with PLD1 that translocated toward the plasma 
membrane within 10 min post addition of Ag ± 10 µM TCS are plotted in (B).  As a control 
showing cellular inhibition by TCS, the percentage of transfected cells undergoing membrane 
ruffling within 10 min (C) was calculated using Fiji image J.  For (B and C), values presented are 
derived from analysis of four independent days of imaging, with 4-13 cells analyzed per 
treatment per day, with error shown as SEM.  Statistically significant results, comparing Ag-
stimulated cells ± TCS exposure, are represented by ** p<0.05, determined by one-tailed t-test.  
 
No oscillatory behavior of PLD1-EGFP movement was displayed: PLD1 stayed at or 
near the plasma membrane once translocated, at least within the 10-15 min imaging period. As in 
Figures 3.2-3.4, we again analyzed the percentage PLD1-EGFP-transfected cells that underwent 
cytoskeleton ruffling within 10 min of Ag addition, ± TCS, which showed both the expected 
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robust stimulation of membrane ruffling by Ag and triclosan’s inhibition of it (Fig. 3.6C). This 
ruffling analysis (Fig. 3.6C) shows that overexpression of the PLD1-EGFP construct does not 
interfere with triclosan’s ability to inhibit mast cell signaling.   
 
3.4.6 TCS does not directly inhibit PLD activity 
To determine whether TCS directly binds to and inhibits PLD activity, we used purified 
PLD from Arachis hypogaea (peanut), which contains two HKD domains, similar to those found 
in mammalian PLD isoforms (Guo et al., 2006).  Purified PLD was prepared in buffer conditions 
that mimic our cell-based PLD activity assays and then was exposed to varying concentrations of 
TCS (0 – 20 μM). There was no effect of TCS on PLD from Arachis hypogaea (Fig. 3.7), 
suggesting the triclosan’s inhibition of mammalian PLD activity (Fig. 3.5A) may not be due to 
direct binding of TCS to PLD.  A similar lack of direct TCS effect on PLD activity was found in 
experiments using a different purified PLD, from Streptomyces chromofuscus (Fig. B3). 
 
Figure 3.7. TCS effects on purified PLD from Arachis hypogaea. PLD activity was measured 
using the Amplex® Red PLD assay kit after incubating purified Arachis hypogaea PLD with 0 
to 20 µM TCS for 1 hour. Values were normalized to the control (0µM TCS) and presented as 
means ± SEM of three independent days of experiments; with triplicates per treatment per 
experiment. No significance was determined by one-way ANOVA followed by Tukey’s post-hoc 
test. 
 
 
 
 
86 
 
3.4.7 Structural analysis of triclosan’s inhibition of mast cell degranulation: comparison to 
sucralose 
In order to investigate the roles of triclosan’s chemical structural features in its ability to 
inhibit mast cell degranulation, we assayed degranulation upon co-exposure of Ag with sucralose 
(main ingredient in Splenda®) which has structural similarities to TCS (Fig. B4). We found that 
sucralose, at doses relevant to human exposure, does not affect degranulation, at least during the 
one hour time frame assessed (Fig. B4). These data indicate that presence of two carbon rings 
(combined in ether linkage) decorated with three chlorines is insufficient to affect mast cell 
function.  This result lends further support to the idea that the proton ionophore nature of TCS is 
the key structural determinant of its modulation of mast cells (Weatherly et al., 2016). 
 
3.5 Discussion 
In this investigation of the biochemical mechanisms underlying triclosan disruption of 
mast cell signaling, we have revealed triclosan’s effects on activity and on spatial and temporal 
subcellular localization of crucial signaling molecules. We found that, although TCS surprisingly 
does not inhibit Ag-stimulated PKC activity, TCS delays the translocations of PKC isoforms βII 
and δ to the plasma membrane and dissociation of the PKC substrate MARCKS from the plasma 
membrane (events which occur during the 10 min period following Ag stimulation). Conversely, 
TCS inhibits Ag-stimulated PLD activity by 15 min post Ag stimulation but does not affect 
translocation of PLD1 toward the plasma membrane, movement which largely occurs within the 
first 10 min post Ag. Of interest, a previous study also found that inhibition of PLD activity (via 
primary alcohol treatment) suppresses mast cell degranulation but does not affect translocation of 
PLD1 (Brown et al., 1998). 
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An overarching finding of this mechanistic investigation of TCS degranulation 
suppression is that, during the first ~10 min following Ag stimulation, several of the major early 
biochemical events are not significantly inhibited by TCS, despite strong TCS inhibition of 
degranulation within 1 hour (Weatherly et al., 2013).  Originally, we had hypothesized that PKC 
activity (measured by ELISA, Fig. 3.1 and by translocation of its substrate MARCKS, Fig. 3.4) 
would be inhibited because TCS reduces the cytosolic Ca2+ concentration following Ag 
stimulation (Weatherly et al., 2018). A PKC isoform key to mast cell degranulation (Yanase et 
al., 2011), βII, contains a C2 domain (Blobe et al., 1996)  responsible for modulating Ca2+-
responsive activation of the enzyme. However, TCS actually increases efflux of Ca2+ out of the 
endoplasmic reticulum (and into the cytosol) within the first 3 min post-Ag and increases influx 
of Ca2+ into the mitochondria within the first 4 min post-Ag (Table 3.2 and (Weatherly et al., 
2018)): changes that promote degranulation.   
Additionally, intracellular levels of reactive oxygen species (ROS) are enhanced by TCS 
(Table 3.2 and (Weatherly et al., 2018)) — another TCS effect that is actually supportive of 
degranulation because ROS activates degranulation (Swindle et al., 2004).  Reduction in the 
level of Ca2+ within the cytosol (the cellular compartment that contains PKC) does not occur 
until at least 10 min post Ag exposure (Weatherly et al., 2018) and does not reach ~20% 
inhibition (area under the curve) until 15 min (and ~50% inhibition until 1 hour).   Thus, even 
though PKC activity is robustly stimulated by Ag within 10 min, it is unaffected by TCS (Fig. 
3.1A), likely both due to the longer time frame required (>10 min) for TCS to robustly inhibit 
cytosolic Ca2+ (Weatherly et al., 2018) and due to triclosan’s stimulation of ROS leading to 
stimulation of ROS-activated PKC isoforms such as PKCδ (Cho et al., 2004;  Yoshida, 2007;  
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Lee and Yang, 2010)(Fig. 3.1B).  Table 3.2 summarizes TCS effects on biochemical events in 
the mast cell degranulation pathway and their timing.  
These data support the conclusion that PKC can still do its job (translocate to the plasma 
membrane, oscillate between the cytosol and plasma membrane, actively process its substrate 
MARCKS) during the first ~10 min of Ag and TCS co-exposure—even while the delays in PKC 
(from ~2.7 to 4.2 min) and MARCKS (from ~2.8 to 4 min) movement are early indicators of 
problems to come. The major disruptive events caused by TCS do not commence until ~15 min, 
including ~20% decrease in integrated cytosolic Ca2+ level, significantly inhibited PLD activity, 
and disruption in microtubule formation (Table 3.2):  defects which are key to inhibiting 
degranulation.  
Even though PLD activity is inhibited by TCS by 15 min post Ag, translocation of PLD1 
is unaffected, likely because its movement toward the plasma membrane begins within ~2 min 
post-Ag and has occurred to a large degree with the first 10 min. However, after PLD has been 
largely re-located to or near the plasma membrane, its activity is inhibited.  Taken together, these 
PKC and PLD studies strongly suggest that a significant accumulated decrease in cytosolic Ca2+ 
concentration, which does not occur until ~15 min post-Ag, is the key event leading to inhibition 
of degranulation.  Below we discuss how dampened cytosolic Ca2+ could cause the inhibitory 
events in Table 2 (red arrows:  translocation delays, decreased PLD activity, and inhibited 
microtubule polymerization).   
Our lab and others previously demonstrated that TCS is a proton ionophore mitochondrial 
uncoupler, which disrupts mitochondrial function in multiple cell types (Ajao et al., 2015;  
Weatherly et al., 2016;  Weatherly et al., 2018) and in zebrafish embryos (Shim et al., 2016b;  
Raftery et al., 2017).  We previously showed, though, that mitochondrial uncoupling is not the 
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main mechanism causing triclosan’s inhibition of degranulation (Weatherly et al., 2018). 
However, proton ionophoric effects of TCS on the mast cell plasma membrane may be the cause 
of degranulation inhibition. Support for this hypothesis includes findings of a recent study which 
demonstrated that TCS is a proton ionophore in artificial bilayer lipid membranes and can 
depolarize bacterial membrane potential (Popova et al., 2018).  Because Ca2+ flows down its 
electrochemical gradient through mast cell plasma membrane CRAC channels following Ag 
stimulation, TCS perturbation of plasma membrane potential could be the mechanism underlying 
TCS disruption of Ca2+ influx into the cytosol. Future studies will address whether triclosan’s 
proton ionophore nature perturbs the electrochemical potential of the mast cell plasma membrane 
(preliminary experiments using membrane potential sensitive organic dyes were inconclusive 
due to TCS interference with the dye’s fluorescence (Weatherly et al., 2018)). 
Sucralose, the active ingredient in artificial sweetener Splenda®, exhibits structural 
similarities to TCS:  both molecules are comprised of two carbon rings combined in ether 
linkage and decorated with a total of three chlorines (Fig. B4).  However, unlike TCS, sucralose 
does not affect degranulation, indicating that presence of the three chlorines on the two ether-
linked rings is insufficient to affect mast cell function, at least during the one hour time frame 
assessed (Fig. B4). This result lends further support to the hypothesis that the proton ionophore 
nature of TCS is the key determinant of its modulation of mast cells (Weatherly et al., 2016).  
While we suspect that TCS lowers Ag-stimulated cytosolic Ca2+ levels by disrupting the 
plasma membrane potential and, hence, by disrupting a driving force for Ca2+ influx, there are 
other potential mechanisms underlying TCS inhibition of cytosolic Ca2+. One is that TCS could 
inhibit the early phosphorylation cascade that leads to PLC γ activation.  PLC γ inhibition would 
lead to decreases in both DAG and IP3 generation, which would subsequently result in hindered 
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IP3-mediated ER Ca
2+ release.  However, TCS does the opposite: Ag-stimulated ER Ca2+ release 
is actually enhanced by TCS with Ag (Weatherly et al., 2018), and this result strongly suggests 
that biochemical events upstream of ER Ca2+ mobilization are uninhibited by TCS—hence our 
focus on effectors of Ca2+ influx, PKC and PLD, in this study.  
Table 3.2. Triclosan effects on mast cell degranulation pathway: Time to first signaling 
defect, following co-exposure to Ag+ TCS 
Signaling Event* TCS Effect on 
this event** 
Time of first defect caused by 
TCS*** 
References 
Efflux of Ca2+ 
from ER 
 3 min  (Weatherly et 
al., 2018) 
Influx of Ca2+ into 
mitochondria 
 4 min (Weatherly et 
al., 2018) 
Mitochondrial 
Ca2+ oscillations 
 10 min (Weatherly et 
al., 2018) 
Influx of Ca2+ into 
cytosol 
 10 min (~10%   ) 
15 min (~20%   ) 
1 hr (~50%   ) 
(Weatherly et 
al., 2018) 
PKC βII and 
PKCδ  
translocation 
 
Delay 
Delayed from ~ 2.7 min (-TCS, + 
Ag) to ~ 4.2 min (+ TCS, +Ag)  
Fig. 3.2C & 
3.3C 
PKC activity  45 min  Fig. 3.1B 
MARCKS 
translocation 
Delay Delayed from ~ 2.8 min (-TCS, + 
Ag) to ~ 4 min (+ TCS, +Ag) 
Fig. 3.4C 
Actin cytoskeleton 
ruffling 
 10 min  Fig. 3.2D, 
3.3D, 3.4D & 
3.6C 
PLD1 
translocation 
None Within 10 min Fig. 3.6B 
PLD activity  15 min Fig. 3.5A 
Microtubule 
polymerization 
 15 min (Weatherly et 
al., 2018) 
ROS formation  ~45 min (Weatherly et 
al., 2018) 
* Ag concentration used:0.005 -0.1μg/mL(these doses caused roughly maximal degranulation  
   in absence of TCS. 
** Items in red indicate mechanisms of TCS inhibition of degranulation. 
*** TCS concentration used: 10-20μM 
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Delays in PKC translocation caused by TCS may be due to attenuation of microtubule 
polymerization by TCS (Weatherly et al., 2018) at early time points after Ag stimulation. In 
CHO cells, microtubule integrity is required for translocation of PKC δ, in a complex with 
cytoskeletal protein Annexin V (Kheifets et al., 2006).  Though drastic TCS inhibition of 
microtubule polymerization was documented at 15 min post Ag in (Weatherly et al., 2018), and 
that time point was chosen for its unambiguous TCS effects, defects in microtubule formation 
may potentially begin to accumulate at earlier time points and may thereby explain slowed PKC 
translocation.  TCS may inhibit microtubule polymerization via its depression of cytosolic Ca2+:  
Ag-stimulated elevation of cytosolic Ca2+ levels stimulates the association of the positive 
regulator protein GIT1 with tubulin, in turn leading to enhanced microtubule polymerization and 
degranulation (Sulimenko et al., 2015).  
PKC βII phosphorylates myosin and also binds actin in mast cells (Ludowyke et al., 
2006). Myosin phosphorylation is thought important for degranulation (Ludowyke et al., 1989;  
Choi et al., 1994). Moreover, the C2-like domain of PKC δ binds to F-actin to regulate actin 
redistribution in neutrophils (Lopez-Lluch et al., 2001) as well as in airway epithelial cells 
(Smallwood et al., 2005). Thus, inhibition of actin polymerization, as shown by inhibition of 
membrane ruffling, could be another explanation of triclosan’s delay of PKC movement to the 
plasma membrane. 
PLD plays important roles in mast cell degranulation (Brown et al., 1998;  Cissel et al., 
1998;  Way et al., 2000), and its Ag-stimulated activity is inhibited by TCS (Table 3.2). 
Transient expression PLD experiments in RBL-2H3 cells show both isoforms are activated by 
Ag stimulation (Chahdi et al., 2002;  O'Luanaigh et al., 2002). In mast cells, PLD1 is associated 
with granule membranes while PLD2 with the plasma membrane (Brown et al., 1998;  Choi et 
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al., 2002). PLD1 has low basal activity, and its activation requires interactions with PKC and/or 
small GTPases such as ADP-ribosylation factor (ARF) and Rho family members (Liscovitch et 
al., 2000;  Peng and Frohman, 2012).  PLD1 is stimulated in vitro and in vivo directly by Ca2+-
dependent cPKC isoforms (PKCα and β) (Hammond et al., 1997;  Kim et al., 1999;  Zhang et 
al., 1999) in a PIP2-dependent manner (Hammond et al., 1995;  Rumenapp et al., 1995;  Bae et 
al., 1998).  In contrast, PLD2 is constitutively active and is more dependent on the presence of 
PIP2 than other activators (Lopez et al., 1998;  Sung et al., 1999).  Background studies of basal 
PLD activity showed that TCS has no effect on constitutive PLD activity (data not shown), even 
as TCS strongly inhibits Ag-stimulated PLD activity (Fig. 3.5A).  These results suggest that 
constitutively-active PLD2 is less of a target of TCS than is PLD1, due to PLD1’s low basal 
activity and high activation potential.    
 FIPI, a potent dual inhibitor for PLD1 and PLD2, was employed in our study as a 
comparison to triclosan’s inhibitory action on PLD activity and on degranulation. FIPI 
irreversibly binds to a serine residue within the HKD (histidine, lysine, aspartic acid) domain in 
the catalytic site of PLD, preventing the cleavage of phosphatidylcholine, thus blocking PA 
production (Su et al., 2009b). While we observed decreased PLD activity by FIPI, to our 
surprise, FIPI’s inhibition of both PLD isoforms had no effect on overall degranulation in Ag-
stimulated mast cells.  Currently there is some controversy about the role of PLD1 and PLD2 in 
mast cells. It has been long believed that both PLD1 and PLD2 play a positive role in mast cell 
degranulation, in that PLD1 is involved in the granule transport to the plasma membrane (Chahdi 
et al., 2002;  Hitomi et al., 2004;  Peng and Beaven, 2005) and PLD2 is a fusogenic protein for 
granule’s docking and fusion to the plasma membrane (Chahdi et al., 2002;  Choi et al., 2002;  
Lee et al., 2006;  Marchini-Alves et al., 2012). However, an intriguing recent study using PLD1- 
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and PLD2- knockout mice found that PLD1 positively regulates degranulation, while PLD2 is a 
negative regulator (Zhu et al., 2015).  RhoA, which is directly affected by Ca2+ (though does not 
directly bind Ca2+), interacts with PLD2 to play a negative role in microtubule formation.  The 
authors also showed that mast cells isolated from double knockout mice (PLD1-/- and PLD2-/-) 
exhibited normal degranulation compared to the control (Zhu et al., 2015), suggesting that PLD1 
(positive) and PLD2 (negative) may effectively cancel out each other’s roles in regulating 
degranulation.  Another recent study from this group demonstrates the importance of PLD1, but 
not PLD2, in T cell activation (Zhu et al., 2018).  Thus, our study using FIPI agrees with this 
finding that equally impeding the two PLD isoforms simultaneously yields no change in 
degranulation. Taken together with our results showing a lack of TCS effect on basal PLD 
activity, these findings provide further credence to the idea that triclosan’s inhibitory action on 
PLD activity is targeted to PLD1, which is a positive regulator in degranulation--such that 
decreased PLD activity by TCS results in decreased degranulation.  
Our study with purified PLD protein in vitro suggests that TCS does not directly bind to 
and inhibit activity of PLD; thus, PLD activity is more likely indirectly inhibited by TCS-
induced decreases in cytosolic Ca2+ level.  The PLD used in this study was derived from Arachis 
hypogaea and has an HKD domain which contains a serine residue and which is highly 
homologous to the HKD domains found in rat and human PLD1 and PLD2 proteins.  Even 
though PLD does not directly interact with Ca2+, the activities of its activation cofactors, such as 
small GTPase proteins, PKC, and PIP2, are dependent on Ca
2+ signaling (Wakelam et al., 1997). 
Moreover, several studies have demonstrated that degranulation requires activation of PLD 
accompanied by sustained cytosolic Ca2+ levels (Lin and Gilfillan, 1992;  Ozawa et al., 1993a;  
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Cissel et al., 1998;  Chahdi et al., 2002).  Thus, the data suggest that PLD activity and, hence, 
degranulation, is inhibited by triclosan’s inhibition of Ca2+ influx into the cytosol. 
The role of PLD has been implicated in various essential cellular functions in various cell 
types:  signal transduction in embryonic kidney cells (Fang et al., 2001), cell migration in breast 
cancer cells (Hui et al., 2006), membrane vesicular trafficking (Du et al., 2003) and cytoskeletal 
reorganization (Colley et al., 1997) in fibroblasts, autophagy (Dall'Armi et al., 2010) in cervical 
cancer cells, and viral infections (Oguin et al., 2014) in alveolar basal epithelial cells.  Due to 
these diverse roles of PLD in biology, PLD is involved in numerous physiological and disease 
states, including cancer (Su et al., 2009a), neurodegenerative disorders (Cai et al., 2006), 
cardiovascular problems (Chiang, 1994), and infectious diseases (Taylor et al., 2015). Therefore, 
inhibition of PLD by TCS might affect these different health problems. 
In conclusion, we have elucidated biochemical mechanisms underlying inhibition of mast 
cell function by TCS, at dosages relevant to human exposure, by interrogating the activity and 
localization of key signaling enzymes. Combined with our previous findings on triclosan’s 
effects on calcium mobilization and microtubules, these results provide the temporal details of 
TCS-induced defects in PKC and PLD signaling steps, which lead to degranulation inhibition. In 
addition to TCS inhibition of mast cells, any cell type that depends on PLD function may be 
inhibited by TCS.  
 
 
 
 
 
 
 
95 
 
CHAPTER 4 
SEARCHING FOR TRYPTASE IN THE RBL-2H3 MAST CELL MODEL: 
PREPARATION FOR COMPARATIVE MAST CELL TOXICOLOGY  
STUDIES WITH ZEBRAFISH2 
4.1 Abstract 
Mast cells comprise a physiologically and toxicologically important cell type that is 
ubiquitous among species and tissues. Mast cells undergo degranulation, in which characteristic 
intracellular granules fuse with the plasma membrane and release many bioactive substances, 
such as the enzymes β-hexosaminidase and tryptase. Activity of mast cells in the toxicology 
model organism zebrafish has been monitored via tryptase release and cleavage of substrate 
BAPNA. An extensively-used in vitro mast cell model for studying toxicant mechanisms is the 
RBL-2H3 cell line. However, instead of tryptase, granule contents such as β-hexosaminidase 
have usually been employed as RBL-2H3 degranulation markers. In order to align RBL-2H3 cell 
toxicological studies to in vivo mast cell studies using zebrafish, we aimed to develop an RBL-
2H3 tryptase assay. Unexpectedly, we discovered that tryptase release from RBL-2H3 cells is 
not detectable, using BAPNA substrate, despite optimized assay that can detect as little as 1 ng 
tryptase. Additional studies performed with another substrate, tosyl-Gly-Pro-Lys-pNA, and with 
an ELISA also revealed a lack of tryptase protein released from stimulated RBL-2H3 cells. 
Furthermore, none of the eight rat tryptase genes (Tpsb2, Tpsab1, Tpsg1, Prss34, Gzmk, Gzma, 
Prss29, Prss41) are expressed in RBL-2H3 cells, even though all are found in RBL-2H3 
genomic DNA and even though β-hexosaminidase mRNA is constitutively expressed. Therefore, 
mast cell researchers should utilize β-hexosaminidase or another reliable marker for RBL-2H3 
                                                 
2 A portion (15%) of this work was performed by Rachel Kennedy with the remainder being performed by Juyoung 
Shim 
 
 
96 
 
degranulation studies, not tryptase. Comparative toxicity testing in RBL-2H3 cells in vitro and in 
zebrafish mast cells in vivo will require use of a degranulation reporter different from tryptase. 
 
4.2 Short Abstract 
Mast cells degranulate, releasing substances such as β-hexosaminidase and tryptase. Mast 
cell activity in zebrafish is monitored via tryptase release. To align in vitro RBL-2H3 mast cell 
line studies to in vivo mast cell zebrafish studies, we aimed to develop an RBL-2H3 tryptase 
assay. However, tryptase protein is not released from stimulated RBL-2H3 cells. Also, no rat 
tryptase gene is expressed in RBL-2H3s. Comparative toxicity testing in RBL-2H3 cells and in 
zebrafish mast cells will require a non-tryptase degranulation reporter. 
 
4.3 Introduction 
Mast cells (MCs) are highly granulated cells that are typically recognized for their role in 
allergies and asthma (Kuby, 1997). However, they are also involved in many helpful immune 
functions such as host defense (Galli et al., 2008;  Abraham and St John, 2010), bacterial and 
parasitic clearance (Pawankar, 2005), and recruitment of neutrophils to sites of infection 
(Echtenacher et al., 1996;  Malaviya et al., 1996). MCs possess additional immune-related 
functions that affect diseases such as cancer (Coussens et al., 1999;  Gounaris et al., 2007), 
autoimmune disorders (Lee et al., 2002), and inflammatory bowel disease (Wilcz-Villega et al., 
2013). Interestingly, MCs also have roles in neurological processes and diseases such autism 
(Theoharides et al., 2012b), anxiety disorders (Silver et al., 1996;  Nautiyal et al., 2008), and 
multiple sclerosis (Rozniecki et al., 1995). MCs, found in nearly all human tissues, are 
prominent in tissues in contact with the external environment, such as skin, blood capillaries, 
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nerve terminals, gastrointestinal tract, respiratory mucosa, etc. (reviewed in (Galli et al., 2005b)). 
Also MCs are found in numerous different organisms (Baccari et al., 2011). Due to their 
physiological importance, ubiquity, and location near surface tissues, MCs are key toxicological 
targets. 
MCs exhibit the unmistakably distinctive morphological feature of densely populated 
cytoplasmic granules, which get secreted upon MC stimulation: a process called degranulation 
(Kuby, 1997). Degranulation is typically initiated via multivalent antigen (Ag) crosslinking of 
immunoglobulin E (IgE) receptor-bound FcεRI receptors but can be stimulated in numerous 
ways, including via compound 48/80 (c48/80) or calcium ionophore application. The resulting 
signaling cascade culminates in degranulation, the release of granule-associated bioactive 
mediators, such as histamine, serotonin, β-hexosamindase (β-hex), and tryptase (Schwartz and 
Austen, 1980). Assays for release of these mediators (and more) have been extensively utilized 
to test mast cell function.  
Thus, the presence of granules containing tryptase is considered a canonical marker of 
MCs, and release of tryptase (into cell supernatant in vitro or into the bloodstream in vivo) has 
often been utilized as a test of mast cell stimulation and function (Irani et al., 1986).  Mast cell 
tryptase is a family of trypsin-like serine proteases that cleave sites after basic amino acids such 
as Arg and Lys (Lehninger et al., 2005). Tryptase requires the glycosaminoglycan heparin for its 
activity (Hallgren et al., 2001). In general, tryptases can be grouped into three main types, α (I-
II), β (I-III), and γ (transmembrane). Most tryptase purified from human tissues is a mixture of β 
isoforms which are the products of two genes, TPSB2 and TPSAB1 (Caughey, 2011). Numerous 
distinct roles of mast cell tryptase have been reported:  some protective/anti-inflammatory, and 
some pro-inflammatory (reviewed in (Caughey, 2011)). One example of a mechanism of action 
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of tryptase is cleavage and inactivation of calcitonin gene-related peptide, thus regulating 
vasodilation (Tam and Caughey, 1990;  Walls et al., 1992).  Tryptase acts upon many other 
substrates as well. Mast cell tryptase is also involved in angiogenesis (Stack and Johnson, 1994;  
Crivellato et al., 2004) and in development of multiple sclerosis (Rozniecki et al., 1995). In the 
laboratory, the presence of active tryptase in a solution can be detected by incubation with a 
chromogenic substrate such as N-α-benzoyl-DL-Arg-p-nitroanilide (BAPNA) or tosyl-Gly-Pro-
Lys-p-nitroanilide: tryptase cleaves the bond between the Arg or Lys and the p-nitroaniline 
(pNA), releasing yellow-colored pNA, measurable in a plate reader  (Lavens et al., 1993). Other 
chromogenic and fluorogenic tryptase substrates are also available. 
Zebrafish (Danio rerio) (ZF) are a powerful, human-disease relevant (Ward and 
Lieschke, 2002;  Lieschke and Currie, 2007) model organism for toxicology studies (Garcia et 
al., 2016).  Zebrafish and humans share a highly conserved FcεRI receptor, and mast cells of 
both species share similarities in innate and adaptive immune responses (Dobson et al., 2008;  
Da'as et al., 2011;  Da'as et al., 2015). Two methods for assessing mast cell function in zebrafish 
have recently been developed. Both methods use tryptase as the mast cell marker. First, a method 
has been developed to quantify mast cell degranulation in adult ZF, by assaying for tryptase in 
blood, using the substrate BAPNA (Dobson et al., 2008;  Da'as et al., 2011). Intraperitoneal 
injection of adult zebrafish with an MC stimulant (such as c48/80) causes a large rise in blood 
plasma tryptase level (pNA production), as compared to saline-injected control animals (Dobson 
et al., 2008). Zebrafish have granzyme A (also known as granzyme K-like), a gene orthologue 
for human granzyme K (GZMK), which is conserved in rat (Gzmk), mouse, and ZF. Granzyme 
tryptases, including granzyme A and K, are serine proteases and shown to cleave after the basic 
residues Arg and Lys ((Plasman et al., 2014), so this ZF granzyme tryptase may be the enzyme 
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cleaving BAPNA in this ZF assay. Also, Dobson et al. (Dobson et al., 2008) and Balci et al. 
(Balci et al., 2014) detected staining of ZF tissues with a monoclonal anti-human MC tryptase 
antibody specific for TPSAB1, although an orthologue to this specific gene has not yet been 
cloned from ZF.  Second, a tryptase assay using ZF embryos also has been developed (Yang et 
al., 2015). In this method, all the drugs and reagents, including stimulant (e.g., c48/80) and 
substrate (e.g., BAPNA), are directly added to the fish water.  
   In addition to animal models for studies of mast cells, in vitro mast cell models have 
contributed enormously to scientists’ understanding of the biochemical details of mast cell 
signaling and of drug and toxicant modes of action on MCs. Among mast cell models, the rat 
basophilic leukemia - clone 2H3 (RBL-2H3) cell line has been used widely as a well-accepted 
model of mast cell signaling and function (Barsumian et al., 1981). RBL-2H3 cells, used 
extensively for over 40 years, are an important mast cell model for in vitro studies of MC 
toxicology and pharmacology. Other experimental mast cells exist, but each has advantages and 
disadvantages, such as human HMC-1 cells which lack FcεRI (Nilsson et al., 1994), human 
LAD2 cells which contain FcεRI but which require >2 weeks for each doubling (Jensen et al., 
2005), P815 cells which are largely non-adherent, and primary bone marrow-derived mouse mast 
cells which senesce after a brief time in culture. RBL-2H3 (“RBL”) cells are easy to quickly and 
continuously culture in large quantities, contain the core signaling machinery of mature human 
mast cells (Fewtrell, 1979;  Metzger et al., 1982), and are functionally homologous to rodent 
mucosal mast cells (Seldin et al., 1985).  Many molecular similarities between human and rodent 
mast cells have been detailed in (Abramson and Pecht, 2007). The pathway leading to 
degranulation in RBL cells is very well described, allowing for the identification of pathway 
targets for toxicants or drugs that affect this signaling system.   
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For many of the studies documented to date, RBL degranulation has been quantified via 
measurement of released β-hex: β-hex in the supernatant over stimulated cells is incubated with 
fluorogenic substrate 4-methylumbelliferyl-N-acetyl-β-D-glucosaminide (4-MU), and the 
resulting fluorescent product is detected in a microplate reader (Naal et al., 2004). β-hex enzyme 
catalyzes degradation of GM2 ganglioside, and mutations in this enzyme lead to 
neurodegenerative diseases (Bayleran et al., 1987;  Tifft and Proia, 1997). β-hex has been 
successfully used as a MC function marker because it is released in parallel with canonical MC 
marker histamine (Schwartz et al., 1979). The homologs of β-hex genes have been identified in 
ZF (hexa and hexb)(Zizioli et al., 2014). Of note, activated human primary lung mast cells 
secrete tryptase in parallel with histamine (Schwartz et al., 1981), but tryptase release has not 
typically been used as a RBL-2H3 degranulation marker. 
Previously, we discovered that MC degranulation is disrupted by environmental 
toxicants, such as arsenic (Hutchinson et al., 2011;  Shim et al., 2016a), and by the antimicrobial 
drug triclosan (TCS) (Palmer et al., 2012;  Weatherly et al., 2013).  Along with other cell types, 
these studies utilized RBL-2H3 cells and β-hex detection to quantify MC degranulation. 
However, all published studies of mast cells in ZF have, instead, utilized tryptase as the 
biochemical marker of mast cell function. Thus, in order to align our cell culture-based 
toxicological studies in this proven RBL mast cell model to in vivo toxicological studies of mast 
cells in the ZF model organism, we became interested in using tryptase as a marker for 
degranulation of RBL-2H3 cells. Measurement of tryptase release from RBL-2H3 cells would 
lay the groundwork for comparative/confirmative high-throughput toxicology assays of mast cell 
function and signaling that could use both ZF and this canonical mast cell model, RBL cells. For 
example, we are interested in studying and comparing effects of TCS on mast cells in ZF as a 
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whole organism follow-up to our findings that TCS inhibits function of RBL-2H3 cells (Palmer 
et al., 2012) and of human HMC-1 mast cells (Weatherly et al., 2016).  Parallel studies of RBL-
2H3 mast cells and ZF have already proven to be instructive in toxicology:  for example, ZF 
mitochondrial function is inhibited by TCS (Shim et al., 2016b) at similar doses and time frames 
that also depress mitochondrial function in RBL-2H3 cells (Weatherly et al., 2016). Thus, we 
were motivated to develop a tryptase release assay from RBL-2H3 cells in order to design 
parallel assays of toxicant effects on MC function in both ZF and RBL-2H3, for applied 
toxicology investigations linking in vitro and in vivo systems. Background studies showing that 
TCS does not directly affect activity of purified tryptase (Kennedy, 2013) further bolstered our 
belief that it would be possible to use this degranulation marker for comparative mast cell 
toxicology studies of TCS. 
In this study, we have optimized the conditions of a substrate-based assay for tryptase 
activity and have applied it to assess degranulation of RBL-2H3 cells. We report the results of 
three separate assay methods for detecting tryptase protein secreted from degranulated RBL-2H3 
cells, as well as of PCRs performed to detect mRNA transcripts of eight distinct tryptase genes 
within these cells.  
 
4.4 Materials and Methods 
4.4.1 Chemicals and reagents 
Purified human lung tryptase (E.C. Number 3.4.21.59; corresponds to human gene 
symbols TPSD1, TPSB2, TPSAB1) was purchased from Calbiochem /EMD Millipore (Billerica, 
MA, USA) and was stored as aliquots wrapped in aluminum foil at -20 °C. BAPNA (Nα -
Benzoyl -D,L-arginine-p-nitroanilide • HCl) tryptase substrate (Bachem, Bubendorf, 
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Switzerland) was stored at -20°C in an amber bottle and wrapped in aluminum foil. Anti-
dinitrophenyl (DNP) mouse Immunoglobulin E (IgE) (monoclonal, clone SPE-7), Ca2+ 
ionophore A23187, heparin, dimethyl sulfoxide (DMSO) were purchased through Sigma (St. 
Louis, MO, USA). Triton-X 100 (TX) was obtained from Thermo (Rockford, IL, USA).  
Tryptase from human lung (TFHL) buffer was prepared to match the buffer contained in 
the purified tryptase purchased through Calbiochem, and contained 1 M NaCl, 50 mM acetate 
buffer, and 0.05 mM heparin (0.09% heparin), which was titrated to pH 5 with 10 N sodium 
hydroxide. 15-mL aliquots were frozen at -20 °C, and thawed as needed.  
The components of Tyrodes buffer are that of (Hutchinson et al., 2011) and (Weatherly et 
al., 2013). Modified Tyrodes buffer (mT), pH 7.4, contained lower NaCl and lower CaCl2 than 
typical Tyrodes, and was made by combining 100 mM NaCl, 5 mM KCl, 0.9 mM CaCl2, 1 mM 
MgCl2, 20 mM HEPES, and 5.6 mM glucose. As needed, bovine serum albumin (BSA) at 1 
mg/ml was added to mT on the day of an experiment. BAPNA buffer solution I was prepared by 
first combining 1 mM MgCl2, 0.1 M Trizma base (Sigma, St. Louis, MO, USA), and 1 M 
glycerol (Promega, Madison, WI, USA). After mixing well, 0.02% heparin (w/v) was added, and 
the pH of this solution was titrated to either 9 or 8, depending on the experiment. Similarly, 
BAPNA solution II was prepared in the same manner as solution I, only it contained the added 
component of 0.8 mM BAPNA (in assays, final concentration of BAPNA was 0.4 mM). These 
two buffer solutions were made fresh daily. 
A23187 Ca2+ ionophore was prepared by dissolving A23187 powder into 100% DMSO 
for a final concentration of 2.5 mg mL-1 h and stored as aliquots wrapped in aluminum foil at -
20 °C. On the day of an experiment, this stock was diluted directly into Tyrodes-BSA solution or 
mT-BSA to create necessary ionophore concentrations. 
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Cell harvest buffer (10X) was prepared with 1.35 M NaCl, 0.05 M KCl, 0.17 M HEPES, 
and 0.02 M EDTA, which was titrated to pH 7.6. 
Chemicals of the highest possible purity were used. All buffers and media were sterile 
filtered using 0.2 μM VacuCap filters (Pall Corporation, Port Washington, NY, USA).  
 
4.4.2 Purified tryptase assay 
Purified tryptase working solutions containing 1-500 ng tryptase were prepared by 
making dilutions in TFHL buffer. Using a clear 96-well half-area plate (Grenier Bio-One, 
Monroe, NC, USA), 50 μL of 0.02% heparin (w/v) mT-BSA was added to each sample well. 
From all wells, 1 μL was removed, and tryptase (1 μL) at the varying levels indicated replaced 
this volume. To these 50-μL samples, 50 μL BAPNA solution II (containing BAPNA substrate) 
was added; controls lacking BAPNA substrate contained 50 μL BAPNA solution I (containing 
no BAPNA substrate). Tryptase activity was detected spectrophotometrically in a Synergy 2 
plate reader (Biotek, Winooski, VT, USA) by measuring the colorimetric cleavage product p-
nitroaniline (pNA) at 410 nm. The plate was read immediately (t = 0), as well as periodically, up 
to 72 h (Lavens et al., 1993). During incubation at 37 °C/5% CO2, the plate was tightly sealed 
with parafilm, and the plate lid was weighted down by a lead ring; these methods, along with 
glycerol, aided in preventing sample loss over the 72-h time period. 
 
4.4.3 Cell culture 
RBL culture methods were those of (Hutchinson et al., 2011) and NIH-3T3 mouse 
fibroblast culture methods were those of (Weatherly et al., 2016). 
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4.4.4 Stimulation of RBL-2H3 cells induced via IgE-receptor crosslinking by antigen or 
Ca2+ ionophore 
Cells were stimulated with either DNP-BSA multivalent antigen (Ag) (following IgE 
sensitization) or A23187 Ca2+ ionophore, essentially as described (Weatherly et al., 2013) except 
that mT-BSA buffer was used in place of BT buffer. DMSO (0.004% final) was also used in 
spontaneous, 0.2% TX, and background wells to control for vehicle effects.  
Following cell stimulation for 1h at 37°C, resulting β-hex or tryptase released into cell 
supernatant was quantified as described in (Weatherly et al., 2013) or tryptase assay described in 
“RBL-2H3 cell degranulation assay for tryptase release, measured by BAPNA substrate,” below. 
Additionally, to test the effects of heparin on this process, 0.02% heparin was added to A23187, 
spontaneous, 0.2% TX, and background samples.  
 
4.4.5 RBL-2H3 cell degranulation assay for tryptase release, measured by BAPNA 
substrate 
Following treatment for cell stimulation described above, cell supernatant (50 μL) was 
transferred to a 96-well half-area plate (Grenier Bio-One, Monroe, NC, USA) that contained 50 
μL of BAPNA solution II. The absorbance of the colorimetric cleavage product pNA was 
detected over a 72-h period as with the purified tryptase experiments. 
 
4.4.6 RBL-2H3 cell degranulation assay for tryptase release, measured by commercial kit 
utilizing tosyl-Gly-Pro-Lys-pNA substrate 
All the reagents were prepared following manufacturer’s protocol (EMD Millipore, 
Billerica, MA, USA) unless otherwise indicated in individual figure legends.  RBL supernatant 
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were obtained as described in previous section. Lysates from RBL cells were obtained in 2 steps: 
first, RBL cells were harvested using 1X cell harvest buffer (diluted from 10X with cell culture 
water) and centrifuged for 8 min at 500xg. After removal of supernatant, cell pellet was washed 
with PBS and resuspended in 1X assay buffer. Next, the cell supernatant from the lysate was 
obtained as described under Syk ELISA assay in (Shim et al., 2016a) and incubated with tosyl-
Gly-Pro-Lys-pNA substrate. For statistical analysis, first raw absorbance data from each 
treatment were processed by subtracting average background values (1X assay buffer with 
substrate) from each sample, and the background-adjusted triplicates were then averaged. These 
values were normalized to the unstimulated (no Ag or no ionophore) control for each 
experimental day when compared among supernatants. For comparison between RBL 
supernatant and RBL lysates, values were normalized to the RBL supernatant. 
Lysates from NIH-3T3 cells were obtained in the same manner as the RBL cell lysis 
methods as described above. To determine total protein concentration from the RBL and NIH-
3T3 cell lysates, the bicinchoninic acid (BCA) assay (Pierce BCA protein assay kit [Thermo]) 
was performed, following the manufacturer’s protocol. Raw tryptase degranulation absorbance 
data obtained from lysate samples were averaged after subtracting average background values 
(1X assay buffer with substrate) from each sample. Background-subtracted values were then 
divided by the total protein concentration of that particular sample. Finally, these values were 
normalized to RBL lysates for each experimental day.  
 
4.4.7 Tryptase (TPSAB1) ELISA 
 Tryptase ELISA kit (Cell Signaling Technologies, Beverly, MA, USA) was used to 
detect levels of rat (Rattus norvegicus) TPSAB1 protein according to the manufacturer’s 
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instructions. For this assay, RBL-2H3 were cultured in 6-well plates, stimulated and lysed as 
described under Syk ELISA assay in (Shim et al., 2016a). A volume of 300 µL of cell lysate 
supernatant was placed into an appropriate ELISA well in duplicates per treatment. The 
remaining steps were carried out according to the manufacturer’s directions.  
 
4.4.8 RNA extraction and cDNA synthesis from RBL-2H3 cells 
Total RNA was isolated from RBL-2H3 cells using Trizol® reagent (Life Technologies, 
Grand Island, NY, USA) following the manufacturer’s instructions. The concentration and purity 
of the total RNA were determined by Nanodrop-1000 UV-Vis spectrometer (Thermo Scientific, 
Rockford, IL, USA). Total RNA (10 μg per sample) was treated with TURBO DNA-free kit 
(Ambion, Grand Island, NY, USA) to remove any contaminating genomic DNA. The RNA 
preparation was reverse-transcribed to cDNA using an iScript cDNA synthesis kit (Bio-Rad, 
Hercules, CA, USA) according to the manufacturer’s protocol. 
 
4.4.9 Genomic DNA extraction from RBL-2H3 cells 
DNeasy Blood & Tissue Kit (Qiagen, Valencia, CA, USA) was used for genomic DNA 
extraction from RBL-2H3 cells by following the manufacturer’s instructions. The concentration 
of genomic DNA was measured using Nanodrop-1000 UV-Vis spectrometer (Thermo scientific, 
Rockford, IL, USA). 
4.4.10 Polymerase chain reaction (PCR) for rat tryptase genes 
Primers for each Rattus norvegicus tryptase genes were inferred from NCBI 
(http://www.ncbi.nlm.nih.gov). Primers were designed using NCBI Primer Blast 
(http://www.ncbi.nlm.nih.gov/tools/primer-blast) and IDT Oligoanalyzer software 
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(https://www.idtdna.com/analyzer/Applications/OligoAnalyzer), and synthesized by Integrated 
DNA Technologies (Coralville, Iowa, USA). Sequences for PCR primer pairs, annealing 
temperatures, and size of the transcripts for tryptase genes are shown in Fig 4.6C and Fig 4.7B.   
PCR was carried out in a 50uL reaction volume, utilizing 100ng of the cDNA or genomic 
DNA as a template and 0.4 μM of each primer. The amplicons were generated using a Phusion 
High-Fidelity DNA polymerase from New England Biolabs (Ipswich, MA, USA) and following 
PCR conditions: initial one cycle of 98°C for 30sec, then 35 cycles of 98°C for 10sec, 51.5-
58.5C (depending on the genes) for 30sec, and 72°C for 30sec and followed by one cycle of a 
final 72°C extension for 5 min.  A mock PCR, in which the DNA template was excluded, was 
also performed as a negative control. Amplification of rat β-actin, rat β-hexosaminidase A and B 
genes were used as positive controls.   
For gel electrophoresis, Seakeam LE agarose (Cambrex, Rockland, ME, USA) and 1Kb 
plus DNA ladder (Life Technologies, Grand Island, NY, USA) were purchased. The PCR 
products were analyzed in a 1% agarose gel and stained with 0.5 μg/mL of ethidium bromide 
(Sigma, St Louis, MO, USA).  
 
4.4.11 Sequencing analyses 
To confirm the identity of amplified sequences, the PCR products were separated in a 1% 
agarose gel to extract the single specific band, which was subsequently purified using a Qiaquick 
Gel extraction kit (Qiagen, Valencia, CA, USA). Each purified product was then sequenced at 
the University of Maine Sequencing facility using an ABI 3730 DNA sequencer (Applied 
Biosystems, Foster City CA, USA). The obtained DNA sequences were confirmed by NCBI 
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BLAST search (http://blast.ncbi.nlm.nih.gov/Blast.cgi) and ClustalW2 alignment program 
(http://www.ebi.ac.uk/Tools/msa/clustalw2). 
 
4.4.12 Statistical analysis 
Unless otherwise indicated in individual figures, results from degranulation experiments 
are reported as mean ± SEM, with significant differences determined by either a One-Way 
ANOVA (Analysis of Variance) followed by Tukey's post-hoc test or One-sample t-test, using 
Graphpad Prism software (San Diego, CA, USA).  
 
4.5 Results 
4.5.1 The tryptase activity assay is optimized to detect as low as 1 ng of purified human 
lung tryptase using BAPNA (Nα-Benzoyl-D, L-Arg-p-nitroanilide) substrate. 
Eight rat tryptase or tryptase-like genes were found in the rat genome database (RGD: 
http://rgd.mcw.edu) and were compared to their human orthologs (HGNC: 
http://www.genenames.org) (Table 4.1).  
Before testing RBL-2H3 mast cells, we optimized the tryptase assay in cell-free system, 
based on the protocol developed by Lavens et al. (Lavens et al., 1993), which is able to detect 
tryptase by measuring the cleavage product (p-nitroanilide [pNA]) of a known tryptase substrate 
BAPNA and purified human lung tryptase. The purified human lung tryptase that was utilized 
contains three tryptase species:  TPSAB1, TPSB2 and TPSD1.  
When various doses of purified tryptase (0-500ng) were incubated with BAPNA and 
absorbance at 410 nm was read in a plate reader, detection of pNA plateaued within 72 hours 
(Fig. 4.1A). Following optimization of both timing (Fig. 4.1A; including modifying assay 
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parameters to minimize sample loss) and of buffer components (pH, heparin concentration, 
levels of Ca2+ and Na+, addition of heparin and bovine serum albumin, etc), we successfully 
detected pNA production from as little as 1ng of purified tryptase tested (Fig. 4.1B).  Previously, 
the lowest level of pNA detected by Lavens et al. was 10ng (Lavens et al., 1993). 
   Table 4.1. Tryptase and tryptase-like proteins in rats and human 
 
A                                                                                  B 
    
Figure 4.1. Measurement of interaction of purified human lung tryptase 
(TPSAB1/TPSB2/TPSD1) with N-benzoyl-DL-arginine-p-nitroanilide (BAPNA) substrate. 
(A) As described in Materials & Methods, purified tryptase was incubated at the concentrations 
indicated over 72 hours with BAPNA. A410 is plotted against the time in h. In (B) tryptase 
concentration is detected at a single, 72-h time point; tryptase (ng) is depicted versus the pNA 
signal. Statistical significance was determined GraphPad Prism using a one-way ANOVA 
followed by a Tukey’s post test; ***p<0.001, **p<0.01. 
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4.5.2 Tryptase is not detectable in the supernatant from degranulated RBL-2H3 mast cells, 
using BAPNA substrate. 
        Following our purified tryptase experiments, our next goal was to detect tryptase released 
from a mast cell model line RBL-2H3 using the same tryptase substrate, BAPNA, incubated for 
a period of 72 h. Because the plan was to stimulate RBL-2H3 to degranulate for one hour with 
Ca2+ ionophore A23187 and to collect the cell supernatants to test for the presence of tryptase by 
measuring pNA production, we first tested the conditions of a modified Tyrodes buffer with no 
BSA on A23187 ionophore dose response degranulation curve in RBL-2H3. We monitored the 
release of β-hexosaminidase from these cells using 4-MU (4-methylumbelliferone) substrate.  
As seen in Fig. 4.2A, we detected robust increases in β-hexosaminidase released from 
RBL-2H3 due to ionophore stimulation. Then we used the same exact conditions for stimulating 
RBL-2H3 to degranulate, with the exception that now we assayed the cell supernatant for 
tryptase activity (pNA) using BAPNA substrate.  
Surprisingly, we were unable to detect any significant release of tryptase from RBL-2H3 
cells (Fig. 4.2B). Importantly, we performed control studies in which 25 ng purified tryptase was 
incubated with BAPNA in a background of various reagents used in the degranulation assay 
(A23187 ionophore, DMSO [ionophore vehicle], TX, and BSA), and found that these variables 
do not significantly affect the ability of purified tryptase to cleave BAPNA substrate (Fig.C1).  
Taken together, these data indicate that RBL-2H3 cells likely do not release active 
tryptase protein that is able to cleave the BAPNA substrate. 
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Figure 4.2. Measurement of β-hexosaminidase and tryptase in the supernatant of RBL-2H3 
mast cells stimulated with calcium ionophore A23187. RBL-2H3 cells were incubated for one 
hour with A23187 ionophore in modified Tyrodes buffer, and degranulation was quantified after 
incubation with (A) 4-Methylumbelliferone (4MU) substrate for β-hexosaminidase or with (B) 
BAPNA substrate for tryptase. Data are from one representative experiment; values represent 
means ± SD of triplicate samples. Statistical significance was determined by one-way ANOVA 
followed by Tukey’s post test. 
 
4.5.3 Tryptase is not detectable in the supernatants from degranulated RBL-2H3 mast 
cells, using tosyl-Gly-Pro-Lys-pNA substrate. 
After observing no tryptase detection from degranulated RBL cells using the BAPNA 
tryptase substrate, we utilized the commercially available tryptase degranulation kit from EMD 
Millipore, which contains another known tryptase substrate:  tosyl-Gly-Pro-Lys-pNA, instead of 
BAPNA. First, a high dose of antigen (1μg/mL) in modified Tyrodes buffer (following IgE 
sensitization) was applied for RBL cell stimulation, but no tryptase was detected from the 
supernatants of stimulated RBL cells (Fig. 4.3A). Then we examined the release of tryptase after 
stimulating RBL cells with 1μg/mL antigen in the proprietary assay buffer which was provided 
in the kit, and, again, no tryptase was detected (Fig. 4.3B). Lastly, we stimulated RBL cells with 
A23187 ionophore, strictly following the manufacturer’s protocol provided by EMD Millipore, 
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and measured the production of pNA from the cell supernatant. There was no significant 
difference compared to unstimulated control cells in this condition, either (Fig. 4.3C). 
A     B    C 
    
 
Figure 4.3. Measurement of tryptase in the supernatant of RBL-2H3 mast cells stimulated 
with antigen or A23187 ionophore using tosyl-gly-pro-lys-pNA tryptase substrate. RBL-
2H3 cells were sensitized for one hour with 0.1μg mL-1anti-DNP mouse IgE in RBL media (A 
and B). In (A), plated cells were treated with DNP-BSA Ag (1μg mL-1) for 15 minutes in 
modified Tyrodes buffer. In (B), cells in suspension were treated with DNP-BSA Ag (1μg mL-1) 
treatment for 1 hour in 1X Assay buffer provided in the Mast cell degranulation assay kit (EMD 
Millipore). In (C), cells in suspension were stimulated with 200nM A23187 ionophore for 1 
hour. Degranulation was quantified with tosyl-gly-pro-lys-pNA tryptase substrate provided by 
the Mast cell degranulation assay kit (EMD Milipore). Error bars represent the standard error of 
the mean of the data from three experiments; triplicates per sample were done on each 
experimental day. No statistical significance was determined by one-sample t-tests. 
 
4.5.4 Lysates from RBL-2H3 mast cells and from NIH-3T3 fibroblast cells contain a 
substance that can cleave the tosyl- Gly-Pro-Lys-pNA substrate. 
Since tryptase release from RBL cells was not detectable using either of those tryptase 
substrates, we next tested RBL cell lysates. Compared to the signal from RBL cell supernatant, 
lysates from RBL cells displayed significantly higher readings when incubated with tosyl-Gly-
Pro-Lys-pNA substrate (Fig. 4.4A). To test whether the signals obtained from the RBL lysates 
were due to the presence of tryptase, we also examined NIH-3T3 cell lysates because NIH-3T3 
cells are non-granulated fibroblasts which do not contain mast cell markers.  We found that there 
was no significant difference between NIH-3T3 lysates and RBL-2H3 lysates (Fig. 4.4B). 
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                  A      B 
               
Figure 4.4. Measurement of tryptase from RBL-2H3 and NIH-3T3 cell lysates using tosyl-
gly-pro-lys-pNA tryptase substrate. Lysates from RBL-2H3 cells (A) and NIH-3T3 cells (B) 
were collected as described in Materials & Methods and incubated with tosyl-gly-pro-lys-pNA 
tryptase substrate for 72 hours. Error bars represent the standard error of the mean of the data 
from three experiments; triplicates per sample were done on each experimental day.  (A) 
Statistical significance, as compared to the RBL supernatant sample, was determined by one-
sample t-tests.  **p<0.01 (B) No statistical significance was determined in comparing RBL-2H3 
and NIH-3T3 lysates samples by one-sample t-test. 
 
4.5.5 Tryptase is not detectable in the supernatants from degranulated RBL-2H3 mast 
cells, using rat TPSAB1 ELISA. 
Using two different tryptase substrates, BAPNA (Fig. 4.2) and tosyl- Gly-Pro-Lys-pNA 
(Fig. 4.3), no active tryptase protein (capable of cleaving either of these substrates) was detected 
in the supernatants of degranulated RBL-2H3 mast cells.  Those data suggest that no active 
tryptase protein is present in the RBL cells’ granules. To further investigate whether 
degranulated RBL cell supernatants contain tryptase, regardless of protein activity level, we 
utilized a sandwich ELISA kit, which detects one of the key rat tryptase protein types, TPSAB1. 
This ELISA kit detects as little as 0.3 ng/mL tryptase (as shown in a standard curve generated 
using purified rat TPSAB1 protein [provided in the kit], Fig. C2).  Again, no tryptase was 
detected in the supernatants of Ag-stimulated, degranulated RBL cells (compare “RBL control 
supernatant” to “RBL Ag supernatant” in Fig. 4.5), another indication that tryptase is not present 
in the granules of RBL cells. However, the phenomenon of apparent tryptase signal found in 
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RBL lysates, as in Fig. 4, was also found in RBL lysates via this ELISA measurement (Fig. 4.5). 
Again, though, the TPSAB1 ELISA signal from RBL lysates was equivalent to the ELISA signal 
arising from NIH-3T3 cell lysates (Fig. 4.5). Thus, the apparent TPSAB1 signal in RBL cell 
lysates is not a granule-associated protein. 
 
Figure 4.5. Measurement of Tpsab1 tryptase from RBL and NIH cells by ELISA. RBL-2H3 
cells were sensitized with anti-DNP IgE (0.1μg mL-1) for 1 hr before being treated with DNP-
BSA Ag (1μg mL-1) for 15 min. Rat tryptase protein (Tpsab1) was measured using a sandwich 
ELISA kit (Biomatik). Data are from one representative experiment; values represent means ± 
SD of duplicate samples. Statistical significance was determined as compared to the RBL control 
supernatant sample, by one-way ANOVA followed by Tukey’s post test. ***p<0.001   
 
4.5.6 No rat tryptase mRNA was detected in RBL-2H3 cells using PCR. 
Because three distinct methods of tryptase protein detection (Figs. 4.2, 4.3, and 4.5) 
failed to find tryptase protein released from degranulated RBL cells, we next used PCR to 
investigate whether tryptase mRNA transcripts are present in RBL cells. To generate cDNA 
template, total RNA was extracted from antigen-stimulated RBL-2H3 cells and was reverse-
transcribed. Numerous cell treatment experimental conditions prior to the RNA extraction are 
listed in supplementary material Table C1, including several variations of IgE sensitization, 
antigen stimulation, and timeframe conditions. Primer pairs and the size of amplicons for eight 
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rat tryptase genes are shown in Fig. 4.6C. In addition, mRNA of two rat β-hexosaminidase genes 
(Hexa and Hexb) and of β-actin (Actb) were amplified as positive controls.  
 
         B 
 
C
 
 
Figure 4.6. Measurement of rat tryptase and β-hexosaminidase mRNA from RBL-2H3 cells 
using PCR. Eight target rat tryptase genes’ mRNA (A) and two β-hexosaminidase genes’ 
mRNA (B) were analyzed. Total RNA was extracted from RBL-2H3 cells, and reverse 
transcription was performed as described in Materials & Methods in order to generate cDNA, 
which was amplified by PCR. Actin was used as a positive control. The primer pairs and the size 
of PCR products are listed in the table (C). The PCR amplicons were subjected to electrophoresis 
in 1% agarose gels, and the target bands were extracted for sequencing to be confirmed (data not 
shown). Data shown are representative of all cell stimulation conditions and timeframes 
(supplement table S1). None of tryptase genes’ mRNA was found in any of the stimulation 
conditions whereas actin and β-hexosaminidase genes’ mRNA were always detected. NTC is no 
template control; MW is molecular weight marker. 
 
 (bp)    MW  NTC  Hexa  Hexb  
MW 1000 
850 
650 
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In fifteen separate testing conditions, from unstimulated controls to cells treated with 
high Ag doses to various RNA collection timepoints up to 24 hours post Ag stimulation, none of 
the eight tested tryptase genes’ mRNA was detected by PCR (Fig. 4.6A). This lack of tryptase 
transcript detection stands in contrast to consistent robust detection of actin transcripts (Fig. 4. 
6A) and of both β-hexosaminidase mRNAs (Fig. 4.6B), over all fifteen cell-treatment conditions 
listed in Table C1.  Therefore, these findings show that no tryptase genes are expressed in RBL-
2H3 cells. 
 
4.5.7 Genomic DNA of all rat tryptase genes was detected using PCR, in RBL-2H3 cells. 
 
B
 
 
Figure 4.7. Measurement of rat tryptase genomic extracted from RBL-2H3 cells using 
PCR. A) Eight target tryptase genes’ genomic DNA were amplified by PCR as described in 
Materials & Methods. The primer pairs and the size of PCR products are listed in the table (B).  
PCR amplicons were subjected to electrophoresis in 1% agarose, and the target bands were 
extracted for sequencing confirmation (data not shown). MW is molecular weight marker. 
 
A 
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Because none of the tryptase genes’ mRNA was detected, we next questioned whether 
tryptase genomic DNA is present in this cell line. To determine whether these eight tryptase 
genes exist in the RBL genome, we extracted genomic DNA from RBL-2H3 cells and amplified 
with the gene-specific primer pairs shown in Fig. 4.7B. Genomic DNA from all eight tryptase 
genes was detected by PCR (Fig. 4.7A), and each band was excised, cleaned, sequenced, and 
confirmed as the correct gene (sequence data not shown). Overall, our results suggest that RBL-
2H3 cells do not transcribe and translate tryptase genes even though all tryptase genes exist in 
the genomic DNA of RBL-2H3 cells. 
 
4.6 Discussion 
In this study, we optimized an assay, based upon cleavage of BAPNA substrate, for 
detection of as little as 1 ng active tryptase per sample. While this assay is 10-fold more sensitive 
than the BAPNA-based method published by Lavens et al. (which could pick up ≥10 ng tryptase) 
(Lavens et al., 1993), we were unable to find any tryptase released from stimulated, degranulated 
RBL-2H3 cells.  In this assay, ~100,000 RBL-2H3 cells per well of a 96-well plate were 
stimulated under conditions causing robust degranulation and β-hex release, and one-quarter of 
the resulting cell supernatant (50 μL out of 200 μL supernatant in each well; equivalent to the 
contents released from ~25,000 RBL-2H3 cells) was incubated with BAPNA substrate. 
According to Lavens et al. (1993), human lung mast cells contain 11.2 ± 0.7 pg tryptase 
per cell, so, if RBL-2H3 cells contained similar tryptase levels, we would expect ~280 ng 
tryptase per sample from fully-degranulated cells or perhaps 28 ng tryptase per sample from 
modestly-degranulated cells—levels far above the assay’s sensitivity, 1 ng. Therefore, our results 
with the BAPNA substrate suggest that RBL-2H3 cells contain very little or no active tryptase 
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protein. Additional studies with an alternative tryptase substrate, tosyl-Gly-Pro-Lys-pNA, and 
with ELISA assays for TPSAB1 protein also revealed a lack of tryptase protein released from 
RBL-2H3 cells stimulated via multiple means.  
Thus, we also investigated whether tryptase mRNA transcripts are found in RBL-2H3 
cells. We found none of the mRNA transcripts of the rat tryptase genes (Tpsb2, Tpsab1, Tpsg1, 
Prss34, Gzmk, Gzma, Prss29, Prss41) in RBL-2H3 cells, whereas genomic DNA of all the 
tryptase genes was readily detected by PCR. Since these genes were found in genomic DNA, we 
looked for tryptase gene expression following a wide range of RBL-2H3 stimulation conditions, 
from 1 to 24 hours post antigen stimulation (Table C1), but no mRNA transcripts were found 
under any condition. The reason for testing at varied time points is that mast cells undergo 
recovery and regeneration/refilling of the granules after degranulation (Dvorak et al., 1986;  
Dvorak et al., 1988), so we had hypothesized that tryptase gene expression may fluctuate over 
time, before and after degranulation. Also, we performed clonogenic cytotoxicity assays and 
found that RBL-2H3 cells survive post-degranulation (data not shown), a necessary control for 
Table C1 experiments. We did find that mRNA levels of another MC granule component, β-
hexosaminidase (both forms A and B), are constitutively robust in RBL-2H3 cells, regardless of 
time point or stimulation method:  further evidence that, if any of these eight tryptase genes were 
expressed in RBL-2H3 cells, we would have been able to find its transcript in at least one of the 
sixteen cell stimulation conditions tested. 
There were occasional, faint bands in gels assessing mRNA expression of tryptase genes 
(Fig. 4.6A), though these were not the correct product sizes of the expected tryptases (Fig. 4.6C). 
For example, from one gel, a faint band was excised from the Prss34 lane, purified, sequenced, 
and determined to be not tryptase but, rather, carboxypeptidase A3 (data not shown). The 
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nucleotide sequence homology between rat Prss34 and carboxypeptidase A3 is significant, so, 
most likely, the primers used for Prss34 accidentally amplified a small amount of this off-target 
gene after multiple rounds of PCR. Another time, a faint band from the Tpsab1 lane was 
sequenced and found to correspond to a histone deacetylase. Attempts to isolate and sequence a 
faint band, positioned below the expected Gzma size, from the Gzma lane were unsuccessful, 
likely because there was very little material present. Also, other researchers reported a lack of 
Gzma mRNA in RBL-2H3 cells (Nakajima et al., 1995). Overall, no tryptase mRNA was 
detected for any of the eight tested tryptase genes. 
Other researchers have previously reported a lack of certain tryptases in RBLs. Similar to 
our Fig. 4.2 results, two other studies also observed a lack of tryptase via BAPNA assay in 
supernatants of degranulated RBL cells, even while β-hex release was readily measured in the 
same supernatants (Peng et al., 2011;  Tang et al., 2012). Mass spectrometry analyses of cell 
supernatants from degranulated RBL-2H3s also found no tryptase proteins (Sadroddiny et al., 
2012a;  Sadroddiny et al., 2012b). Furthermore, Ide et al. reported that no mRNA of Tpsb2 
(noted as rMCT [rat mast cell tryptase] in the article) was located in RBL-2H3 cells (Ide et al., 
1995). However, one publication did report high levels of tryptase (as measured by BAPNA 
reaction) released into the supernatants of unstimulated RBL-2H3 cells, with further increases 
due to hypoxia (Maxova et al., 2010).  This result is puzzling because, typically, very low levels 
of spontaneous degranulation occur in unstimulated (no antigen, no ionophore, etc) RBL-2H3 
cells. 
Two additional studies have reported detection of tryptase in RBL-2H3 cells (Small-Howard and 
Turner, 2005;  Song et al., 2016). However, these two studies measured tryptase (via ELISA in 
Song et al. and via substrate activity assay in Small-Howard and Turner) within cell lysates, not 
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from the supernatants of stimulated intact cells. Since our current study demonstrated that lysates 
from both RBL-2H3 and NIH-3T3 cells processed tosyl-Gly-Pro-Lys-pNA substrate (Fig. 4.4) 
and yielded tryptase ELISA absorbance (Fig. 4.5), these signals are likely not from MC granule 
tryptases. Rather, other, non-granule-associated serine proteases may be picked up by these two 
studies and in Figs.4.4 and 4.5. For example, retinoid-inducible serine carboxypeptidase 1 (also 
known as carboxypeptidase C) is found in RBL-2H3 cells (Sadroddiny et al., 2012a). Also, the 
substrate tosyl-Gly-Pro-Lys-pNA can be cleaved by enzymes other than tryptase, including 
plasmin/plasminogen (Wiedow et al., 1997;  Vakili et al., 2001;  Drinane et al., 2006).  The key 
mast cell function is release of granule contents from safe storage in intracellular granules, into 
extracellular fluids, via plasma membrane fusion; thus, analyzing the contents of MC whole-cell 
lysates is an erroneous measure of MC function.  
Because tryptase is known to be localized within granules and exclusively expressed in 
mast cells (Schwartz et al., 1987;  da Silva et al., 2014), we had anticipated to find tryptase 
released into the supernatants of degranulated RBL-2H3 cells in this study. One possible reason 
for our findings is that RBL cells are physiologically similar to rodent mucosal mast cells (Seldin 
et al., 1985). MCs display a high degree of heterogeneity in contents of granules, as a 
consequence of their ubiquitous location and a wide range of microenvironments they encounter 
(da Silva et al., 2014). Human MCs are divided into two subsets based on protease content: 
MCTC, containing tryptase, chymase, and carboxypeptidases, or MCT, containing only tryptase 
(Irani et al., 1986).  Rodent MCs are subcategorized into mucosal mast cells (MMCs) and 
connective tissue mast cells (CTMCs) (Metcalfe et al., 1997). While tryptase is present in all 
human MCs (Irani et al., 1986), rodent MMCs do not express tryptase but, rather, predominantly 
express chymase (Le Trong et al., 1987;  Reynolds et al., 1990;  Serafin et al., 1990;  Huang et 
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al., 1991;  Lutzelschwab et al., 1997). Thus, RBL-2H3 cells’ similarity to MMCs might explain 
the lack of tryptase expression.   
In summary, this current study is the first comprehensive report on detection of tryptase 
protein and transcripts from RBL-2H3 cells. Multiple lines of experimental evidence indicate 
that mRNA from eight tryptase genes is not present and that tryptase protein is either not present 
or is below detection limits of the assay in supernatants from degranulated RBL-2H3 cells.  
Instead, mast cell researchers should utilize β-hex, histamine, serotonin, or other reliable markers 
for RBL-2H3 degranulation studies. Comparative studies of toxicant effects on RBL-2H3 mast 
cells in vitro and in zebrafish in vivo will require use of a degranulation reporter different from 
tryptase.   
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CHAPTER 5 
TRICLOSAN IS A MITOCHONDRIAL UNCOUPLER IN LIVE ZEBRAFISH 
5.1 Abstract 
Triclosan (TCS) is a synthetic antimicrobial agent used in many consumer goods at 
millimolar concentrations.  As a result of exposure, TCS has been detected widely in humans. 
We have recently discovered that TCS is a proton ionophore mitochondrial uncoupler in multiple 
types of living cells. Here we present novel data indicating that TCS is also a mitochondrial 
uncoupler in a living organism: 24 hour post fertilization zebrafish embryos.  These experiments 
were conducted using a Seahorse Bioscience XFe 96 Extracellular Flux Analyzer modified for 
bidirectional temperature control, using the XF96 spheroid plate to position and measure one 
zebrafish embryo per well.  Using this method, following acute exposure to TCS, basal oxygen 
consumption rate (OCR) increases, without a decrease in survival or heartbeat rate. TCS also 
decreases ATP-linked respiration and spare respiratory capacity and increases proton leak: all 
indicators of mitochondrial uncoupling. Our data indicate, that TCS is a mitochondrial uncoupler 
in vivo, which should be taken into consideration when assessing the toxicity and/or 
pharmaceutical uses of TCS. This is the first example of usage of a Seahorse Extracellular Flux 
Analyzer to measure bioenergetic flux of a single zebrafish embryo per well in a 96 well assay 
format. The method developed in this study provides a high-throughput tool to identify 
previously-unknown mitochondrial uncouplers in a living organism. 
 
5.2 Short Abstract 
Antimicrobial agent triclosan (TCS) is a mitochondrial uncoupler in multiple cell types. 
Here we present data, obtained with a Seahorse Bioscience XFe 96 Extracellular Flux Analyzer, 
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indicating that TCS is also a mitochondrial uncoupler in living zebrafish (24 hpf; 1 
embryo/well).  TCS increases oxygen consumption rate and proton leak and decreases ATP-
linked respiration and spare respiratory capacity without affecting survival or heartbeat rate.  
These data indicate, for the first time, that TCS is a mitochondrial uncoupler in vivo.  
 
5.3 Introduction 
 Triclosan (5-chloro-2-(2,4-dichlorophenoxy)phenol; TCS) is a synthetic antimicrobial 
agent (Lyman and Furia, 1968) that has been used in hospitals since the 1970’s.  TCS can be 
found in soaps, deodorants, mouthwashes, toothpastes, household cleaners, and more products 
typically at concentrations up to several mM (Jones et al., 2000;  Rodricks et al., 2010). Most 
U.S. citizens are exposed to triclosan (Calafat et al., 2008). Chronic exposure of zebrafish 
embryo/larvae to TCS has been found to cause delayed development, malformations, delayed 
hatching and inhibition of growth (Oliveira et al., 2009). 
Recently, it has been published that TCS is a proton ionophore mitochondrial uncoupler 
in living rat (RBL-2H3) and human (HMC-1) mast cells, mouse fibroblasts (NIH-3T3), and 
primary human keratinocytes (Weatherly et al., 2016).  Without cytotoxicity, TCS reduces ATP 
production and increases oxygen consumption rate (OCR), while its non-protonated sister 
compound TCS-methyl causes no such effects (Weatherly et al., 2016).   Triclosan has also been 
shown to impair mitochondrial function in isolated rat liver mitochondria (Newton et al., 2005;  
Ajao et al., 2015).  Additionally, in vitro studies suggest that TCS inhibits mitochondrial 
membrane potential (Attene-Ramos et al., 2015), an indicator of proton ionophore mitochondrial 
uncoupling (Suzuki et al., 2006;  Kuznetsov et al., 2011).   
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In the present study, we investigate whether TCS is a mitochondrial uncoupler in an 
intact living organism, the 24 hour post fertilization (hpf) zebrafish embryo.  Carbonyl cyanide 
p-triflouromethoxyphenylhydrazone (FCCP) is an ionophore proton ion carrier which disrupts 
ATP synthesis by transporting hydrogen ions across the inner mitochondrial membrane, thus 
bypassing the proton channel of ATP synthase (Heytler and Prichard, 1962).  In this study, we 
utilized FCCP, a known mitochondrial uncoupler, as a reference compound to compare the 
effects of TCS on mitochondrial fidelity.  This study is the first demonstration of TCS’s 
mitochondrial effects in vivo, and our results indicate that the previous in vitro findings are valid.  
Recently, Seahorse Bioscience XF-24 Extracellular Flux Analyzers have been used 
successfully to assess the bioenergetics of zebrafish (Stackley et al., 2011;  Gibert et al., 2013;  
Bestman et al., 2015).  One of the studies measured OCR and bioenergetics of zebrafish from 3 
to 48 hpf (Stackley et al., 2011).  They also validated the XFe 24 measurements with the Clark 
electrode method (Stackley et al., 2011). Another XF-24 study analyzed the bioenergetics effects 
of the known mitochondrial uncoupler 2,4-dinitrophenol (DNP) on 3-72 hpf zebrafish (Bestman 
et al., 2015). However, these published studies have utilized relatively low-throughput 24-well 
plates, time-consuming placement of islet capture screens, and multiple fish per well (required to 
attain suitable signal-to-noise ratios). The present study is the first instance of using chorionated 
zebrafish in a custom-modified Seahorse Bioscience XFe 96 Extracellular Flux Analyzer, which 
allows temperature-controlled, high-throughput (96-well) bioenergetic measurements with a 
single embryo per well, without a need of an islet capture screen. 
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5.4 Materials and Methods  
5.4.1 Animals and Ethics Statement 
 The fertilized eggs of wild-type zebrafish (Danio rerio, AB strain) were obtained from 
the Zebrafish Facility at the University of Maine by natural crosses. Embryos were maintained in 
egg water (60µg/mL Instant Ocean sea salts [Aquarium Systems, Mentor, OH, USA]) at 28 ºC 
with a 14/10 hr light/dark cycle. All experiments were performed with 24 hpf zebrafish, which 
remain in the chorion at this stage. Animal studies were approved by the Institutional Animal 
Care and Use Committee (IACUC) at the University of Maine and performed in accordance with 
the defined guidelines for use of zebrafish embryos. 
 
5.4.2 TCS preparation 
 Triclosan (TCS) was purchased from Sigma-Aldrich (St. Louis, MO, USA) (“irgasan,” 
≥97% by HPLC; CAS no. 3380-34-5).  A starting TCS stock (22.5 or 45 µM) was freshly 
prepared for each experimental day by dissolving TCS in egg water, without use of organic 
solvents, following our published protocol (Weatherly et al., 2013). TCS concentration was 
determined by UV-Vis spectrophotometry (Weatherly et al., 2013). 
 
5.4.3 Mitochondrial oxygen consumption assay 
A modified XFe 96 Extracellular Flux Analyzer (Seahorse Bioscience, North Billerica, 
MA, USA; details of the commercially-available instrument are found at 
http://www.seahorsebio.com/products/how-xf-works.php) was used to measure oxygen 
consumption rate (OCR).  Three modifications of published methods were used for this study: 1.) 
instrument re-configuration to allow for bi-directional temperature control; 2.) use of chorionated 
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zebrafish embryos to obviate the need for islet capture screens; and 3.) the use of one embryo per 
well rather than the two or more embryos required per well in previous studies. A novel 
modification of this instrument was made to allow for bi-directional temperature control, in order 
to allow temperature stabilization at the moderate levels (28-29ºC) favored by zebrafish. Prior to 
each run, calibration was performed using XF Calibrant solution (200 µL per well) (Seahorse 
Bioscience) in a XFe 96 Extracellular Flux assay kit (Seahorse Bioscience) using an automated 
process by the analyzer.  
Live zebrafish embryos (24 hpf) were arrayed in XFe 96 Spheroid microplate (Seahorse 
Bioscience) with 50 µL of egg water (1 embryo/well). These chorionated embryos were briefly 
checked to confirm that they had settled into the center of the wells.  We found that the chorion 
provides enough mass to weigh down the embryos to keep them settled at the bottom centers of 
the wells, where they remained for the duration of the assays, thus obviating the need for time-
consuming placement of islet capture screens. In contrast to the previously published zebrafish 
work utilizing the XF-24 Seahorse equipment (Bestman et al., 2015; Gibert et al., 2013; Stackley 
et al., 2011), only one embryo per well (rather than multiple fish) were required to attain a robust 
signal-to-noise ratio.  The XF-24 system’s micro-chambers utilize a measurement volume of 7 
μL, whereas the XFe 96’s flux measurements occur in a volume of <2 μL.  This ~4X reduction in 
volume translates to improved sensitivity which allows for the use of a single embryo per well.  
OCR values resulting from one 24 hpf zebrafish embryo/well were 100-150 pmol/min, and OCR 
values resulting from background control wells which contained egg water but no fish were close 
to 0 pmol/min, ± 9-11 pmol/min (standard deviation). Thus, the signal from one chemically-
untreated 24 hpf embryo is 10-15 times the noise, a robust signal-to-noise level.  
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 Next, 100 µL of either 22.5 µM or 45 µM of TCS were added to the appropriate wells, 
for final concentrations of 15 and 30 µM TCS, respectively. FCCP (provided in the XF Mito 
Stress Test Kit, Seahorse Bioscience), at a final concentration of 0.5µM, was also added (100 
µL) as a positive control to the appropriate wells. Measurements of total zebrafish OCR were 
started immediately and performed according to the manufacturer’s instructions. Thirteen basal 
readings were performed, each with 2 minutes of mixing and 3 minutes of measuring.  When the 
readings were completed, the mortality of each embryo was determined by heartbeat 
measurement manually by eye under the light microscope for 30 seconds per embryo (Oliveira et 
al., 2009;  Nesan and Vijayan, 2012;  Pylatiuk et al., 2014). 
 
5.4.4 XF Cell Mito Stress Test Kit OCR assay 
The XF Cell Mito Stress Test kit (Seahorse Bioscience) contains three inhibitors, 
oligomycin, FCCP, and rotenone/antimycin-A, which target the functions of ATP synthase, 
mitochondrial uncoupling, and complex I/III, respectively. Oligomycin is used to distinguish the 
percentage of oxygen consumption devoted to ATP synthesis and the percentage of oxygen 
consumption required to overcome the natural proton leak across the inner mitochondrial 
membrane. The OCR stimulated by FCCP treatment can be used to calculate the spare 
respiratory capacity of cells, which is highly effective for determining mitochondrial fidelity and 
function.  Rotenone/antimycin-A shuts down mitochondrial respiration and enables the 
delineation of mitochondrial versus non-mitochondrial OCR fractions contributing to respiration. 
All drugs were prepared following the manufacturer’s recommendations and were 
dissolved in egg water. The inhibitors were then loaded into XFe 96 extracellular flux assay plate 
(Seahorse Bioscience). Titrations were performed to determine the optimal concentration of each 
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inhibitor (data not shown). Before successive injections of these three drugs, basal OCR  (± 
TCS) was measured for ~1 hour (12 cycles, each consisting of 1.5 min mixing and 3 min 
measurement). Then, sequential injections of 12.5 µM oligomycin, 2 µM FCCP, and 0.5 µM 
rotenone/antimycin-A were performed, and OCR measurements were recorded for 3 minutes 
(following 2 minutes of mixing) for 14, 3, and 14 times, respectively. Proton leak (which is 
defined as [lowest OCR measurement following oligomycin addition] - [OCR following 
rotenone/antimycin-A treatment]), ATP-linked respiration (which is defined as [final basal OCR 
measurement before oligomycin addition] - [lowest OCR measurement following oligomycin 
addition]), and spare respiratory capacity (which is defined as [maximal respiration following 
FCCP injection] - [final basal OCR measurement before oligomycin addition)] were calculated 
by the XF Cell Mito Stress Test Report Generator (Seahorse Bioscience). The applied 
concentrations of oligomycin and FCCP were previously found not to cause zebrafish embryo 
death (Stackley et al., 2011).   
 
5.4.5 Statistical Analysis 
 OCR was calculated by the Seahorse Wave software (Seahorse Bioscience).  For figure 
5.1A, data from 16-22 embryo replicates per treatment group per experimental day were 
averaged at each time point.  These averages were then normalized to the last time point of the 
30 µM TCS sample average. These results were then further normalized by comparing them to 
the 0 µM TCS control from the corresponding experimental day and by multiplying by 100% to 
get the percent of control.  Next, these normalized data from 3 independent biological replicate 
experiments performed on different days were averaged together and were plotted as mean ± 
standard error of the mean (SEM).  
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 The data representing proton leak, ATP-linked respiration, and spare respiratory capacity 
from 4 independent biological replicate experiments performed on different days (each 
experiment consisted of 14-16 embryo replicates per treatment group per experimental day) were 
analyzed by the XF Cell Mito Stress Test Report Generator (Seahorse Bioscience). Next, each 
set of experimental data was normalized to either the 0 µM control or 30 µM TCS sample. These 
normalized data (4 experiments) were averaged together to generate the Figure 5.2 bar charts. 
The significance was assessed via one-way analysis of variance (ANOVA) with Tukey’s or 
Dunnett’s post-hoc test, using Prism software (Graphpad, San Diego, CA, USA).   
 
5.5 Results 
5.5.1 Triclosan increases oxygen consumption rate in living zebrafish. 
 One embryo at 24hpf was placed in each well with egg water. Various concentrations of 
TCS or FCCP were added right before the assay plate was placed in the analyzer for immediate 
OCR measurements for ~1 hour. The first OCR measurement of each experiment was recorded 
~5 minutes after TCS or FCCP exposures began. Both 15 µM and 30 µM TCS cause 
significantly higher basal OCR compared to control (Fig. 5.1A). FCCP (0.5 µM) also displays 
higher OCR compared to the control group (Fig. 5.1A).  Also, ANOVA with Tukey’s post-test 
analysis indicates that the 15 μM TCS sample is different from the 0.5 μM FCCP sample (p < 
0.001) and that the 30 μM TCS sample is different from the 0.5 μM FCCP sample (p < 0.05). 
For each experiment, 4-6 wells were assigned as background wells, that contained egg 
water ± TCS, but no embryos. Background OCR levels were not significantly altered by 30 µM 
TCS compared to control (data not shown), indicating that the effect on OCR is due to a 
biological response to TCS. When the assay was completed, the heartbeat of each embryo was 
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measured for 30 seconds under a light microscope. No mortality was observed in any of the 
groups (Fig. 5.1B). Also, TCS exposure did not affect heartbeat rate; however, 0.5 µM FCCP 
seemed to slow heartbeat rate compared to control, although this effect was not statistically 
significant (Fig 5.1B). 
 
 
 
Figure 5.1. Measurement of basal OCR of living zebrafish embryos exposed to TCS. A) 
Basal OCR was measured for ~1 hour (13 readings), immediately after 24 hpf embryos were 
exposed to 0, 15, 30 µM TCS or 0.5 µM FCCP in egg water.  At each timepoint, measurements 
were normalized to the first reading from the 0 µM control for that experimental day. Values 
represent means ± SEM for three independent experiments, where 16-22 embryos per treatment 
group were tested for each experiment. One-way ANOVA with Dunnett’s post-tests (compared 
to the 0 µM control) were performed using Graphpad Prism software; *p< 0.05, **p< 0.01. B) 
Immediately after each basal OCR assay was completed, measurements of heartbeat of 
individual embryos were taken for 30 seconds, and the survival rate was determined. No 
significance was determined by one-way ANOVA with Dunnett’s post-tests (compared to the 0 
µM control). 
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5.5.2 Triclosan causes uncoupled mitochondrial respiration in living zebrafish 
 To further assess whether non-lethal doses of TCS disrupt mitochondrial function, the XF 
Cell Mito Stress Test Kit, which contains oligomycin, FCCP, and rotenone/antimycin-A, was 
utilized. Immediately following TCS or 0 μM control exposure, 12 measurements of basal OCR 
were taken before sequential injection of oligomycin (12.5 µM), FCCP (2 µM) and 
rotenone/antimycin-A (0.5 µM).  
 
 
Figure 5.2. TCS as a mitochondrial uncoupler in living zebrafish. Zebrafish embryos (24 hpf) 
were exposed to TCS for ~1 hr (12 measurements of basal OCR), then the Mito Stress Test kit 
(Seahorse Bioscience) was performed. A) Proton leak, B) ATP-linked respiration, and C) Spare 
respiratory capacity were calculated using the Mito Stress Test Report Generator V2 (Seahorse 
Bioscience).  Data from individual experimental days were normalized either to 30 µM TCS (A) 
or to 0 µM TCS (B and C) and values represent means ± SEM for four independent experiments, 
where 14-16 embryos per treatment group were tested in each experiment. One-way ANOVA 
with Dunnett’s post-tests (compared to the 0 µM TCS) were performed using Graphpad Prism 
software; *p< 0.05, **p< 0.01 
 
A 
C 
B 
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The proton leak, ATP-linked respiration and spare respiratory capacity were calculated as 
described before using the XF Cell Mito Stress Test Report Generator (Seahorse Bioscience). 
Both 15 and 30 µM TCS cause significant increases in proton leak, compared to 0 µM TCS 
control (Fig. 5.2A). High proton leak values indicate high levels of mitochondrial uncoupling 
and inefficient ATP production (Brand and Nicholls, 2011). ATP-linked respiration (that is, the 
respiration that is correlated with mitochondrial production of ATP) is inhibited by TCS (Fig. 
5.2B). Spare respiratory capacity also decreases significantly at 30 µM TCS (Fig. 5.2C), 
indicating mitochondrial dysfunction during conditions of increased energy demand (Brand and 
Nicholls, 2011). 
 
5.6 Discussion 
Assessment of chemicals that can cause adverse human health and environmental effects 
needs to be conducted robustly and in a cost-effective manner. Zebrafish offer an effective, high-
throughput low-cost alternative to mammalian testing.  Zebrafish embryos have become a useful 
model in the field of toxicology (Nagel, 2002;  Langheinrich, 2003;  Braunbeck et al., 2005;  
Parng, 2005;  McGrath and Li, 2008).  This method we have developed could be a potential 
high-throughput in vivo assay to screen a variety of toxicants or drugs in order to identify novel 
mitochondrial uncoupler or other effectors of bioenergetic function.  
Using zebrafish embryos, here we show that TCS is a mitochondrial uncoupler in vivo.  
We show that basal OCR increases with an increase in TCS and does not decrease survival or 
heartbeat rate at these concentrations.  We also show TCS inhibition of ATP-linked respiration 
and spare respiratory capacity and TCS stimulation of proton leak. Triclosan’s inhibition of 
ATP-linked respiration indicates that TCS inhibits mitochondrial ATP production. The increase 
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in proton leak indicates mitochondrial uncoupling (Brand and Nicholls, 2011) caused by TCS.  
Spare respiratory capacity is a measure of the organism’s ability to respond to an increase in 
energy requirement (Yadava and Nicholls, 2007), and its inhibition by TCS indicates 
mitochondrial dysfunction (Brand and Nicholls, 2011). Decrease in ATP production and increase 
in OCR, both of which are shown here to be caused by TCS in 24 hpf zebrafish, are two of the 
main hallmarks of a mitochondrial uncoupler (Poe et al., 1967;  Hanstein, 1976;  Brand and 
Nicholls, 2011). 
Zebrafish embryos (24-72 hpf) were previously used to assess the bioenergetics of a 
known mitochondrial uncoupler, 2,4-dinitrophenol (DNP), as an in vivo model (Bestman et al., 
2015). This earlier study utilized the XF-24 Extracellular Flux Analyzer (Seahorse Bioscience). 
An islet capture screen was utilized to keep the zebrafish in place. As in a previous study, two 
embryos per well were necessary at the 7-30 hpf stages, and 3 embryos per well were required at 
the 3 hpf stages, in order to achieve sufficient OCR levels. With 3 hr exposure to 0.5 µM DNP, 
beginning at 3hpf, basal OCR levels were significantly increased in zebrafish embryos (Bestman 
et al., 2015). In comparison, we found that basal respiration of 24 hpf embryos is also increased 
due to TCS exposure for 1 hour at 15 and 30 µM (Fig. 5.1A). Proton leak in 24 hpf zebrafish 
embryos that had been treated with 0.5 µM DNP for total of 21 hours was increased (Bestman et 
al., 2015). Similar to this, at 24 hpf, 15 and 30 µM TCS exposure for 1 hour cause significant 
increases in proton leak (Fig. 5.2A).  At 24-72 hpf, zebrafish embryos’ ATP-linked respiration 
was decreased after exposure to 0.5 µM DNP for 21-69 hrs (Bestman et al, 2015).  Similarly, 1 
hour of TCS exposure inhibits ATP-linked respiration (Fig. 5.2B). Our finding that TCS causes 
similar effects on the key bioenergetic parameters basal OCR, ATP-linked respiration, and 
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proton leak, compared to the known mitochondrial uncoupler DNP, further support the idea that 
TCS is a mitochondrial uncoupler in vivo. 
The robust effects of TCS (by immersion) on zebrafish bioenergetics that we report (Fig. 
5.1A and Fig. 5.2) strongly suggest that TCS passes through the chorion.  However, no complete 
assessment of the differential permeability of the chorion, which remains intact in 24 hpf 
embryos, has been performed, but the chorion has been shown to act as a barrier to various 
compounds (Braunbeck et al., 2005;  Carlsson et al., 2013).  The chorion discriminates against 
certain compounds depending on chemical structure (Harvey et al., 1983;  Braunbeck et al., 
2005;  Sachidanandan et al., 2008;  Kais et al., 2013).  However, the exact nature of which 
compounds pass more easily through the chorion is contradictory.  When TCS is in egg water 
(pH 7.0), ~90% of TCS molecules are protonated and, thus, lipophilic.  The lipophilicity of the 
compound does seem to be a factor in the permeability across the chorion, but whether or not 
more lipophilic compounds increase or decrease the permeability remains up for debate 
(Braunbeck et al., 2005; Sachidanandan et al., 2008), and lipophilicity is likely only one of many 
structural factors determining chorion permeability of a particular chemical. A study found that 
exposure to 1.1 µM fipronil (a broad-use insecticide), starting at 1 hpf and ending at 48 hpf, 
caused notochord degeneration in zebrafish (Stehr et al., 2006). The exposure and subsequent 
notochord degeneration occurred while the embryos were still in the chorion, indicating that the 
fipronil most likely crossed the chorion barrier. Fipronil and TCS have similar two-ring 
organohalogen structures.   
Thus, along with the fact that TCS caused extensive bioenergetic effects on the zebrafish, 
it is highly likely that at least some fraction of the applied TCS crossed the chorion during the 
treatment period.  Size of the compound of interest also seems to be a factor in chorion 
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permeability. A study found that 3,000 Da fluorescent dextrans were able to pass through the 
chorion while 10,000 Da dextrans could not permeate the chorion (Creton, 2004).  Because 
triclosan’s molecular weight is ~289 Da, its size is likely not too large to penetrate the chorion.  
However, given the published data relating to the ability of the chorion to present a barrier to 
various xenobiotics (Braunbeck et al., 2005), it is probable that TCS’s potency is greater in 
dechorionated embryos.  
 The present investigation demonstrates that the ubiquitous antimicrobial TCS causes 
mitochondrial uncoupling, with no mortality, in a living organism at concentrations ~1000-fold 
lower than those used in personal care products.  TCS at 30 μM is nearly as potent as 0.5 μM 
FCCP in 24 hpf zebrafish (Fig. 5.1A), and TCS’s uncoupling effect is a biochemical mechanism 
that likely underlies many organismal health effects.  Because triclosan’s toxicity is currently 
being reviewed by U.S. and other government agencies, these live animal, mechanistic data are 
critical.  This study was performed using a novel method, utilizing live, single, chorionated 
zebrafish embryos in a 96-well high-throughput format with bidirectional temperature control.   
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CHAPTER 6 
SUMMARY AND CONCLUSIONS 
Arsenic is an environmental toxicant which causes many human health problems. Arsenic 
exposure has been reported globally since its major route of exposure is via drinking water or 
diet. In some countries, large populations are exposed to high dosages of arsenic. Triclosan is an 
antimicrobial agent, which was found in nearly all the soap products in the late 2000s. Although 
the FDA recently banned its usage in most soap products (consumer and hospital settings), 
triclosan remains as an active ingredient in many consumer products, including a top-selling 
toothpaste, and in household products such as toys and kitchenware.   
 Mast cells are important immune cells that are involved in numerous physiological 
functions and diseases, including allergic reaction, inflammatory responses, host defense, 
neurological processes and more. Mast cells reside in nearly every tissue, particularly in where 
they interface with environment. Therefore, mast cells are easily targeted by toxicants.   
Our lab has found that arsenic and triclosan inhibit mast cell degranulation, which is the 
release of granules containing many active biomediators to the extracellular space. Based on 
these findings, we have investigated the mechanisms underlying inhibitory action by arsenic and 
triclosan.  In Chapter 2, we showed that one of arsenic’s targets is phosphorylation of tyrosine 
kinase Syk, which is found in early mast cell signaling pathway. Additionally, we found that 
phosphorylation/activation of PI3K, one of the direct substrates of Syk, is also inhibited by 
arsenic.  Inhibition of Syk and PI3K activation leads to decreased calcium mobilization, which is 
a critical step leading to MC degranulation. 
 Studies in Chapter 3 elucidated triclosan’s effects two key molecules: phospholipase D 
(PLD) and protein kinase C (PKC). Even though we also revealed that triclosan dampens 
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cytosolic calcium levels as seen in arsenic studies, triclosan does not inhibit tyrosine 
phosphorylation-initiated events such as calcium efflux from the ER. PKC and PLD are central 
players in degranulation after cytosolic calcium rise. We have shown that triclosan decreases 
PLD activity while PKC activity is not inhibited. However, triclosan delays the translocation of 
PKC βII and PKC δ isoforms to the plasma membrane, and subsequently slows down 
dissociation of MARCKS, a substrate of PKC, from the plasma membrane to cytosol.  The 
functions of PKC and PLD are shared in many other cell types and signaling pathways. 
Therefore, our findings on triclosan’s effects on PKC and PLD provide mechanisms of the 
numerous human health problems reported in recent epidemiological studies. 
In addition to revealing triclosan’s targets in the mast cell signaling pathway, we have 
also investigated triclosan toxicity as a mitochondrial uncoupler (MU). Structural similarities 
between triclosan and other known MUs led us to explore this hypothesis. In previous work, we 
first identified that triclosan is indeed an MU in vitro, using several cell types, including mast 
cells, fibroblasts, and primary human skin cells. To compare this in vitro finding, we developed 
an in vivo assay to measure mitochondrial function using zebrafish embryos. Due to 
advantageous of utilizing zebrafish as a model organism, this assay is a high-throughput, 96 
well-microplate based assay which can quickly evaluate a toxicant’s effect in living organism.  
Using this assay, we have shown that mitochondrial toxicity is another mechanism of triclosan, 
in vivo (Chapter 5). 
 Finally, Chapter 4 reported our findings on tryptase detection in RBL-2H3 cells. The 
RBL-2H3 cell line has been extensively utilized as an in vitro mast cell model, but β-
hexosaminidase or histamine have usually been employed as RBL-2H3 degranulation markers 
even though tryptase is considered a canonical marker of mast cells. Since mast cell activity in 
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zebrafish has been measured solely via tryptase release to date, we aimed to develop an RBL-
2H3 tryptase assay in order to align RBL-2H3 cell toxicological studies to in vivo zebrafish mast 
cell studies. Unexpectedly, we have found that neither mRNA nor protein of rat tryptase genes 
are expressed in the RBL-2H3 cell line. Our comprehensive investigation to detect tryptase in 
RBL cells delivers an important message to the mast cell community and necessitates 
development of a separate marker for comparative studies between these two model systems. 
Overall, the findings in this dissertation provide molecular and biochemical mechanisms 
for many human health problems due to arsenic and triclosan and establish groundwork for 
developing comparative toxicological studies using zebrafish to study mast cell toxicology and 
biology. 
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APPENDIX A 
SUPPLEMENTARY INFORMATION TO CHAPTER 2 
 
Figure A.1. As inhibits degranulation of RBL-2H3 cells following 15-min exposure to DNP-
BSA antigen. Effect of As on (A) 15-min Ag-mediated degranulation (an average absolute 
degranulation response of 9.4% ± 0.8% [SEM] in the absence of As) or (B) 15-min spontaneous 
release (an average absolute degranulation response of 1.4% ± 0.1% [SEM] in the absence of As). 
Values represent means ± SEM for 5-11 experiments in (A) or n = 3 in (B), where three replicates 
were performed for each condition. Significance was determined by one-way ANOVA followed 
by Tukey’s post test; ** indicates p<0.01, as compared to the 1 ppb column. 
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Figure A.2. ATP levels and cytotoxicity in RBL-2H3 cells exposed to As. (A-B) Exposure to 
various concentrations of As in galactose media and (C-D) in glucose media. Percent untreated 
control is 100% multiplied by the quotient of the fluorescence or luminescence value of each 
sample by the average value of the untreated control. Values are means ± SEM of three 
independent experiments (each with three replicates per dose). One-way ANOVA followed by 
Tukey’s post-hoc test revealed no statistical significance. 
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Figure A.3.  F-actin ruffling during antigen-stimulated degranulation of RBL-2H3 cells. F-
actin was visualized using Alexa Fluor 488 conjugated phalloidin. RBL-2H3 cells were exposed 
to 0.0004 μg mL-1 Ag (left) or to 0.0004 μg mL-1 Ag plus 750 ppb As (right) for one hour before 
being fixed.  A representative set of images is shown. 
 
 
Figure A.4. Combined exposure of experimental As and A23187 ionophore doses causes no 
cytotoxicity in RBL-2H3 cells as determined by lactate dehydrogenase (LDH) cytotoxicity 
assay. To measure the impact of A23187 ionophore and As on viability of RBL-2H3 cells, an 
LDH assay kit was utilized as described in Methods. Arsenic was diluted into A23187 solutions 
of (A) 1.5 x 10-7 M or (B) 2 x 10-7 M to create 100-750 ppb As samples. “True zero” contains 
neither As nor ionophore but does contain the vehicle conditions of the experimental parameters.  
No statistically significant effects were found, by one-way ANOVA and Tukey’s post test. Values 
represent means ± SEM of three experiments of three replicates per experiment. 
 
 
A      B 
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Figure A.5. LDH enzymatic activity is not affected by As and A23187 ionophore 
concentrations used in the degranulation assays. In order to test whether or not the LDH enzyme 
activity is altered by various chemical combinations used in the LDH experiment, LDH standard 
testing was performed in the presence of 2 x 10-7 M A23187, As, and vehicle conditions (0.004% 
DMSO). In a clear 96-well plate, a 50 μL sample of 0.000625 U/mL purified LDH enzyme 
standard (Cayman chemical company; Ann Arbor, MI, USA) was incubated with an equal volume 
of A23187/2x As, no A23187 or DMSO, A23187 only, or 0.002% DMSO (2x concentration of 
0.004% DMSO vehicle) for one hour (37 °C/5% CO2). The final A23187 concentration was 1.0 x 
10-7 M; the final As concentrations represented a range from 100 to 750 ppb. The remainder of the 
experiment followed manufacturer’s recommended protocol (Cytotoxicity detection kit LDHPLUS; 
Roche Diagnostics). Absorbance values for experimental data sets were normalized against the 0 
ppb As/LDH standard control, and plotted against treatment conditions. Statistical testing was 
performed in Prism using a one-way ANOVA and Tukey’s post test. Values represent means ± 
SEM of two data sets (3 replicates per experiment) for each treatment condition. 
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Figure A.6. DMSO vehicle concentration used for A23187 dilutions has no effect on 
antigen-stimulated degranulation of RBL-2H3 cells. Antigen-stimulated degranulation 
experiments were carried out to examine the effect of 0.004% DMSO vehicle used for A23187 
dilutions. (A-B) IgE-sensitized mast cells were stimulated using a 0.00016 μg mL-1 dilution of 
DNP-BSA (no A23187 was utilized); in (A), all samples contained 0.004% DMSO. The plate 
was read in a fluorescence microplate reader (Synergy 2, Biotek), using 360/40 nm excitation 
and 460/40 nm emission filters. Data processing was performed as described by Palmer et 
al.(Palmer et al., 2012). Following one-way ANOVA, a Tukey’s post test was used to assess 
significance (comparisons made to 0 ppb As). In (A-B) error bars represent means ± SD from 
three replicate data sets, and significance is indicated; ***p<0.001,**p<0.01, *p<0.05. In (C) a 
direct comparison of the data found separately in (A) and (B) is made. For these combined data, 
a two-way ANOVA with Bonferroni post test was performed to compare the Ag-stimulated 
degranulation in the presence and absence of 0.004% DMSO. No significant difference was 
found between either set of experiments.  
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Figure. B.1. TCS does not affect PKC activity in Ag-stimulated RBL-2H3 mast cells within 
15 (A) or 30 min (B).  Cells were stimulated with 0.005 g/ml Ag ± 10 µM TCS in BT.  After 
exposure, PKC activity was measured via ELISA, and absorbance was read at 450 nm using a 
microplate reader. Raw data were processed as described in the main text Methods section to 
normalize to both total protein concentration and to unstimulated controls, in order to calculate 
percentage increase of PKC activity over unstimulated control. Data presented are means ± SEM 
of at least three independent experiments; duplicates per treatment per experiment. No statistical 
significance was determined by one tailed t-test (GraphPad prism).  
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Figure. B.2. TCS does not interfere with components (choline oxidase [A] and horseradish 
peroxidase [B]) in the Amplex® Red phospholipase D assay kit. The Amplex® kit (Thermo 
Scientific), containing phosphatidylcholine, choline oxidase, horseradish peroxidase (HRP), and 
Amplex® Red reagent, works in the following process: PLD cleaves the substrate 
phosphatidylcholine into choline and phosphatidic acid. Choline is then oxidized by choline 
oxidase into betaine and hydrogen peroxide. HRP uses Amplex® red as an electron donor in the 
reduction of hydrogen peroxide to water, in a 1:1 stoichiometry to convert Amplex® red into 
resorufin whose fluorescence is measured at 530/25 excitation and 590/30 emission. To test the 
effects of TCS on the components of the kit, we initiated this process at different points and 
measured the fluorescence when exposed to varying TCS concentrations, from 0-20 M. (A) We 
first examined the effect of TCS on choline oxidase activity. Choline chloride was purchased 
(MP Biomedicals) to initiate the cascade at the choline oxidase step. Choline chloride was 
prepared in 0.2% Triton-X (TX) and co-exposed with various concentrations of TCS (dissolved 
in BT) for 15 min.  Next, 100 L of the choline chloride ± TCS was added to 100 L of master 
mix of the Amplex® Red kit for 30 min, followed by fluorescence measurement as described in 
the main text Methods section. Final choline chloride concentration was 1.5 M, a level chosen 
to result in RFU readings similar to those obtained in the cellular PLD experiments.  Overall, this 
control experiment’s components were designed to utilize the same buffer conditions and 
concentrations as those found in cellular PLD experiments such as in main text Fig. 3.5A.  (B) A 
similar experiment was used to determine whether TCS could inhibit HRP activity. This time the 
cascade was initiated by using hydrogen peroxide that was provided in the Amplex® kit. 
Fluorescence of resorufin was measured as in Methods. Values were normalized to 0 M TCS of 
each experiment and represented as means ± SEM of three independent experiments; three 
replicates per treatment per experiment. No statistical significance was determined by one-way 
ANOVA followed by Tukey’s post-hoc test (GraphPad Prism). Data show that TCS does not 
interfere with this PLD activity assay. 
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Figure. B.3. TCS has no effect on purified PLD from Streptomyces chromofuscus. Purified 
Streptomyces chromofuscus PLD (Sigma P0065) was diluted from glycerol stock in Tyrodes buffer 
and further diluted with 0.2% Triton X incubated with TCS ranging from 0- 20µM concentrations 
to be 0.125U/mL. After a 15 min exposure, PLD activity was measured using the Amplex® Red 
PLD assay kit (Thermo Scientific), which was prepared following the manufacturer’s instructions.  
Overall, this experiment’s components were designed to utilize the same buffer conditions and 
concentrations as those found in cellular PLD experiments such as in main text Fig. 3.5A. Values 
were normalized to 0 M TCS of each experiment and represented as means ± SEM of three 
independent experiments; three replicates per treatment per experiment. No statistical significance 
was determined by one-way ANOVA followed by Tukey’s post-hoc test (GraphPad Prism). 
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sucralose (CAS # 56038-13-2) triclosan (CAS # 3380-34-5) 
 
      (images from Sigma) 
 
 
Figure. B.4. Sucralose shares structural similarities with triclosan but does not affect 
degranulation of Ag-stimulated RBL-2H3 cells. Similarities between triclosan and sucralose 
(both pictured above) include presence of two carbon rings combined in ether linkage, three 
chlorines decorating the two rings, and presence of hydroxyl groups on the rings.  Sucralose 
(>98.0%) (TCI America) was dissolved for 20 min with stirring into Tyrodes buffer to prepare a 1 
mM sucralose solution. Cells were sensitized with with 0.1µg/mL IgE for 1 hr, and stimulated 
with ± 0.0002 µg/mL Ag ± sucralose (0.1 to 500 M) in BT buffer for 1 hr. Degranulation was 
assessed as a measurement of β-hexosaminisase release, described in (Weatherly et al., 2013), and 
the 0.0002 µg/mL Ag dose elicited a moderate absolute degranulation percentage response of ~18% 
in the absence of sucralose. Concentrations of sucralose tested were biologically relevant:  these 
levels were detected in human blood plasma and urine samples following consumption of 
beverages containing sucralose at concentrations similar to those found in commercial products 
(de Ruyter et al., 2012;  Sylvetsky et al., 2017a;  Sylvetsky et al., 2017b;  Rother et al., 2018). As 
an amphipathic molecule, sucralose is able to traverse cellular plasma membranes through simple 
diffusion, down its concentration gradient. Sucralose has been observed to passively diffuse from 
the gastro-intestinal tract into the blood (Grice and Goldsmith, 2000), though it can be metabolized 
by cytochrome p-450 and can be subject to efflux via p-glycoprotein (Abou-Donia et al., 2008). 
Values are normalized to the Ag control (no sucralose) and represented as means ± SEM from 
three independent experiments, with three replicates pre- treatment group per experiment. No 
statistical significance was determined by one-way ANOVA followed by Tukey's post test 
(GraphPad Prism).   Thus, we conclude that the presence of two carbon rings in ether linkage and 
three chlorines positioned on the rings are insufficient for mast cell effects caused by triclosan, 
lending further evidence that the proton ionophoric properties of triclosan caused its effects. 
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APPENDIX C 
 
SUPPLEMENTARY INFORMATION TO CHAPTER 4 
 
 
Figure C.1. Various buffer components do not interfere with BAPNA-tryptase substrate-
enzyme reaction. Various buffer components, as indicated, were incubated with 25 ng tryptase 
for 72 h, after which absorbance at 410 nm was detected. Values represent triplicates replicates 
from one experiment (with the exception of 0.004% DMSO sample, which contains duplicates). 
No significant difference was determined by one-way ANOVA followed by Tukey’s post test, 
with comparisons made to the mT buffer. 
 
 
 
Figure C.2. TPSAB1 tryptase standard samples measured by ELISA. Rat TPSAB1 standard 
protein, provided in the tryptase ELISA kit (Biomatik), was measured. Values represent means ± 
SD of duplicate samples. 
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Table C.1. Various RBL-2H3 cell stimulation conditions before RNA extraction for PCR 
Stimulation 
Conditions 
Time of 
collection** 
Tps
b2 
Tpsab
1 
Tpsg1 Gz
mk 
Prss
29 
Prss
41 
Gz
ma 
Prss
34 
Hex
a 
Hex
b 
Actb 
No IgE, No Ag 24h - - - - - - - - + + + 
Overnight IgE, 
No Ag  
24h - - - - - - - - + + + 
Overnight IgE+ 
1h high*Ag  
4h - - - - - - - - + + + 
1 hr IgE+ 1h low* 
Ag 
24h - - - - - - - - + + + 
1 hr IgE+ 1h high 
Ag 
1h - - - - - - - - + + + 
1 hr IgE+ 1h high 
Ag 
4h - - - - - - - - + + + 
1 hr IgE+ 1h high 
Ag 
16h - - - - - - - - + + + 
1 hr IgE+ 1h high 
Ag 
24h - - - - - - - - + + + 
1 hr IgE, No Ag immediately - - - - - - - - + + + 
1 hr IgE+ 5 min 
high Ag 
immediately - - - - - - - - + + + 
1 hr IgE+ 10 min 
high Ag 
immediately - - - - - - - - + + + 
1 hr IgE+ 15min 
high Ag 
immediately - - - - - - - - + + + 
1 hr IgE+ 20 min 
high Ag 
immediately - - - - - - - - + + + 
1 hr IgE+ 30 min 
high Ag  
immediately - - - - - - - - + + + 
1 hr IgE+ 1h high 
Ag  
immediately - - - - - - - - + + + 
*High Ag dose:  1 g/mL; Low Ag dose:  0.1 g/mL 
**Time of collection:  time between the end of Ag stimulation (stopped by washing) and cell 
harvest for Trizol® extraction. 
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APPENDIX D 
SUPPLEMENTARY INFORMATION TO CHAPTER 5 
 
        
Figure D.1. Effects of TCS on maximal respiration and non-mitochondrial respiration in 
living zebrafish. Zebrafish embryos (24 hpf) were exposed to TCS for ~1 hr (12 measurements of 
basal OCR), then the Mito Stress Test kit (Seahorse Bioscience) was performed. A) Maximal 
respiration and B) Non-mitochondrial respiration were calculated using the Mito Stress Test 
Report Generator V2 (Seahorse Bioscience).  Data from individual experimental days were 
normalized either to 0 µM TCS and values represent means ± SEM for four independent 
experiments, where 14-16 embryos per treatment group were tested in each experiment. One-way 
ANOVA with Dunnett’s post-tests (compared to the 0 µM TCS) were performed using Graphpad 
Prism software.  
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Table D.1. Optimizing 24hpf ZF microinjection to measure the effect of TCS using 
Seahorse analyzer* 
Injection conditions** Results 
Microinjection (of HSBB+ Phenol red 
dye[ “dye”] to visualize the droplet 
from the injector) to the yolk, which is 
~80-90% of the body mass at 24hpf 
ZF 
Needle is not readily going into the yolk. 
The droplets are stuck in the injection site, not 
being spread. 
Microinjection (dye) to the vein Impossible due to the lack of vein 
development at 24hpf 
Microinjection(dye) to any parts of 
the body, excluding the yolk 
Impossible due to the movement of fish (since 
they are not euthanized) 
Microinjection(dye) into the chorion, 
not into the animal 
More than 4nL/injection volume harms the 
chorion (either the chorion will be torn or 
ruptured when pulling off the needle). 
More than 40nL total (4nL/injection*10 
times) leads to damage to the chorion. 
Microinjection of FCCP into the 
chorion 
40nL (4nL/injection x 10 times) of 1.7uM 
FCCP (final FCCP in the chorion is ~0.8uM) 
increased OCR with ~45% mortality. 
20nL (4nL/injection x 5 times) of 2.4uM 
FCCP (final FCCP in the chorion is ~0.7uM) 
increased OCR without mortality. 
Microinjection of TCS into the 
chorion 
24nL (4nL/injection x 6 times) of 56.4uM 
TCS (final TCS concentration is ~19.6 uM 
TCS) causes ~17% mortality. 
40nL (4nL/injection x 10 times) of 56.4uM 
TCS (final TCS concentration is ~26.5 uM 
TCS) causes ~25% mortality. 
*Embryos are not euthanized during the injection. 
** These microinjection to the ZF were also attempted by other students (Hina Hashmi and 
Denise Jay) in the Kim lab who are proficient in microinjection. 
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